<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section - Griffiths, JD - 2021 | Cochrane Library</title> <meta content="Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section - Griffiths, JD - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007579.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section - Griffiths, JD - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007579.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007579.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section" name="citation_title"/> <meta content="James D Griffiths" name="citation_author"/> <meta content="Royal Women's Hospital" name="citation_author_institution"/> <meta content="jamesgriffiths@me.com" name="citation_author_email"/> <meta content="Gillian ML Gyte" name="citation_author"/> <meta content="University of Liverpool" name="citation_author_institution"/> <meta content="Phil A Popham" name="citation_author"/> <meta content="Royal Women's Hospital" name="citation_author_institution"/> <meta content="Kacey Williams" name="citation_author"/> <meta content="Monash Medical Centre, Monash Health" name="citation_author_institution"/> <meta content="Shantini Paranjothy" name="citation_author"/> <meta content="School of Medicine, Cardiff University" name="citation_author_institution"/> <meta content="Hannah K Broughton" name="citation_author"/> <meta content="School of Medicine, Cardiff University" name="citation_author_institution"/> <meta content="Heather C Brown" name="citation_author"/> <meta content="Royal Sussex County Hospital" name="citation_author_institution"/> <meta content="Jane Thomas" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD007579.pub3" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/05/18" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007579.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007579.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007579.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acupressure; Adrenal Cortex Hormones [therapeutic use]; Anesthesia, Conduction [*adverse effects]; Bias; *Cesarean Section; Dopamine Antagonists [therapeutic use]; Elective Surgical Procedures; Hypnotics and Sedatives [therapeutic use]; Intraoperative Complications [*prevention &amp; control]; Nausea [*prevention &amp; control]; Postoperative Nausea and Vomiting [prevention &amp; control]; Pregnancy Complications [*prevention &amp; control]; Randomized Controlled Trials as Topic; Serotonin Antagonists [therapeutic use]; Vomiting [*prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007579.pub3&amp;doi=10.1002/14651858.CD007579.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="l7AWCCEw";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007579\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007579\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","zh_HANT","ru","th","ko","ms","ja","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007579.pub3",title:"Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section",firstPublishedDate:"May 18, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=l7AWCCEw&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007579.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007579.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007579.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007579.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007579.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007579.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007579.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007579.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007579.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007579.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6291 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007579.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-sec-0167"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-sec-0016"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-sec-0017"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-sec-0056"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-sec-0160"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/appendices#CD007579-sec-0172"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/supinfo/CD007579StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/supinfo/CD007579StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information#CD007579-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>James D Griffiths</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information#CD007579-cr-0005">Gillian ML Gyte</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information#CD007579-cr-0006">Phil A Popham</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information#CD007579-cr-0007">Kacey Williams</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information#CD007579-cr-0008">Shantini Paranjothy</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information#CD007579-cr-0009">Hannah K Broughton</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information#CD007579-cr-0010">Heather C Brown</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information#CD007579-cr-0011">Jane Thomas</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information/en#CD007579-sec-0178">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 18 May 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007579.pub3">https://doi.org/10.1002/14651858.CD007579.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007579-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007579-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007579-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007579-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007579-abs-0016">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD007579-abs-0010">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD007579-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007579-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007579-abs-0001" lang="en"> <section id="CD007579-sec-0001"> <h3 class="title" id="CD007579-sec-0001">Background</h3> <p>Nausea and vomiting are distressing symptoms which are experienced commonly during caesarean section under regional anaesthesia and in the postoperative period.  </p> </section> <section id="CD007579-sec-0002"> <h3 class="title" id="CD007579-sec-0002">Objectives</h3> <p>To assess the efficacy of pharmacological and non‐pharmacological interventions versus placebo or no intervention given prophylactically to prevent nausea and vomiting in women undergoing regional anaesthesia for caesarean section. </p> </section> <section id="CD007579-sec-0003"> <h3 class="title" id="CD007579-sec-0003">Search methods</h3> <p>For this update, we searched Cochrane Pregnancy and Childbirth’s Trials Register, <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (16 April 2020), and reference lists of retrieved studies. </p> </section> <section id="CD007579-sec-0004"> <h3 class="title" id="CD007579-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) of studies and conference abstracts, and excluded quasi‐RCTs and cross‐over studies. </p> </section> <section id="CD007579-sec-0005"> <h3 class="title" id="CD007579-sec-0005">Data collection and analysis</h3> <p>Review authors independently assessed the studies for inclusion, assessed risk of bias and carried out data extraction. Our primary outcomes are intraoperative and postoperative nausea and vomiting. Data entry was checked. Two review authors independently assessed the certainty of the evidence using the GRADE approach. </p> </section> <section id="CD007579-sec-0006"> <h3 class="title" id="CD007579-sec-0006">Main results</h3> <p>Eighty‐four studies (involving 10,990 women) met our inclusion criteria. Sixty‐nine studies, involving 8928 women, contributed data. Most studies involved women undergoing elective caesarean section. Many studies were small with unclear risk of bias and sometimes few events. The overall certainty of the evidence assessed using GRADE was moderate to very low. </p> <p><b>5‐HT<sub>3</sub> antagonists:</b> We found intraoperative nausea may be reduced by 5‐HT<sub>3</sub> antagonists (average risk ratio (aRR) 0.55, 95% confidence interval (CI) 0.42 to 0.71, 12 studies, 1419 women, low‐certainty evidence). There may be a reduction in intraoperative vomiting but the evidence is very uncertain (aRR 0.46, 95% CI 0.29 to 0.73, 11 studies, 1414 women, very low‐certainty evidence). There is probably a reduction in postoperative nausea (aRR 0.40, 95% CI 0.30 to 0.54, 10 studies, 1340 women, moderate‐certainty evidence), and these drugs may show a reduction in postoperative vomiting (aRR 0.47, 95% CI 0.31 to 0.69, 10 studies, 1450 women, low‐certainty evidence). </p> <p><b>Dopamine antagonists:</b> We found dopamine antagonists may reduce intraoperative nausea but the evidence is very uncertain (aRR 0.38, 95% CI 0.27 to 0.52, 15 studies, 1180 women, very low‐certainty evidence). Dopamine antagonists may reduce intraoperative vomiting (aRR 0.41, 95% CI 0.28 to 0.60, 12 studies, 942 women, low‐certainty evidence) and postoperative nausea (aRR 0.61, 95% CI 0.48 to 0.79, 7 studies, 601 women, low‐certainty evidence). We are uncertain if dopamine antagonists reduce postoperative vomiting (aRR 0.63, 95% CI 0.44 to 0.92, 9 studies, 860 women, very low‐certainty evidence). </p> <p><b>Corticosteroids (steroids):</b> We are uncertain if intraoperative nausea is reduced by corticosteroids (aRR 0.56, 95% CI 0.37 to 0.83, 6 studies, 609 women, very low‐certainty evidence) similarly for intraoperative vomiting (aRR 0.52, 95% CI 0.31 to 0.87, 6 studies, 609 women, very low‐certainty evidence). Corticosteroids probably reduce postoperative nausea (aRR 0.59, 95% CI 0.49 to 0.73, 6 studies, 733 women, moderate‐certainty evidence), and may reduce postoperative vomiting (aRR 0.68, 95% CI 0.49 to 0.95, 7 studies, 793 women, low‐certainty evidence). </p> <p><b>Antihistamines:</b> Antihistamines may have little to no effect on intraoperative nausea (RR 0.99, 95% CI 0.47 to 2.11, 1 study, 149 women, very low‐certainty evidence) or intraoperative vomiting (no events in the one study of 149 women). Antihistamines may reduce postoperative nausea (aRR 0.44, 95% CI 0.30 to 0.64, 4 studies, 514 women, low‐certainty evidence), however, we are uncertain whether antihistamines reduce postoperative vomiting (average RR 0.48, 95% CI 0.29 to 0.81, 3 studies, 333 women, very low‐certainty evidence). </p> <p><b>Anticholinergics:</b> Anticholinergics may reduce intraoperative nausea (aRR 0.67, 95% CI 0.51 to 0.87, 4 studies, 453 women, low‐certainty evidence) but may have little to no effect on intraoperative vomiting (aRR 0.79, 95% CI 0.40 to 1.54, 4 studies; 453 women, very low‐certainty evidence). No studies looked at anticholinergics in postoperative nausea, but they may reduce postoperative vomiting (aRR 0.55, 95% CI 0.41 to 0.74, 1 study, 161 women, low‐certainty evidence). </p> <p><b>Sedatives:</b> We found that sedatives probably reduce intraoperative nausea (aRR 0.65, 95% CI 0.51 to 0.82, 8 studies, 593 women, moderate‐certainty evidence) and intraoperative vomiting (aRR 0.35, 95% CI 0.24 to 0.52, 8 studies, 593 women, moderate‐certainty evidence). However, we are uncertain whether sedatives reduce postoperative nausea (aRR 0.25, 95% CI 0.09 to 0.71, 2 studies, 145 women, very low‐certainty evidence) and they may reduce postoperative vomiting (aRR 0.09, 95% CI 0.03 to 0.28, 2 studies, 145 women, low‐certainty evidence). </p> <p><b>Opioid antagonists:</b> There were no studies assessing intraoperative nausea or vomiting. Opioid antagonists may result in little or no difference to the number of women having postoperative nausea (aRR 0.75, 95% CI 0.39 to 1.45, 1 study, 120 women, low‐certainty evidence) or postoperative vomiting (aRR 1.25, 95% CI 0.35 to 4.43, 1 study, 120 women, low‐certainty evidence). </p> <p><b>Acupressure:</b> It is uncertain whether acupressure/acupuncture reduces intraoperative nausea (aRR 0.55, 95% CI 0.41 to 0.74, 9 studies, 1221 women, very low‐certainty evidence). Acupressure may reduce intraoperative vomiting (aRR 0.52, 95% CI 0.33 to 0.80, 9 studies, 1221 women, low‐certainty evidence) but it is uncertain whether it reduces postoperative nausea (aRR 0.46, 95% CI 0.27 to 0.75, 7 studies, 1069 women, very low‐certainty evidence) or postoperative vomiting (aRR 0.52, 95% CI 0.34 to 0.79, 7 studies, 1069 women, very low‐certainty evidence). </p> <p><b>Ginger:</b> It is uncertain whether ginger makes any difference to the number of women having intraoperative nausea (aRR 0.66, 95% CI 0.36 to 1.21, 2 studies, 331 women, very low‐certainty evidence), intraoperative vomiting (aRR 0.62, 95% CI 0.38 to 1.00, 2 studies, 331 women, very low‐certainty evidence), postoperative nausea (aRR 0.63, 95% CI 0.22 to 1.77, 1 study, 92 women, very low‐certainty evidence) and postoperative vomiting (aRR 0.20, 95% CI 0.02 to 1.65, 1 study, 92 women, very low‐certainty evidence). </p> <p>Few studies assessed our secondary outcomes including adverse effects or women's views.</p> </section> <section id="CD007579-sec-0007"> <h3 class="title" id="CD007579-sec-0007">Authors' conclusions</h3> <p>This review indicates that 5‐HT<sub>3</sub> antagonists, dopamine antagonists, corticosteroids, sedatives and acupressure probably or possibly have efficacy in reducing nausea and vomiting in women undergoing regional anaesthesia for caesarean section. However the certainty of evidence varied widely and was generally low. Future research is needed to assess side effects of treatment, women's views and to compare the efficacy of combinations of different medications. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007579-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007579-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD007579-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD007579-abs-0019">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007579-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007579-abs-0017">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD007579-abs-0013">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD007579-abs-0011">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007579-abs-0012">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD007579-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD007579-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007579-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD007579-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007579-abs-0002" lang="en"> <h3>Reducing nausea and vomiting in women having a caesarean birth with regional anaesthesia</h3> <p><b>What is the issue?</b> </p> <p>The aim of this Cochrane Review was to find out from randomised controlled trials how effective drugs and other treatments are for reducing nausea and vomiting during and after caesarean section with epidural or spinal anaesthesia, when compared with an inactive control. We searched for all relevant studies to answer our review question (April 2020). </p> <p><b>Why is this important?</b> </p> <p>Women often prefer to be awake for the birth of their child, so when possible, a caesarean is performed under regional anaesthesia (spinal or epidural). Nausea and vomiting are commonly experienced during and immediately after caesarean section with regional anaesthesia. This is distressing for women. Vomiting during surgery can also challenge the operating surgeon and put the mother at risk of fluids from the stomach going into her windpipe. </p> <p>Several drugs are commonly used to reduce nausea and vomiting. There are also some non‐drug approaches such as acupressure/acupuncture and ginger. Possible side effects include headaches, dizziness, low blood pressure and itching. </p> <p><b>What evidence did we find?</b> </p> <p>We identified 69 randomised controlled studies (involving 8928 women) that provided data. Data were mostly on non‐emergency caesareans and most findings were supported only by low or very low‐certainty evidence. This was due to many of the studies being old, with small numbers of participants or unclear methodology. A few outcomes had moderate‐certainty evidence. </p> <p>5‐HT<sub>3</sub> antagonists (like ondansetron, granisetron): these probably reduce nausea after surgery, and they may also reduce nausea during surgery (low‐certainty evidence) and vomiting after surgery, but any effect on vomiting during surgery is unclear. </p> <p>Dopamine antagonists (like metoclopramide, droperidol): these may reduce vomiting during surgery and nausea after surgery, but it is unclear whether they reduce nausea during surgery and vomiting after surgery. </p> <p>Steroids (like dexamethasone): these probably reduce nausea after surgery and may reduce vomiting after surgery, but it is unclear whether steroids reduce nausea and vomiting during surgery. </p> <p>Antihistamines (like dimenhydrinate, cyclizine): these may reduce nausea after surgery, but they make little or no difference to nausea and vomiting during surgery and vomiting after surgery. </p> <p>Anticholinergics (like glycopyrrolate, scopolamine): these may reduce nausea during surgery and vomiting after surgery, but they may make little to no difference to vomiting during surgery. There were no studies on nausea after surgery, </p> <p>Sedatives (like propofol, midazolam, ketamine): these probably reduce nausea and vomiting during surgery and may reduce vomiting after surgery, but it is uncertain whether they reduce nausea after surgery. </p> <p>Opioid antagonists (like nalbuphine): only one small study provided data on nausea and vomiting after surgery, and found they may make little or no difference. </p> <p>Acupressure/acupuncture: this may reduce vomiting during surgery but it is uncertain if it reduces nausea during surgery or nausea and vomiting after surgery. </p> <p>Ginger: it is unclear if ginger reduces nausea and vomiting during surgery or nausea and vomiting after surgery. </p> <p>Few studies assessed women's views. What limited data there were on side effects did not find any differences. </p> <p><b>What does this mean?</b> </p> <p>Several classes of drugs may help to reduce the number of women who experience nausea and vomiting during and after regional anaesthesia for caesarean births, although more data are needed. Acupressure may also help but we did not find enough data on ginger. Very few studies looked at women’s views and overall, there were not enough data on possible side effects. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007579-sec-0167" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007579-sec-0167"></div> <h3 class="title" id="CD007579-sec-0168">Implications for practice</h3> <section id="CD007579-sec-0168"> <p>This study indicates that many agents, from a diverse range of pharmacological classes, may have efficacy in preventing intraoperative and postoperative emetic symptoms at caesarean section. This is perhaps consistent with the multi‐factorial pathogenesis of the condition. Of the included interventions, 5HT<sub>3</sub> antagonists, dopamine antagonists, corticosteroids, sedatives and acupressure all showed a reduction in all of our primary outcomes. However, the certainty of evidence was generally low/very low. </p> <p>Several other classes of drugs and interventions show effects on some of these outcomes only, for example, antihistamines and anticholinergics. This may reflect the amount of data available. </p> <p>The studies suggest that emetic symptoms are very common both during and following caesarean section. Placebo arms of trials included in this review suggest an intraoperative incidence of nausea in the order of 20% to 60%. This gives some weight to published guidelines recommending prophylaxis rather than treatment of emesis at caesarean section (<a href="./references#CD007579-bbs2-0376" title="National Collaborating Centre for Women's and Children's Health. Caesarean section: NICE clinical guideline. 2nd edition. London: RCOG Press, 2011.">NICE 2011</a>). </p> </section> <h3 class="title" id="CD007579-sec-0169">Implications for research</h3> <section id="CD007579-sec-0169"> <p>Whilst this review provides evidence that many single agents are efficacious in preventing nausea and vomiting much of it is low/very low in certainty. A network meta‐analysis might be undertaken to compare different drugs and drug groups. There are no data comparing the efficacy of agents for treatment of established nausea and vomiting although these would be dealt with in a separate review. Future studies should assess potential adverse effects and women's views. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007579-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007579-sec-0008"></div> <div class="table" id="CD007579-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">5‐HT3 antagonists compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>5‐HT3 antagonists compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing regional anaesthesia for caesarean section<br/><b>Setting:</b> hospitals across low‐, middle‐ and high‐income countries<br/><b>Intervention:</b> 5‐HT3 antagonists<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with 5‐HT3 antagonists</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.55<br/>(0.42 to 0.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1419<br/>(12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>479 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>263 per 1000<br/>(201 to 340) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.46<br/>(0.29 to 0.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1414<br/>(11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>3 4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>241 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>111 per 1000<br/>(70 to 176) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.40<br/>(0.30 to 0.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1340<br/>(10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>338 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>135 per 1000<br/>(101 to 183) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.47<br/>(0.31 to 0.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1450<br/>(10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>5 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>228 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>107 per 1000<br/>(71 to 157) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 1 for risk of bias: &gt; 90% of data comes from studies with unclear selection bias </p> <p><sup>2</sup> Downgrade 1 for inconsistency: there may be substantial heterogeneity I<sup>2</sup> = 65%, Chi<sup>2</sup> P = 0.0009. </p> <p>3 Downgrade 1 for risk of bias: &gt; 80% of data comes from studies with unclear selection bias </p> <p>4 Downgrade 1 for inconsistency: there may be substantial heterogeneity I<sup>2</sup> = 58%, Chi<sup>2</sup> P = 0.008. </p> <p>5 Downgrade 1 for publication bias: there is some evidence of possible publication bias in the funnel plot. </p> <p>6 Downgrade 1 for risk of bias: &gt; 65% of data comes from studies with unclear selection bias </p> <p>7 Downgrade 1 for risk of bias: &gt; 70% of data comes from studies with unclear selection bias </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007579-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Dopamine antagonists compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dopamine antagonists compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing regional anaesthesia for caesarean section<br/><b>Setting:</b> hospitals across low‐, middle‐ and high‐income countries<br/><b>Intervention:</b> dopamine antagonists<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with dopamine antagonists (B)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.38<br/>(0.27 to 0.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1180<br/>(15 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>444 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>169 per 1000<br/>(120 to 231) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.41<br/>(0.28 to 0.60) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>942<br/>(12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>211 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000<br/>(59 to 127) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.61<br/>(0.48 to 0.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>601<br/>(7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>393 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>240 per 1000<br/>(189 to 311) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.63<br/>(0.44 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>860<br/>(9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>264 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>167 per 1000<br/>(116 to 243) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for risk of bias: all the data come from studies with unclear risk of selection bias. </p> <p><sup>2</sup> Downgrade 1 for inconsistency. Moderate to substantial heterogeneity, I<sup>2</sup> = 54%, Chi<sup>2</sup> P = 0.005 </p> <p><sup>3</sup> Downgrade 1 for publication bias: evidence of some publication bias in the funnel plot </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007579-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Corticosteroids compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Corticosteroids compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing regional anaesthesia for caesarean section<br/><b>Setting:</b> hospitals across low‐, middle‐ and high‐income countries<br/><b>Intervention:</b> corticosteroids<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with corticosteroids (C)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.56<br/>(0.37 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>609<br/>(6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>403 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>226 per 1000<br/>(149 to 334) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.52<br/>(0.31 to 0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>609<br/>(6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>141 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73 per 1000<br/>(44 to 123) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.59<br/>(0.49 to 0.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>733<br/>(6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>491 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>290 per 1000<br/>(240 to 358) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.68<br/>(0.49 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>793<br/>(7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>355 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>241 per 1000<br/>(174 to 337) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for risk of bias: all the data comes from studies with unclear risk of selection bias </p> <p><sup>2</sup> Downgrade 1 for inconsistency: there is moderate heterogeneity I<sup>2</sup> = 50% and Chi<sup>2</sup> P = 0.06. </p> <p><sup>3</sup> Downgrade 1 for imprecision: Wide CI close to line of no difference. Only 61 events out of 609 women. </p> <p><sup>4</sup> Downgrade 1 for risk of bias: 69% of data comes from studies with unclear risk of selection bias. </p> <p><sup>5</sup> Downgrade 1 for risk of bias: 83%% of data comes from studies with unclear risk of selection bias. </p> <p><sup>6</sup> Downgrade 1 for inconsistency: may show moderate heterogeneity. I<sup>2</sup> = 52%. Chi<sup>2</sup> P = 0.03. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007579-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Antihistamines compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Antihistamines compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> preventing nausea and vomiting<br/><b>Setting:</b> in women undergoing regional anaesthesia for caesarean section<br/><b>Intervention:</b> antihistamines<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with antihistamines</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/>(0.47 to 2.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>149<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>155 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>153 per 1000<br/>(73 to 327) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>149<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only one RCT with no intraoperative vomiting events</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.44<br/>(0.30 to 0.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>514<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>309 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>136 per 1000<br/>(93 to 198) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.48<br/>(0.29 to 0.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>333<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>91 per 1000<br/>(55 to 153) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for risk of bias; only one study with unclear risk of bias across 6 domains and high risk for one domain </p> <p><sup>2</sup> Downgrade 2 for imprecision: wide CI, only 23 events out of 149 women in a single study. </p> <p><sup>3</sup> Downgrade 2 for imprecision: there are no events. </p> <p><sup>4</sup> Downgrade 2 for risk of bias: all data from studies with unclear risk of selection bias </p> <p><sup>5</sup> Downgrade 1 for imprecision: only 45 events out of 333 women. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007579-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Anticholinergics compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Anticholinergics compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing regional anaesthesia for caesarean section<br/><b>Setting:</b> hospitals across low‐, middle‐ and high‐income countries<br/><b>Intervention:</b> anticholinergics<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with anticholinergics</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67<br/>(0.51 to 0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>453<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>665 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>446 per 1000<br/>(339 to 579) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.79<br/>(0.40 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>453<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>304 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>240 per 1000<br/>(122 to 468) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.55<br/>(0.41 to 0.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>161<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>728 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>401 per 1000<br/>(299 to 539) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for risk of bias: all the data from studies with unclear selection bias. </p> <p><sup>2</sup> Downgrade 1 for inconsistency: there may be moderate heterogeneity I<sup>2</sup> = 52% Chi<sup>2</sup> P = 0.10. </p> <p><sup>3</sup> Downgrade 1 for imprecision: wide CI, crossing the line of no difference. 120 events out of 453 women participants. </p> <p><sup>4</sup> Downgrade 1 for risk of bias: only one study with unclear allocation concealment but adequate sequence generation </p> <p><sup>5</sup> Downgrade 1 for imprecision: a single study shows a wide confidence interval away from the line of no difference but with 91 events out of 161 women participants. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007579-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Sedatives compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Sedatives compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing regional anaesthesia for caesarean section<br/><b>Setting:</b> hospitals across low‐, middle‐ and high‐income countries<br/><b>Intervention:</b> sedatives<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with sedatives (F)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.65<br/>(0.51 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>593<br/>(8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>375 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>244 per 1000<br/>(191 to 308) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.35<br/>(0.24 to 0.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>593<br/>(8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>294 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1000<br/>(71 to 153) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.25<br/>(0.09 to 0.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>145<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>441 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>110 per 1000<br/>(40 to 313) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.09<br/>(0.03 to 0.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>145<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>356 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000<br/>(11 to 100) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 1 for risk of bias: 56% of data from studies with low risk of selection bias. </p> <p>2 Downgrade 1 for risk of bias: 75% of data were from studies with unclear selection bias. </p> <p><sup>3</sup> Downgrade 1 for inconsistency: moderate heterogeneity. I<sup>2</sup> = 58%. Chi<sup>2</sup> P = 0.09. </p> <p><sup>4</sup> Downgrade 2 for imprecision: low number of events ‐ 37 and low number of participants 145. Wide CI though a reasonable distance from line of no difference. </p> <p><sup>5</sup> Downgrade 2 for imprecision: low number of events ‐ 23 and low number of participants 145. Wide CI but a good distance from the line of no difference although the data of high effectiveness comes from just one study of 44 women. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007579-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Opioid antagonists compared to placebo for preventing nausea and vomiting</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Opioid antagonists compared to placebo for preventing nausea and vomiting</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> preventing nausea and vomiting<br/><b>Setting:</b> in women undergoing regional anaesthesia for caesarean section<br/><b>Intervention:</b> opioid antagonists<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with opioid antagonists</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.75<br/>(0.39 to 1.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>120<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>267 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1000<br/>(104 to 387) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.25<br/>(0.35 to 4.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>120<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000<br/>(23 to 295) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for imprecision. Only 28 events out of 120 women in one study. Wide CI crossing line of no difference. </p> <p><sup>2</sup> Downgrade 2 for imprecision. Only 9 events out of 120 women in one study. Wide CI crossing line of no difference. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007579-tbl-0008"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Acupressure/acupuncture compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Acupressure/acupuncture compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing regional anaesthesia for caesarean section<br/><b>Setting:</b> hospitals across low‐, middle‐ and high‐income countries<br/><b>Intervention:</b> acupressure/acupuncture<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with acupressure/acupuncture (K)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.55<br/>(0.41 to 0.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1221<br/>(9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>466 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>256 per 1000<br/>(191 to 345) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.52<br/>(0.33 to 0.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1221<br/>(9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>236 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>123 per 1000<br/>(78 to 189) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.46<br/>(0.27 to 0.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1069<br/>(7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>411 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1000<br/>(111 to 308) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.52<br/>(0.34 to 0.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1069<br/>(7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>302 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>157 per 1000<br/>(103 to 239) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for risk of bias: all the data comes from studies which are unclear risk of selection bias. </p> <p><sup>2</sup> Downgrade 1 for inconsistency: substantial heterogeneity I<sup>2</sup> = 69% Chi<sup>2</sup> P = 0.0010. </p> <p><sup>3</sup> Downgrade 1 for inconsistency: substantial heterogeneity. I<sup>2</sup> = 81% and Chi<sup>2</sup> P = &lt; 0.0001. Could be downgrade by 2, borderline decision </p> <p><sup>4</sup> Downgrade 1 for inconsistency: moderate heterogeneity. I<sup>2</sup> = 62% and Chi<sup>2</sup> P = 0.01. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007579-tbl-0009"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Ginger compared to placebo for preventing nausea and vomiting</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Ginger compared to placebo for preventing nausea and vomiting</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> preventing nausea and vomiting<br/><b>Setting:</b> in women undergoing regional anaesthesia for caesarean section?<br/><b>Intervention:</b> ginger<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with ginger</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.66<br/>(0.36 to 1.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>331<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>586 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>387 per 1000<br/>(211 to 709) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.62<br/>(0.38 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>331<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>408 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>253 per 1000<br/>(155 to 408) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.63<br/>(0.22 to 1.77) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>92<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>174 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>110 per 1000<br/>(38 to 308) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.20<br/>(0.02 to 1.65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>92<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>5 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>109 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/>(2 to 179) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for risk of bias: Only 2 studies both with unclear risk of selection bias </p> <p><sup>2</sup> Downgrade 1 for inconsistency. Substantial heterogeneity. I<sup>2</sup> = 74%, Chi<sup>2</sup> P = 0.05 </p> <p><sup>3</sup> Downgrade 1 for imprecision. Very wide CI crossing the line of no difference. 170 events and 331 women participants </p> <p><sup>4</sup> Downgrade 1 for imprecision: Wide CI. meeting the line of no difference. 112 events and 331 women participating </p> <p><sup>5</sup> Downgrade 2 for risk of bias: Only 1 study with unclear risk of selection bias </p> <p><sup>6</sup> Downgrade 2 for imprecision: Wide CI. Only 6 events out of 92 women </p> <p><sup>7</sup> Downgrade 2 for imprecision: Wide CI crosses line of no difference. 5 events only and just 92 women included </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007579-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007579-sec-0009"></div> <p>Nausea and vomiting are unpleasant symptoms commonly experienced by pregnant women during caesarean section under regional anaesthesia, and may also occur in the postpartum period following a caesarean under either regional or general anaesthesia. Nausea and vomiting around the time of the birth of a baby can be uncomfortable and distressing for the woman. If vomiting occurs intraoperatively during the caesarean under regional anaesthesia, it offers significant challenges to the operating surgeon, may increase the duration of surgery, the risk of bleeding, the risk of inadvertent surgical trauma and the risk of aspiration of gastric contents (<a href="./references#CD007579-bbs2-0377" title="ParanjothyS , GriffithsJD , BroughtonHK , GyteGM , BrownHC , ThomasJ . Interventions at caesarean section for reducing the risk of aspiration pneumonitis. Cochrane Database of Systematic Reviews2014, Issue 2. Art. No: CD004943. [DOI: 10.1002/14651858.CD004943.pub4]">Paranjothy 2014</a>). </p> <p>Caesarean section is one of the most commonly performed surgical procedures. World Health Organization data indicate that worldwide around 140 million babies are born each year. Globally caesarean rates vary widely; from less than 5% of births in low‐income countries (e.g. Zimbabwe) to above 30% in high‐income countries (e.g. Germany) (<a href="./references#CD007579-bbs2-0360" title="BoermaT , RonsmansC , MelesseDY , BarrosAJD , BarrosFC , JuanL , et al. Global epidemiology of use of and disparities in caesarean sections. Lancet2018;392:1341-8.">Boerma 2018</a>) and in one study of NHS trusts the caesarean section rate ranged from 14.9% to 32.1% (<a href="./references#CD007579-bbs2-0361" title="BraggF , CromwellDA , EdozienLC , Gurol-UrganciI , MahmoodTA , TempletonA , et al. Variation in rates of caesarean section among English NHS trusts after accounting for maternal and clinical risk: cross sectional study. BMJ2010;341:5065.">Bragg 2010</a>). These figures suggest the number of caesareans worldwide is at least 10 to 20 million per year. Caesarean section rates have also risen considerably in many countries in recent years and this trend is continuing (<a href="./references#CD007579-bbs2-0363" title="ChenI , OpiyoN , TavenderE , MortazhejriS , RaderT , PetkovicJ , et al. Non-clinical interventions for reducing unnecessary caesarean section. Cochrane Database of Systematic Reviews2018, Issue 9. Art. No: CD005528. [DOI: 10.1002/14651858.CD005528.pub3]">Chen 2018</a>). There are several reasons why general anaesthesia should be avoided if possible in the later stages of pregnancy, and most women want to be awake for the birth of their child, so except where there is a contraindication or in some emergency situations, most caesareans are carried out under regional anaesthesia using spinal or epidural techniques. </p> <p>Many factors can contribute to the development of nausea and vomiting at caesarean section. While some causes of nausea and vomiting are common to other non‐obstetric surgical procedures, many are unique to caesarean sections. There is a body of published literature, including consensus guidelines (<a href="./references#CD007579-bbs2-0369" title="GanTJ , BelaniKG , BergeseS , ChungF , DiemunschP , HabibAS , et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesthesia &amp; Analgesia2019;131(2):411-48.">Gan 2019</a>), to help anaesthetists reduce the risk of postoperative nausea and vomiting. However, because some of the underlying causes of nausea and vomiting during caesarean section may be specific to the procedure, it is reasonable to assume that the choice of effective treatments may also differ from other types of surgery. Anaesthetists need to consider specific evidence in this setting. Since all interventions are associated with increased healthcare costs and potential risks to the woman (and potentially to the neonate, via either placental transfer or breastfeeding) it is clear that antiemetic use should be evidence‐based. </p> <p>In some countries, for example in the United Kingdom, there is a recommendation that to reduce nausea and vomiting at caesarean delivery the routine administration of drugs (antiemetics ‐ drugs to reduce nausea and vomiting) or acupressure should be considered (<a href="./references#CD007579-bbs2-0376" title="National Collaborating Centre for Women's and Children's Health. Caesarean section: NICE clinical guideline. 2nd edition. London: RCOG Press, 2011.">NICE 2011</a>). However, many anaesthetists may choose to give antiemetic medication only when nausea and vomiting occur (treatment) rather than as prophylaxis (prevention). It is not known to what extent medications which have been shown to be efficacious as treatment are also efficacious as prophylaxis (and vice versa). </p> <p>The aim of this review is to assess the effectiveness of interventions to prevent nausea and vomiting given as prophylaxis during caesarean section under regional anaesthesia. Future reviews will be required to assess studies on interventions for treatment (rather than prevention) of nausea and vomiting, procedures performed as emergencies and caesarean deliveries performed under general anaesthesia. </p> <section id="CD007579-sec-0010"> <h3 class="title" id="CD007579-sec-0010">Description of the condition</h3> <p>Nausea is the unpleasant subjective urge to vomit, while vomiting is the physiological process associated with propulsive abdominal muscular spasms leading to the expulsion of gastric contents. Retching involves the same propulsive muscular spasms as vomiting but without the expulsion of any gastric contents. </p> <p>There are several aetiological factors (factors causing or contributing to the development of a condition or disease) which may contribute to the development of nausea and vomiting during caesarean section. These may include the following. </p> <p> <ul id="CD007579-list-0001"> <li> <p>Haemodynamic changes (i.e. changes in blood flow) such as hypotension (low blood pressure ‐ a frequent side effect of regional anaesthesia, <a href="./references#CD007579-bbs2-0364" title="ChooiC , CoxJJ , LumbRS , MiddletonP , ChemaliM , EmmettRS , et al. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database of Systematic Reviews2017, Issue 8. Art. No: CD002251. [DOI: 10.1002/14651858.CD002251.pub3]">Chooi 2017</a>) and reduced cardiac output from aorto‐caval compression resulting from placing the woman on her back (supine position) (<a href="./references#CD007579-bbs2-0365" title="CookeRD , ComynDJ , BallRW . Prevention of postoperative nausea and vomiting by domperidone: a double-blind randomized study using domperidone, metoclopramide and a placebo. South African Medical Journal1979;56(21):827-9.">Cooke 1979</a>). </p> </li> <li> <p>Surgical stimulation from visceral traction such as manual delivery of the baby and in particular, exteriorisation of the uterus(temporary removal of the uterus from the abdominal cavity to facilitate repairing the incision), <a href="./references#CD007579-bbs2-0379" title="WahabMA , KarantzisP , EccersleyPS , RussellIF , ThompsonJW , LindowSW . A randomised, controlled study of uterine exteriorisation and repair at caesarean section. British Journal of Obstetrics and Gynaecology1999;106(9):913-6.">Wahab 1999</a>). </p> </li> <li> <p>Intraoperative medications may contribute to nausea and include opiates, antibiotics and administered uterotonics such as oxytocin and particularly ergometrine (<a href="./references#CD007579-bbs2-0366" title="De GrootAN , Van DongenPW , VreeTB , HeksterYA , Van RoosmalenJ . Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology. Drugs1998;54(4):523-35.">De Groot 1998</a>). </p> </li> <li> <p>Psychological factors such as stress, anxiety, fatigue and prolonged starvation should not be underestimated as contributors to nausea and vomiting. This may particularly be the case with emergency caesarean delivery. </p> </li> <li> <p>Medications given prior to the caesarean, such as medications to reduce the risk of aspiration (<a href="./references#CD007579-bbs2-0377" title="ParanjothyS , GriffithsJD , BroughtonHK , GyteGM , BrownHC , ThomasJ . Interventions at caesarean section for reducing the risk of aspiration pneumonitis. Cochrane Database of Systematic Reviews2014, Issue 2. Art. No: CD004943. [DOI: 10.1002/14651858.CD004943.pub4]">Paranjothy 2014</a>). If the woman has been in labour prior to surgery then pain relief already provided such as opioids and nitrous oxide may also have residual emetogenic effects. </p> </li> </ul> </p> <p>Few prospective observational studies or audit data have been published and so the underlying incidence of nausea and vomiting during caesarean section is uncertain. It is also likely that the baseline rate will vary considerably depending on the anaesthetic, analgesic and vasopressor regimen that is being used. However, it would seem reasonable to use the rates in the placebo arms of well‐designed randomised trials as an indication of the baseline rate of nausea and vomiting. Published placebo data show rates of intraoperative nausea in the order of 48% (<a href="./references#CD007579-bbs2-0024" title="HabibAS , GeorgeRB , McKeenDM , WhiteWD , ItukUS , MegallaSA , et al. Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. Obstetrics and Gynecology2013;121(3):615-23. NCT01216410. Prevention of intraoperative nausea and vomiting during cesarean section. Https://clinicaltrials.gov/show/NCT01216410 (first received 2010 Oct 6). [CENTRAL: CN-02025773] ">Habib 2013</a>) to 79% (<a href="./references#CD007579-bbs2-0003" title="AbouleishEI , RashidS , HaqueS , GiezentannerA , JoyntonP , ChuangAZ . Ondansetron versus placebo for the control of nausea and vomiting during caesarean section under spinal anaesthesia. Anaesthesia1999;54:479-82. ">Abouleish 1999</a>). Vomiting rates are typically lower than the rates of nausea, in the order of 15% (<a href="./references#CD007579-bbs2-0079" title="VoigtM , FrohlichCW , HuttelC , KrankeP , MennenJ , BoessneckO , et al. Prophylaxis of intra- and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. Medical Science Monitor2013;19:993-1000. ">Voigt 2013</a>) to 38% (<a href="./references#CD007579-bbs2-0021" title="El-DeebAM , AhmadyMS . Effect of acupuncture on nausea and/or vomiting during and after cesarean section in comparison with ondansetron. Journal of Anesthesia2011;25(5):698-703. ">El‐Deeb 2011a</a>). Most studies recruit women in the setting of elective caesarean section, and it is likely that rates are higher in the setting of emergency caesarean section. </p> <p>Nausea and vomiting in the postpartum period are also common, and can affect women who received either regional or general anaesthesia. In most types of surgery, the use of regional anaesthesia is thought to be associated with lower rates of postoperative nausea and vomiting than general anaesthesia (<a href="./references#CD007579-bbs2-0369" title="GanTJ , BelaniKG , BergeseS , ChungF , DiemunschP , HabibAS , et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesthesia &amp; Analgesia2019;131(2):411-48.">Gan 2019</a>); however, this difference may not be apparent following caesarean delivery. Almost all postoperative analgesia regimens involve the use of opioid type medications, either by oral, intravenous or neuraxial (spinal or epidural) routes, all of which can contribute to nausea and vomiting. </p> </section> <section id="CD007579-sec-0011"> <h3 class="title" id="CD007579-sec-0011">Description of the intervention</h3> <p>In this review, we have included pharmacological and non‐pharmacological interventions given specifically for the purpose of preventing nausea and vomiting in women undergoing caesarean under regional anaesthesia. Whilst hypotension is an important cause of these symptoms during a caesarean, treatment for hypotension during regional anaesthesia has already been specifically addressed in another Cochrane Review (<a href="./references#CD007579-bbs2-0364" title="ChooiC , CoxJJ , LumbRS , MiddletonP , ChemaliM , EmmettRS , et al. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database of Systematic Reviews2017, Issue 8. Art. No: CD002251. [DOI: 10.1002/14651858.CD002251.pub3]">Chooi 2017</a>). Similarly, interventions to reduce the risk of acid aspiration may well affect nausea and vomiting and these interventions have also been addressed in another Cochrane Review (<a href="./references#CD007579-bbs2-0377" title="ParanjothyS , GriffithsJD , BroughtonHK , GyteGM , BrownHC , ThomasJ . Interventions at caesarean section for reducing the risk of aspiration pneumonitis. Cochrane Database of Systematic Reviews2014, Issue 2. Art. No: CD004943. [DOI: 10.1002/14651858.CD004943.pub4]">Paranjothy 2014</a>). </p> <p>The pharmacological interventions available include medications from a wide range of drug classes including serotonin and dopamine receptor antagonists, corticosteroids, antihistamines, sedatives and anticholinergics (<a href="./references#CD007579-bbs2-0367" title="FlakeZA , ScalleyRD , BaileyAG . Practical selection of antiemetics. American Family Physician2004;69(5):1169-74.">Flake 2004</a>). A number of non‐pharmacological approaches have also been used traditionally to treat nausea in pregnancy, and some of these have been studied in this setting. These include acupuncture or acupressure (<a href="./references#CD007579-bbs2-0029" title="HoCM , TsaiHJ , ChanKH , TsaiSK . P6 acupressure does not prevent emesis during spinal anesthesia for cesarean delivery. Anesthesia and Analgesia2006;102(3):900-3. HoCM , TsaiSK . P-6 acupressure do not prevent emesis during cesarean section [abstract]. Canadian Journal of Anesthesia2002;49(6 Suppl):A51. ">Ho 2006</a>) and oral ginger (<a href="./references#CD007579-bbs2-0035" title="KalavaA , DarjiSJ , KalsteinA , YarmushJM , SchianodiColaJ , WeinbergJ . Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;169(2):184-8. KalavaA , WeinbergJ , JayakumarM , YarmushJM , SchianodiColaJJ . Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. In: http://www.asaabstracts.com/strands/asaabstracts/abstract.htm;jsessionid=0507CB47FEB444D841EEF290BF35A8BF?year=2011&amp;index=13&amp;absnum=4726 (accessed 1 Febraury 2012). 2011. NCT01733212. Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. Https://clinicaltrials.gov/show/NCT01733212 2012 Nov 26. [CENTRAL: CN-02041676] ">Kalava 2013</a>). </p> </section> <section id="CD007579-sec-0012"> <h3 class="title" id="CD007579-sec-0012">How the intervention might work</h3> <section id="CD007579-sec-0013"> <h4 class="title">Pharmacological interventions</h4> <p>For many of the recognised interventions used for the prevention of nausea and vomiting, the mechanism of action is not well understood. However, most treatments can be classed pharmacologically based on their biochemical receptor target. Nausea and vomiting caused by visceral stimulation is thought to be mediated predominantly via serotonin (5‐HT) and dopamine receptors. The chemoreceptor trigger zone (CTZ) is a small region within the brainstem responsible for the symptoms of medication and toxin related emesis, including post anaesthetic nausea and vomiting, and is also mediated by serotonin and dopamine. In contrast, nausea and vomiting caused by central nervous system and vestibular mechanisms, such as motion sickness, are thought to be mediated mainly via histamine and acetylcholine. </p> <p>The main classes of medications in use include the following (<a href="./references#CD007579-bbs2-0367" title="FlakeZA , ScalleyRD , BaileyAG . Practical selection of antiemetics. American Family Physician2004;69(5):1169-74.">Flake 2004</a>; <a href="./references#CD007579-bbs2-0368" title="GanTJ , MeyerT , ApfelCC , ChungF , DavisPJ , EubanksS , et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesthesia and Analgesia2003;97(1):62-71.">Gan 2003</a>). </p> <p> <ol id="CD007579-list-0002"> <li> <p>Serotonin (5‐HT<sub>3</sub>) receptor subtype‐3 antagonists (e.g. ondansetron, granisetron) antagonise the emetic effects of serotonin in the small bowel, vagus nerve and CTZ (<a href="./references#CD007579-bbs2-0064" title="PeixotoAJ , CelichMF , ZardoL , Peixoto FilhoAJ . Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine. European Journal of Anaesthesiology2006;23(8):670-5. ">Peixoto 2006</a>). They are effective (<a href="./references#CD007579-bbs2-0370" title="RonaldGB , AllenTK , HabibAS . Serotonin receptor antagonists for the prevention and treatment of pruritus, nausea, and vomiting in women undergoing cesarean delivery with intrathecal morphine: a systematic review and meta-analysis. Anesthesia &amp; Analgesia2009;109(1):174-82.">George 2009</a>) and have few side effects. </p> </li> <li> <p>Dopamine receptor antagonists (e.g. metoclopramide, prochlorperazine, droperidol, domperidone) antagonise the effects of dopamine at the D2 receptors in the CTZ. They have a wide variety of associated side effects including sedation, agitation, and extra‐pyramidal effects (<a href="./references#CD007579-bbs2-0015" title="ChestnutDH , BatesJN , ChoiWW , VandewalkerGE . Administration of metoclopramide for prevention of nausea and vomiting during regional anesthesia for cesarean section: a randomized, double blind, placebo controlled study. Anesthesiology1986;65:390. ChestnutDH , VandewalkerGE , OwenCL , BatesJN , ChoiWW . Administration of metoclopramide for prevention of nausea and vomiting during epidural anesthesia for elective cesarean section. Anesthesiology1987;66:563-6. ">Chestnut 1987</a>). Droperidol has been associated with very rare, but potentially life‐threatening, cardiac arrhythmias. </p> </li> <li> <p>Corticosteroids also known as steroids (most commonly dexamethasone) are regarded as being highly effective, but their mechanism of action is unclear (<a href="./references#CD007579-bbs2-0076" title="TzengJI , WangJJ , HoST , TangCS , LiuYC , LeeSC . Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline. British Journal of Anaesthesia2000;85(6):865-8. ">Tzeng 2000</a>). Whilst long‐term steroid use can lead to a wide variety of side effects such as fluid and electrolyte changes, obesity, and diabetes, single antiemetic doses are well tolerated, even in diabetics. </p> </li> <li> <p>Antihistamines (e.g. promethazine and cyclizine (<a href="./references#CD007579-bbs2-0058" title="NortcliffeSA , BuggyDJ . Prophylaxis of nausea and vomiting after spinal morphine analgesia for caesarean section: comparison between cyclizine, dexamethasone, and placebo [abstract]. British Journal of Anaesthesia2001;87(4):657P. NortcliffeSA , ShahJ , BuggyDJ . Prevention of postoperative nausea and vomiting after spinal morphine for caesarean section: comparison of cyclizine, dexamethasone and placebo. British Journal of Anaesthesia2003;90(5):665-70. ">Nortcliffe 2003</a>) can cause a variety of adverse effects including sedation and dry mouth. </p> </li> <li> <p>Anticholinergic agents (e.g. glycopyrrolate (<a href="./references#CD007579-bbs2-0078" title="UreD , JamesKS , McNeillM , BoothJV . Glycopyrrolate reduces nausea during spinal anaesthesia for caesarean section without affecting neonatal outcome. British Journal of Anaesthesia1999;82(2):277-9. ">Ure 1999</a>) and scopolamine (<a href="./references#CD007579-bbs2-0041" title="KotelkoDM , RottmanRL , WrightWC , StoneJJ , YamashiroAY , RosenblattRM . Transderm SCOP decreases post-cesarean nausea and vomiting in patients receiving epidural morphine. Anesthesiology1988;69:A666. KotelkoDM , RottmanRL , WrightWC , StoneJJ , YamashiroAY , RosenblattRM . Transdermal scopolamine decreases nausea and vomiting following cesarean section in patients receiving epidural morphine. Anesthesiology1989;71:675-8. ">Kotelko 1989</a>) are mainly useful for nausea and vomiting caused via the vestibular system, i.e. motion sickness. They can also cause a dry mouth and potentially urinary retention. </p> </li> <li> <p>Sedatives. Very low doses of sedatives such as midazolam or propofol (<a href="./references#CD007579-bbs2-0054" title="MukherjeeS , RudraA , MandelM , KumarP . Optimum dose of propofol for prevention of emetic episodes during caesarean delivery: an evaluation. Journal of Anaesthesia and Clinical Pharmacology2006;22(2):139-43. ">Mukherjee 2006</a>; <a href="./references#CD007579-bbs2-0074" title="TarhanO , CanbayO , CelebiN , UzunS , SahinA , CoskunF , et al. Subhypnotic doses of midazolam prevent nausea and vomiting during spinal anesthesia for cesarean section. Minerva Anestesiologica2007;73(12):629-33. ">Tarhan 2007</a>) seem to have antiemetic efficacy. The mechanism of action is unclear, but may relate to the contribution of psychological factors such as stress and anxiety to the incidence of emetic symptoms. </p> </li> <li> <p>Opioids antagonists or partial agonists. A number of studies have attempted to demonstrate the beneficial effects of opioids. Whilst opioids would generally be considered a cause, rather than a treatment, of nausea and vomiting, it is possible that when two opioids are administered together, one of them may reduce the opioid‐induced emetic symptoms caused by the other. If one drug is an opioid antagonist or partial agonist (such as naloxone or nalbuphine) (<a href="./references#CD007579-bbs2-0013" title="CharuluxanananS , KyokongO , SomboonviboonW , NarasethakamolA , PromlokP . Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesthesia and Analgesia2003;96(6):1789-93. ">Charuluxananan 2003</a>), then it may reduce the opioid‐related side effects (such as nausea, itch and constipation) without unduly reducing the analgesic benefits. </p> </li> </ol> </p> </section> <section id="CD007579-sec-0014"> <h4 class="title">Non‐pharmacological interventions</h4> <p> <ol id="CD007579-list-0003"> <li> <p>Acupuncture or acupressure: acupressure or acupuncture at the P6 point at the wrist has long been a traditional treatment for nausea, particularly sea sickness. The mechanism of action of acupuncture and acupressure is not well understood (<a href="./references#CD007579-bbs2-0019" title="DuggalKN , DouglasMJ , PeterEA , MerrickPM . Acupressure for intrathecal narcotic-induced nausea and vomiting after caesarean section. International Journal of Obstetric Anesthesia1998;7(4):231-6. ">Duggal 1998</a>; <a href="./references#CD007579-bbs2-0025" title="HarmonD , RyanM , KellyA , BowenM . Acupressure and prevention of nausea and vomiting during and after spinal anaesthesia for caesarean section. British Journal of Anaesthesia2000;84(4):463-7. HarmonD , RyanM , KellyA , BowenM . Acupressure and the prevention of nausea and vomiting during and after spinal anaesthesia for caesarean section. British Journal of Anaesthesia1999;82 Suppl:161. ">Harmon 2000</a>). Potential adverse effects of acupuncture include infection or trauma from acupuncture needles. </p> </li> <li> <p>Alternative natural therapies such as ginger (<a href="./references#CD007579-bbs2-0035" title="KalavaA , DarjiSJ , KalsteinA , YarmushJM , SchianodiColaJ , WeinbergJ . Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;169(2):184-8. KalavaA , WeinbergJ , JayakumarM , YarmushJM , SchianodiColaJJ . Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. In: http://www.asaabstracts.com/strands/asaabstracts/abstract.htm;jsessionid=0507CB47FEB444D841EEF290BF35A8BF?year=2011&amp;index=13&amp;absnum=4726 (accessed 1 Febraury 2012). 2011. NCT01733212. Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. Https://clinicaltrials.gov/show/NCT01733212 2012 Nov 26. [CENTRAL: CN-02041676] ">Kalava 2013</a>; <a href="./references#CD007579-bbs2-0084" title="ZeraatiH , ShahinfarJ , HesariSI , MasrorniyaM , NasimiF . The effect of ginger extract on the incidence and severity of nausea and vomiting after cesarean section under spinal anesthesia. Anesthesiology and Pain Medicine2016;6(5):e38943. [CENTRAL: CN-01760273] [EMBASE: 612722027] [PMID: 27847700]">Zeraati 2016</a>) and peppermint (<a href="./references#CD007579-bbs2-0208" title="LaneB , CannellaK , BowenC , CopelanD , NteffG , BarnesK , et al. Examination of the effectiveness of peppermint aromatherapy on nausea in women post C-section. Journal of Holistic Nursing2012;30(2):90-104. ">Lane 2012</a>; <a href="./references#CD007579-bbs2-0233" title="NiakiMT , AtarodZ , OmidvarS , ZafariM , AghamohammadiA , AsadiT , et al. Comparing the effects of cumin, peppermint, and milk of magnesia on gastrointestinal complications after caesarean section. Global Journal of Health Science2016;8(12):78-86. ">Niaki 2016</a>) also have long histories of use as traditional treatments for reducing nausea in pregnancy. Although associated with minimal side effects, their efficacy is uncertain (<a href="./references#CD007579-bbs2-0374" title="MatthewsA , HaasDM , O'MathúnaDP , DowswellT . Interventions for nausea and vomiting in early pregnancy. Cochrane Database of Systematic Reviews2015, Issue 9. Art. No: CD007575. [DOI: 10.1002/14651858.CD007575.pub4]">Matthews 2015</a>). </p> </li> </ol> </p> </section> </section> <section id="CD007579-sec-0015"> <h3 class="title" id="CD007579-sec-0015">Why it is important to do this review</h3> <p>Nausea and vomiting are very common symptoms experienced both during and following caesarean section, may increase morbidity, and can be very distressing for women and their families. Many interventions are available and routine prophylactic treatment has been proposed (<a href="./references#CD007579-bbs2-0376" title="National Collaborating Centre for Women's and Children's Health. Caesarean section: NICE clinical guideline. 2nd edition. London: RCOG Press, 2011.">NICE 2011</a>). The available interventions have widely varying cost and significant side‐effect profiles. Whilst guidelines exist for the prevention of nausea and vomiting after general anaesthesia in non‐pregnant patients (<a href="./references#CD007579-bbs2-0369" title="GanTJ , BelaniKG , BergeseS , ChungF , DiemunschP , HabibAS , et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesthesia &amp; Analgesia2019;131(2):411-48.">Gan 2019</a>), the aetiology of emetic symptoms at caesarean section are clearly multifactorial and the current literature may not be directly applicable. This review is important to ensure that women undergoing caesarean section are offered interventions to prevent nausea and vomiting which are safe, efficacious and cost‐effective. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007579-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007579-sec-0016"></div> <p>To assess the efficacy of pharmacological and non‐pharmacological interventions versus placebo or no intervention given prophylactically to prevent nausea and vomiting in women undergoing regional anaesthesia for caesarean section. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007579-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007579-sec-0017"></div> <section id="CD007579-sec-0018"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007579-sec-0019"> <h4 class="title">Types of studies</h4> <p>We included published and unpublished randomised controlled trials (RCTs), including conference abstracts. We planned to include cluster‐randomised trials, but none were identified. Quasi‐RCTs and cross‐over studies were excluded. </p> </section> <section id="CD007579-sec-0020"> <h4 class="title">Types of participants</h4> <p>Pregnant women undergoing elective or emergency caesarean section under regional anaesthesia.</p> </section> <section id="CD007579-sec-0021"> <h4 class="title">Types of interventions</h4> <p>In this updated review, we have included studies where the participants were women undergoing caesarean section under regional anaesthesia (either spinal, epidural or both) comparing interventions for nausea and vomiting against placebo or no intervention. Intervention versus intervention comparisons were excluded. We included studies where the intervention was given with the express purpose of preventing nausea and vomiting, either intraoperative, postoperative, or both. </p> <p>Interventions included the following categories.</p> <p> <ol id="CD007579-list-0004"> <li> <p>Serotonin (5‐HT<sub>3</sub>) receptor antagonists (e.g. ondansetron, granisetron). </p> </li> <li> <p>Dopamine receptor antagonists (e.g. metoclopramide, prochlorperazine, droperidol, domperidone). </p> </li> <li> <p>Corticosteroids (e.g. dexamethasone).</p> </li> <li> <p>Antihistamines (e.g. promethazine, cyclizine).</p> </li> <li> <p>Anticholinergic agents (e.g. glycopyrrolate, scopolamine).</p> </li> <li> <p>Sedatives (e.g. midazolam, propofol).</p> </li> <li> <p>Opioids antagonists or partial agonists (e.g. nalbuphine).</p> </li> <li> <p>Acupressure/acupuncture.</p> </li> <li> <p>Alternative therapies such as ginger or peppermint.</p> </li> </ol> </p> <p>We compared the different drug classes against placebo, setting out individual drugs and doses as subgroups. </p> <p>We excluded:</p> <p> <ol id="CD007579-list-0005"> <li> <p>studies where the authors were comparing two different treatments (unless there was also a control/placebo arm) and studies investigating combinations of treatments; </p> </li> <li> <p>studies where the intervention was for reducing aspiration pneumonitis, as this is the subject of another review (<a href="./references#CD007579-bbs2-0377" title="ParanjothyS , GriffithsJD , BroughtonHK , GyteGM , BrownHC , ThomasJ . Interventions at caesarean section for reducing the risk of aspiration pneumonitis. Cochrane Database of Systematic Reviews2014, Issue 2. Art. No: CD004943. [DOI: 10.1002/14651858.CD004943.pub4]">Paranjothy 2014</a>); </p> </li> <li> <p>studies where the express purpose was to treat another problem which may impact upon the development of nausea or vomiting, such as studies assessing agents for treating hypotension. This has also been studied in another review (<a href="./references#CD007579-bbs2-0364" title="ChooiC , CoxJJ , LumbRS , MiddletonP , ChemaliM , EmmettRS , et al. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database of Systematic Reviews2017, Issue 8. Art. No: CD002251. [DOI: 10.1002/14651858.CD002251.pub3]">Chooi 2017</a>); </p> </li> <li> <p>studies where a recognised antiemetic was given, but the focus of the study was on another effect of that medication (for example, studies on the haemodynamic effects of ondansetron); </p> </li> <li> <p>studies which assessed the efficacy of interventions for treatment, rather than prevention, of nausea and vomiting. This may be the subject of a separate future review; </p> </li> <li> <p>studies where the intervention was not recognised as an antiemetic and did not have a reasonable theoretical justification for affecting nausea and vomiting, e.g. supplemental oxygen; intravenous fluids; anticonvulsants; antidepressants, opioid agonists. </p> </li> </ol> </p> </section> <section id="CD007579-sec-0022"> <h4 class="title">Types of outcome measures</h4> <section id="CD007579-sec-0023"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD007579-list-0006"> <li> <p>Nausea intraoperatively.</p> </li> <li> <p>Vomiting (and/or retching) intraoperatively.</p> </li> <li> <p>Nausea postoperatively.</p> </li> <li> <p>Vomiting (and/or retching) postoperatively.</p> </li> </ol> </p> </section> <section id="CD007579-sec-0024"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD007579-list-0007"> <li> <p>Nausea plus vomiting/retching.</p> </li> <li> <p>Maternal adverse effects: e.g. sedation, restlessness, extra‐pyramidal effects, surgical bleeding, hypotension, atonic uterus. </p> </li> <li> <p>Neonatal morbidity: e.g. Apgar scores less than seven at five minutes.</p> </li> <li> <p>Initiation of breastfeeding.</p> </li> <li> <p>Duration of exclusive breastfeeding.</p> </li> <li> <p>Maternal satisfaction (using a validated questionnaire).</p> </li> </ol> </p> <p>In this review, when authors reported retching and vomiting separately, we combined these data, as we believe retching is more pathophysiologically analogous to vomiting than nausea. In this update, we clarified our approach to the postoperative data. Where a paper reports a number of time epochs (for example, zero to four hours, four to eight hours, etc), we have included data from the earliest reported time period because we believe these data were most likely to reflect the efficacy of the intervention. </p> </section> </section> </section> <section id="CD007579-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD007579-sec-0026"> <h4 class="title">Electronic searches</h4> <p>For this update, we searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (16 April 2020). </p> <p>The Register is a database containing over 25,000 reports of controlled trials in the field of pregnancy and childbirth. It represents over 30 years of searching. For full current search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this <a href="https://pregnancy.cochrane.org/pregnancy-and-childbirth-groups-trials-register" target="_blank">link</a>. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD007579-list-0008"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set that has been fully accounted for in the relevant review sections (<a href="./references#CD007579-bbs1-0001" title="">Included studies</a>, <a href="./references#CD007579-bbs1-0002" title="">Excluded studies</a>, <a href="./references#CD007579-bbs1-0003" title="">Studies awaiting classification</a> or <a href="./references#CD007579-bbs1-0004" title="">Ongoing studies</a>). </p> <p>In addition, we searched <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) for unpublished, planned and ongoing trial reports (1 April 2020) using the search methods described in <a href="./appendices#CD007579-sec-0173">Appendix 1</a>. </p> </section> <section id="CD007579-sec-0027"> <h4 class="title">Searching other resources</h4> <p>We searched for further studies in the reference list of the studies identified.</p> <p>We did not apply any language or date restrictions.</p> </section> </section> <section id="CD007579-sec-0028"> <h3 class="title" id="CD007579-sec-0028">Data collection and analysis</h3> <p>For methods used in the previous version of this review, <i>see</i><a href="./references#CD007579-bbs2-0382" title="GriffithsJD , GyteGM , ParanjothyS , BrownHC , BroughtonHK , ThomasJ . Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section. Cochrane Database of Systematic Reviews2012, Issue 9. Art. No: CD007579. [DOI: 10.1002/14651858.CD007579.pub2]">Griffiths 2012</a>. </p> <p>For this update, the following methods were used for assessing the 174 new studies that were identified as a result of the updated search. </p> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD007579-sec-0029"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies identified as a result of the search strategy. We resolved any disagreement through discussion or, if required, we consulted the third review author. </p> </section> <section id="CD007579-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted the third review author. Data were entered into Review Manager software (<a href="./references#CD007579-bbs2-0378" title="Review Manager (RevMan). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">RevMan 2020</a>) and checked for accuracy. </p> <p>When information regarding any of the above was unclear, we planned to contact authors of the original reports to provide further details. </p> </section> <section id="CD007579-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007579-bbs2-0371" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al editors. Cochrane Handbook for Systematic Reviews of Interventions. 2nd edition. Oxford: Wiley &amp; Sons Ltd, 2019.">Higgins 2019</a>). Any disagreement was resolved by discussion or by involving a third assessor. </p> <section id="CD007579-sec-0032"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD007579-list-0009"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007579-sec-0033"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD007579-list-0010"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007579-sec-0034"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD007579-list-0011"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD007579-sec-0035"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD007579-list-0012"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007579-sec-0036"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re‐include missing data in the analyses which we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD007579-list-0013"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007579-sec-0037"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD007579-list-0014"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007579-sec-0038"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we had about other possible sources of bias. </p> </section> <section id="CD007579-sec-0039"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD007579-bbs2-0371" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al editors. Cochrane Handbook for Systematic Reviews of Interventions. 2nd edition. Oxford: Wiley &amp; Sons Ltd, 2019.">Higgins 2019</a>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings. In future updates, we will explore the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD007579-sec-0052">Sensitivity analysis</a>. </p> </section> </section> <section id="CD007579-sec-0040"> <h4 class="title">Measures of treatment effect</h4> <section id="CD007579-sec-0041"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. Where a random‐effects model has been used, we report this as an average risk ratio (aRR). </p> </section> <section id="CD007579-sec-0042"> <h5 class="title">Continuous data</h5> <p>We planned to use mean difference if outcomes were measured in the same way between trials and standardised mean difference to combine trials that measured the same outcome, but used different methods. </p> </section> </section> <section id="CD007579-sec-0043"> <h4 class="title">Unit of analysis issues</h4> <section id="CD007579-sec-0044"> <h5 class="title">Cluster‐randomised trials</h5> <p>We planned to include cluster‐randomised trials in the analyses along with individually‐randomised trials, but did not identify any. Had we identified any, we would have adjusted their standard error using the methods described in the <i>Handbook</i> <i>[Section16.3.4 and 16.3.6]</i> using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we had used ICCs from other sources, we would have reported this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we had identify both cluster‐randomised trials and individually‐randomised trials, we planned to synthesise the relevant information. We would have considered it reasonable to combine the results from both if there is little heterogeneity between the study designs. We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD007579-sec-0045"> <h5 class="title">Cross‐over trials</h5> <p>We excluded cross‐over trials.</p> </section> <section id="CD007579-sec-0046"> <h5 class="title">Other unit of analysis issues</h5> <p>Where we found multi‐arm studies, we assessed which arms were relevant to our question and included data taking care not to double count the data in the placebo group by dividing the placebo data equally amongst the relevant comparisons such that when the data were pooled, the correct number of events and participants were included. </p> </section> </section> <section id="CD007579-sec-0047"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. In future updates, if more eligible studies are included, the impact of including studies with high levels of missing data in the overall assessment of treatment effect will be explored by using sensitivity analysis. </p> <p>For all outcomes, analyses were carried out, as far as possible, on an intention‐to‐treat basis i.e. we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD007579-sec-0048"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as reported in the Cochrane Handbook (<a href="./references#CD007579-bbs2-0371" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al editors. Cochrane Handbook for Systematic Reviews of Interventions. 2nd edition. Oxford: Wiley &amp; Sons Ltd, 2019.">Higgins 2019</a>): </p> <p> <ul id="CD007579-list-0015"> <li> <p>0% to 40%: might not be important;</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity*;</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity*;</p> </li> <li> <p>75% to 100%: considerable heterogeneity*.</p> </li> </ul> </p> <p>and either a Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. </p> </section> <section id="CD007579-sec-0049"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates, if there are 10 or more studies in the meta‐analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD007579-sec-0050"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager software (<a href="./references#CD007579-bbs2-0378" title="Review Manager (RevMan). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">RevMan 2020</a>). </p> <p>We used random‐effects meta‐analyses for combining data because we considered that there would be heterogeneity sufficient to expect that the underlying treatment effects would differ between trials because our question is around groups of drugs and so we are combining data from different drugs and different doses within the meta‐analyses. </p> <p>The random‐effects summary was treated as the average range of possible treatment effects and we discuss the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials. The results are presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD007579-sec-0051"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we identified substantial heterogeneity, we investigated it using subgroup analyses and sensitivity analyses. We considered whether an overall summary was meaningful, and if it was, we used random‐effects analysis to produce it. </p> <p>We carried out the following subgroup analyses.</p> <p> <ol id="CD007579-list-0016"> <li> <p>Different drugs with the same group of drugs</p> </li> <li> <p>Difference doses of the drugs within the group of drugs</p> </li> </ol> </p> <p>The following four primary outcomes were used in subgroup analyses.</p> <p> <ol id="CD007579-list-0017"> <li> <p>intraoperative nausea</p> </li> <li> <p>intraoperative vomiting</p> </li> <li> <p>postoperative nausea</p> </li> <li> <p>postoperative vomiting</p> </li> </ol> </p> <p>We assessed subgroup differences by interaction tests available within RevMan (<a href="./references#CD007579-bbs2-0378" title="Review Manager (RevMan). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">RevMan 2020</a>). We reported the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD007579-sec-0052"> <h4 class="title">Sensitivity analysis</h4> <p>We carried out sensitivity analyses to explore the effect of trial quality assessed by selection bias (sequence generation and allocation concealment) and attrition bias (incomplete outcome data), with poor‐quality studies (either high risk or unclear risk) being excluded from the analyses in order to assess whether this makes any difference to the overall result. </p> </section> <section id="CD007579-sec-0053"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>For this update, the certainty of the evidence was assessed using the GRADE approach as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE handbook</a> to assess the certainty of the body of evidence relating to the following outcomes for the main comparisons. All nine comparisons were chosen as a specific focus as they represent the most clinically‐relevant comparisons in this updated review. </p> <section id="CD007579-sec-0054"> <h5 class="title">Comparisons for GRADE and Summary of findings</h5> <p> <ol id="CD007579-list-0018"> <li> <p>5‐HT3 antagonists versus placebo</p> </li> <li> <p>Dopamine antagonists versus placebo</p> </li> <li> <p>Corticosteroids versus placebo</p> </li> <li> <p>Antihistamines versus placebo</p> </li> <li> <p>Anticholinergics versus placebo</p> </li> <li> <p>Sedatives versus placebo</p> </li> <li> <p>Opioid antagonists/partial agonists versus placebo</p> </li> <li> <p>Acupressure/acupuncture versus placebo</p> </li> <li> <p>Ginger versus placebo</p> </li> </ol> </p> </section> <section id="CD007579-sec-0055"> <h5 class="title">Outcomes for GRADE and Summary of findings</h5> <p> <ol id="CD007579-list-0019"> <li> <p>Incidence of intraoperative nausea</p> </li> <li> <p>Incidence of intraoperative vomiting/retching</p> </li> <li> <p>Incidence of postoperative nausea</p> </li> <li> <p>Incidence of postoperative vomiting/retching</p> </li> </ol> </p> <p>We used the <a href="http://www.guidelinedevelopment.org/" target="_blank">GRADEpro</a> Guideline Development Tool to import data from Review Manager 5.3 (<a href="./references#CD007579-bbs2-0378" title="Review Manager (RevMan). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">RevMan 2020</a>) in order to create ’Summary of findings’ tables. A summary of the intervention effect and a measure of certainty each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, indirectness, imprecision and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high certainty' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, serious inconsistency, indirectness of evidence, imprecision of effect estimates or potential publication bias. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007579-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007579-sec-0056"></div> <section id="CD007579-sec-0057"> <h3 class="title">Description of studies</h3> <section id="CD007579-sec-0058"> <h4 class="title">Results of the search</h4> <p>We assessed 218 new trial reports, plus the change in scope meant we also reassessed the 204 trial reports referenced in the previous version of the review. </p> <p>All in all in this 2021 update, there are 84 included studies (112 reports) (<a href="./references#CD007579-sec-0184" title="">Characteristics of included studies</a>) and 236 excluded studies (269 reports) (<a href="./references#CD007579-sec-0185" title="">Characteristics of excluded studies</a>). Ten studies are awaiting classification (<a href="./references#CD007579-sec-0186" title="">Characteristics of studies awaiting classification</a>). These are predominantly conference abstracts where we have been unable to contact the authors or studies in a non‐English language where we have been unable to obtain a translation as yet. There are 27 studies identified as ongoing (31 reports) (<a href="./references#CD007579-sec-0187" title="">Characteristics of ongoing studies</a>). </p> <p>The change in scope meant we excluded nine studies from the 2012 publication, six of these studies had provided data (<a href="./references#CD007579-bbs2-0121" title="ChestnutDH , OwenCL , GeigerM , BatesJN , ChoiWW , OstmanPL . Metoclopramide versus droperidol for prevention of nausea and vomiting during epidural anesthesia for cesarean section. Southern Medical Journal1989;82(10):1224-7. ChestnutDH , OwenCL , OstmanLG , BatesJN , ChoiWW . A comparison of metoclopramide and droperidol for prevention of nausea and vomiting during and after elective cesarean section with epidural anesthesia. In: Proceedings of 19th Annual Meeting of Society for Obstetric Anesthesia and Perinatology; 1987 May 20-23; Halifax, Nova Scotia, Canada. 1987:118. ">Chestnut 1989</a>; <a href="./references#CD007579-bbs2-0159" title="GaiserRR , DongY , CheekTG , GutscheBB . Does increased intravenous hydration decrease the incidence of nausea/vomiting following cesarean section? [abstract]. Anesthesiology2002;96(Suppl 1):P83. ">Gaiser 2002</a>; <a href="./references#CD007579-bbs2-0246" title="OwczarzakD , GhellarMR , deOliveiraGR , SemeghiniMM . Ondansetron and epidural morphine-induced pruritus and emesis after caesarean section: comparison with metoclopramide [abstract]. British Journal of Anaesthesia1997;78 Suppl 1:110. ">Owczarzak 1997</a>; <a href="./references#CD007579-bbs2-0251" title="PecoraFS , MalbouissonLM , TorresML . Supplemental oxygen and the incidence of perioperative nausea and vomiting in cesarean sections under subarachnoid block [Oxigenio suplmentar e incidencia de nauseas e vomitos perioperatorios no parto cesariano sob anestesia subaracnoidnea]. Revista Brasileira de Anestesiologia2009;59(5):558-69. ">Pecora 2009</a>; <a href="./references#CD007579-bbs2-0254" title="Phillips TW Jr, BroussardDM , Sumrall WD 3rd, HartSR . Intraoperative oxygen administration does not reduce the incidence or severity of nausea or vomiting associated with neuraxial anesthesia for cesarean delivery. Anesthesia and Analgesia2007;105(4):1113-7. PhillipsTW , HartSR , BroussardD , SumrallWD . Effects of supplemental oxygen administration on the incidence of nausea/vomiting during regional anesthesia for cesarean section [abstract]. Anesthesiology2005;102(Suppl 1):28. ">Phillips 2007</a>; <a href="./references#CD007579-bbs2-0284" title="ShahriariA , KhooshidehM , HeidariMH . Prevention of nausea and vomiting in caesarean section under spinal anaesthesia with midazolam or metoclopramide?JPMA - Journal of the Pakistan Medical Association2009;59(11):756-9. ">Shahriari 2009</a>), and three had provided no data (<a href="./references#CD007579-bbs2-0107" title="BiwasSC , BiswasBN , RudraA , PanA . A comparative study of metoclopramide, glycopyrrolate and combination of metoclopramide and glycopyrrolate in control of intraoperative and postoperative nausea and vomiting after spinal anaesthesia for caesarean section. Journal of Obstetrics and Gynecology of India2002;52(3):73-5. ">Biwas 2002</a>; <a href="./references#CD007579-bbs2-0118" title="ChaudhuriK , ChaudhuriS , LampeC , RiveraJ , Solis-EstradaJ . Does addition of dolasetron to metoclopramide alter nausea and vomiting in cesarean section patients under regional anesthesia [abstract]. Anesthesiology2004;101 Suppl:A1234. ">Chaudhuri 2004</a>; <a href="./references#CD007579-bbs2-0218" title="ManullangTR , ViscomiCM , PaceNL . Intrathecal fentanyl is superior to intravenous ondansetron for the prevention of perioperative nausea during cesarean delivery with spinal anesthesia. Anesthesia and Analgesia2000;90:1162-6. ">Manullang 2000</a>). </p> <p>In addition, there were eight comparisons in multi‐arm studies where, due to our change in scope, some arms were now excluded and the data from these women were not included in our review (<a href="./references#CD007579-bbs2-0002" title="AbdollahpourA , AzadiR , BandariR , MirmohammadkhaniM . Effects of adding midazolam and sufentanil to intrathecal bupivacaine on analgesia quality and postoperative complications in elective cesarean section. Anesthesiology and Pain Medicine2015;5(4):e23565. ">Abdollahpour 2015</a>; <a href="./references#CD007579-bbs2-0024" title="HabibAS , GeorgeRB , McKeenDM , WhiteWD , ItukUS , MegallaSA , et al. Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. Obstetrics and Gynecology2013;121(3):615-23. NCT01216410. Prevention of intraoperative nausea and vomiting during cesarean section. Https://clinicaltrials.gov/show/NCT01216410 (first received 2010 Oct 6). [CENTRAL: CN-02025773] ">Habib 2013</a>; <a href="./references#CD007579-bbs2-0038" title="KhalaylehK , OmarAA . Comparitive antiemetic efficacy of intrathecal fentanyl and intravenous metoclopromide, during Caesarean Section under spinal anaesthesia. Journal of the Bahrain Medical Society2005;17(4):243-7. ">Khalayleh 2005</a>; <a href="./references#CD007579-bbs2-0043" title="LevinD , CohenS , MellenderS , MohiuddinA , ZhaoR , KissG , et al. Transcutaneous P6 acupoint electrical stimulation prevents both nausea and vomiting during elective cesarean section under combined spinal-epidural: a randomized control clinical trial. Anesthesia and Analgesia2018;126(4):421-2. [CENTRAL: CN-01789975] [EMBASE: 626090330]LevinD , CohenS , MellenderS , ShahU , KangP , MohiuddinA , et al. Effectiveness of p6 stimulation for reduction of nausea and vomiting during caesarean section under combined spinal-epidural anaesthesia: a randomised controlled trial. Turkish Journal of Anaesthesiology and Reanimation2019;47(2):120-7. [CENTRAL: CN-02089475] LevinD , CohenS , MohiuddinA , NaftalovichR , KangP , MellenderS , et al. How does acupressure point P6 stimulation compare to pharmacological therapy in reduction of nausea and vomiting during cesarean section with neuraxial anesthesia? Randomized control trial. Regional Anesthesia and Pain Medicine2017;42(6):no pagination. [CENTRAL: CN-01441790] [EMBASE: 619777950]">Levin 2019</a>; <a href="./references#CD007579-bbs2-0053" title="MokiniZ , FabbriE , Dell'AttiI , Di MartinoR , D'EttorreM , PetriniF . A randomized, controlled, double blind trial on the incidence of nausea and vomiting with prophylactic subhypnotic propofol vs metoclopramide and in combination therapy in cesarean section with subarachnoid anesthesia. European Journal of Anaesthesiology2014;31:192. NCT01781377. Prophylactic subhypnotic propofol for nausea and vomiting during for cesarean section under subarachnoid anesthesia. Https://clinicaltrials.gov/show/NCT01781377 (first received 2013 Jan 25). [CENTRAL: CN-01540221] ">Mokini 2014</a>; <a href="./references#CD007579-bbs2-0072" title="ShenYJ , YinYQ , ZhangYJ , ZhuQ , ZhangJH , ZhaoW , et al. Efficacy of intravenous scopolamine for preventing postoperative nausea and vomiting after cesarean section. Acta Academiae Medicinae Sinicae2012;34(1):32-7. ">Shen 2012</a>; <a href="./references#CD007579-bbs2-0079" title="VoigtM , FrohlichCW , HuttelC , KrankeP , MennenJ , BoessneckO , et al. Prophylaxis of intra- and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. Medical Science Monitor2013;19:993-1000. ">Voigt 2013</a>; <a href="./references#CD007579-bbs2-0082" title="WuJI , LoY , ChiaYY , LiuK , FongWP , YangLC , et al. Prevention of postoperative nausea and vomiting after intrathecal morphine for cesarean section: a randomized comparison of dexamethasone, droperidol, and a combination. International Journal of Obstetric Anesthesia2007;16(2):122-7. ">Wu 2007</a>). </p> <p>(See: <a href="#CD007579-fig-0001">Figure 1</a>) </p> <div class="figure" id="CD007579-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD007579-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD007579-sec-0059"> <h4 class="title">Included studies</h4> <p>Of the 84 included studies (involving 10,990 women), 69 studies involving 8928 women provided usable data for this review, taking into account the arms of the multi‐arm studies which are not included in our inclusion criteria (<a href="./references#CD007579-bbs2-0001" title="Abdel-AleemM , OsmanA , MorsyK . Effect of coadministration of dexamethasone with intrathecal morphine on postoperative outcomes after cesarean delivery. International Journal of Gynecology and Obstetrics2012;116(2):158-61. ">Abdel‐Aleem 2012</a>; <a href="./references#CD007579-bbs2-0002" title="AbdollahpourA , AzadiR , BandariR , MirmohammadkhaniM . Effects of adding midazolam and sufentanil to intrathecal bupivacaine on analgesia quality and postoperative complications in elective cesarean section. Anesthesiology and Pain Medicine2015;5(4):e23565. ">Abdollahpour 2015</a>; <a href="./references#CD007579-bbs2-0003" title="AbouleishEI , RashidS , HaqueS , GiezentannerA , JoyntonP , ChuangAZ . Ondansetron versus placebo for the control of nausea and vomiting during caesarean section under spinal anaesthesia. Anaesthesia1999;54:479-82. ">Abouleish 1999</a>; <a href="./references#CD007579-bbs2-0004" title="AhnHJ , KimYA , ChoiDH . The effects of sedation using propofol TCI on the satisfaction level and side effects of parturients during regional anesthesia for a cesarean section. Korean Journal of Anesthesiology2002;43(1):66-72. ">Ahn 2002</a>; <a href="./references#CD007579-bbs2-0005" title="ApiliogullariS , DumanA , GokF . Prophylactic dimenhydrinate (dramamine) is effective in the treatment of nausea-vomiting with intrathecal morphine [abstract]. Regional Anesthesia and Pain Medicine2007;32(5 Suppl):87. ">Apiliogullari 2007</a>; <a href="./references#CD007579-bbs2-0006" title="BaciarelloM , CorniniA , ZasaM , PedronaP , ScrofaniG , VenutiFS , et al. Intrathecal atropine to prevent postoperative nausea and vomiting after cesarean section: a randomized, controlled trial. Minerva Anestesiologica2011;77(8):781-8. ">Baciarello 2011</a>; <a href="./references#CD007579-bbs2-0008" title="BiswasBN , RudraA , DasSK , NathS , BiswasSC . A comparative study of glycopyrrolate, dexamethasone and metoclopramide in control of post-operative nausea and vomiting after spinal anaesthesia for caesarean delivery. Indian Journal of Anaesthesia2003;47(3):198-200. ">Biswas 2003</a>; <a href="./references#CD007579-bbs2-0010" title="CabaF , BernalL , PallaresJA , EchevarriaM , RodriguezR . Prophylaxis for intraoperative nausea and vomiting with subhypnotic doses of propofol during intradural anaesthesia for caesarean section [Profilaxis de nauseas y vomitos intraoperatorios con dosis subhipnoticas de propofol durante anestesia intradural en cesareas]. Revista Espanola de Anestesiologia y Reanimacion1997;44(Suppl 1):122. [CENTRAL: CN-00400431] CabaF , EchevarriaM , Bernal-DavalosL , Pallares-GonzalezJA , Rodriguez-RodriguezR . Prophylaxis for intraoperative nausea and vomiting with nonhypnotic doses of propofol during intradural anesthesia for cesarean delivery [Profilaxis de las nauseas y los vomitos intraoperatorios con dosis subhipnoticas de propofol durante la anestesia intradural en cesareas]. Revista Espanola De Anestesiologia y Reanimacion1997;44:262-6. ">Caba 1997</a>; <a href="./references#CD007579-bbs2-0011" title="CardosoMM , LeiteAO , SantosEA , GozzaniJL , MathiasLA . Effect of dexamethasone on prevention of postoperative nausea, vomiting and pain after caesarean section: a randomised, placebo-controlled, double-blind trial. European Journal of Anaesthesiology2013;30:102-5. ">Cardoso 2013</a>; <a href="./references#CD007579-bbs2-0012" title="CarvalhoJC , NairGS , DowneyK , BalkiM . Prophylactic dimenhydrinate does not reduce nausea and vomiting during cesarean section delivery under spinal anesthesia: a randomized, double-blind, placebo-controlled trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 42nd Annual Meeting; 2010 May 12-16, San Antonio, USA. 2010. NCT00791960. Prophylactic dimenhydrinate for intraoperative nausea and vomiting. Https://clinicaltrials.gov/show/NCT00791960 (first received 2008 Nov 13). [CENTRAL: CN-01485523] ">Carvalho 2010</a>; <a href="./references#CD007579-bbs2-0013" title="CharuluxanananS , KyokongO , SomboonviboonW , NarasethakamolA , PromlokP . Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesthesia and Analgesia2003;96(6):1789-93. ">Charuluxananan 2003</a>; <a href="./references#CD007579-bbs2-0014" title="CherianVT , SmithI . Prophylactic ondansetron does not improve patient satisfaction in women using PCA after caesarean section. British Journal of Anaesthesia2001;87(3):502-4. ">Cherian 2001</a>; <a href="./references#CD007579-bbs2-0015" title="ChestnutDH , BatesJN , ChoiWW , VandewalkerGE . Administration of metoclopramide for prevention of nausea and vomiting during regional anesthesia for cesarean section: a randomized, double blind, placebo controlled study. Anesthesiology1986;65:390. ChestnutDH , VandewalkerGE , OwenCL , BatesJN , ChoiWW . Administration of metoclopramide for prevention of nausea and vomiting during epidural anesthesia for elective cesarean section. Anesthesiology1987;66:563-6. ">Chestnut 1987</a>; <a href="./references#CD007579-bbs2-0016" title="ChoiDH , KimSC , SimWS . Prevention of nausea and vomiting during spinal or epidural anesthesia for cesarean section - the efficacy of metoclopramide and droperidol. Korean Journal of Anesthesiology1999;37(6):1054-9. ">Choi 1999</a>; <a href="./references#CD007579-bbs2-0017" title="DasguptaM , BiswasBN , ChatterjeeS , MazumderP , BhanjaM . Randomized, placebo-controlled trial of granisetron for control of nausea and vomiting during cesarean delivery under spinal anesthesia. Journal of Obstetrics and Gynecology of India2012;62(4):419-23. ">Dasgupta 2012</a>; <a href="./references#CD007579-bbs2-0018" title="Direkvand-MoghadamA , KhosraviA . Effect of acupressure on post-operative nausea and vomiting in cesarean section: a randomised controlled trial. Journal of Clinical and Diagnostic Research2013;7(10):2247-9. IRCT201111146575N4. Comparing the effect of acupressure and metoclopramide on nausea and vomiting in women with spinal anesthesia for cesarean. http://en.irct.ir/trial/7020 (21 December 2011). [CENTRAL: CN-01849415] ">Direkvand‐Moghadam 2013</a>; <a href="./references#CD007579-bbs2-0019" title="DuggalKN , DouglasMJ , PeterEA , MerrickPM . Acupressure for intrathecal narcotic-induced nausea and vomiting after caesarean section. International Journal of Obstetric Anesthesia1998;7(4):231-6. ">Duggal 1998</a>; <a href="./references#CD007579-bbs2-0020" title="ApiliogullariS , GokF , CanpolatA , SoysalS , ToyH , SukanF . Comparison of prophylactic dimenhydrinate and metoclopramide for prevention of nausea-vomiting caused by intrathecal opioids in parturients undergoing caesarean delivery. Regional Anesthesia and Pain Medicine2008;33(5 Suppl 1):131. DumanA , ApiliogullariS , GokF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine in cesarean delivery. Nobel Medicus2010;6(3):13-9. DumanA , ApiliogullariS , GookF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine for cesarean delivery. Data on file. ">Duman 2010</a>; <a href="./references#CD007579-bbs2-0021" title="El-DeebAM , AhmadyMS . Effect of acupuncture on nausea and/or vomiting during and after cesarean section in comparison with ondansetron. Journal of Anesthesia2011;25(5):698-703. ">El‐Deeb 2011a</a>; <a href="./references#CD007579-bbs2-0022" title="Garcia-MiguelFJ , MontanoE , Mart-VicenteV , FuentesAL , AlsinaFJ , San JoseJA . Prophylaxis against intraoperative nausea and vomiting during spinal anesthesia for cesarean section: a comparative study of ondansetron versus metoclopramide. Internet Journal of Anesthesiology2000;4(2). ">Garcia‐Miguel 2000</a>; <a href="./references#CD007579-bbs2-0023" title="HabibAS , Itchon-RamosN , Phillips-ButeBG , GanTJ , the Duke Women's Anesthesia (DWA) Research Group. Transcutaneous acupoint electrical stimulation with the ReliefBand for the prevention of nausea and vomiting during and after cesarean delivery under spinal anesthesia. Anesthesia and Analgesia2006;102(2):581-4. ">Habib 2006</a>; <a href="./references#CD007579-bbs2-0024" title="HabibAS , GeorgeRB , McKeenDM , WhiteWD , ItukUS , MegallaSA , et al. Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. Obstetrics and Gynecology2013;121(3):615-23. NCT01216410. Prevention of intraoperative nausea and vomiting during cesarean section. Https://clinicaltrials.gov/show/NCT01216410 (first received 2010 Oct 6). [CENTRAL: CN-02025773] ">Habib 2013</a>; <a href="./references#CD007579-bbs2-0025" title="HarmonD , RyanM , KellyA , BowenM . Acupressure and prevention of nausea and vomiting during and after spinal anaesthesia for caesarean section. British Journal of Anaesthesia2000;84(4):463-7. HarmonD , RyanM , KellyA , BowenM . Acupressure and the prevention of nausea and vomiting during and after spinal anaesthesia for caesarean section. British Journal of Anaesthesia1999;82 Suppl:161. ">Harmon 2000</a>; <a href="./references#CD007579-bbs2-0026" title="HarnettMJ , O'RourkeN , WalshM , CarabuenaJM , SegalS . Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery. Anesthesia and Analgesia2007;105(3):764-9. ">Harnett 2007</a>; <a href="./references#CD007579-bbs2-0027" title="HassaneinA , MahmoudE . Effect of low dose ketamine versus dexamethasone on intraoperative nausea and vomiting during cesarean section under spinal anesthesia. Egyptian Journal of Anaesthesia2015;31(1):59-63. ">Hassanein 2015</a>; <a href="./references#CD007579-bbs2-0028" title="HoCM , HseuSS , TsaiSK , LeeTY . Effect of P-6 acupressure on prevention of nausea and vomiting after epidural morphine for post-Cesarean section pain relief. Acta Anaesthesiologica Scandinavica1996;40:372-5. ">Ho 1996</a>; <a href="./references#CD007579-bbs2-0029" title="HoCM , TsaiHJ , ChanKH , TsaiSK . P6 acupressure does not prevent emesis during spinal anesthesia for cesarean delivery. Anesthesia and Analgesia2006;102(3):900-3. HoCM , TsaiSK . P-6 acupressure do not prevent emesis during cesarean section [abstract]. Canadian Journal of Anesthesia2002;49(6 Suppl):A51. ">Ho 2006</a>; <a href="./references#CD007579-bbs2-0030" title="HuangWP . Clinical observation of using Metoclopramide to relieve dragging reaction during baby deliver in caesarean operation. Chinese Journal of Anaesthesiology1992;12(1):33. ">Huang 1992</a>; <a href="./references#CD007579-bbs2-0031" title="IbrahimAS , AlyMG , ThabetME , AbdelazizMR . Effect of adding nalbuphine to intrathecal bupivacaine with morphine on postoperative nausea and vomiting and pruritus after elective cesarean delivery: a randomized double blinded study. Minerva Anestesiologica2019;85(3):255-62. [CENTRAL: CN-01939130] [EMBASE: 2001726956] [PMID: 29856176]">Ibrahim 2019</a>; <a href="./references#CD007579-bbs2-0033" title="JaafarpourM , KhaniA , DyrekvandmoghadamA , KhajavikhanJ , SaadipourKH . The effect of dexamethasone on nausea, vomiting and pain in parturients undergoing caesarean delivery. Journal of Clinical and Diagnostic Research2008;2(3):854-8. ">Jaafarpour 2008</a>; <a href="./references#CD007579-bbs2-0035" title="KalavaA , DarjiSJ , KalsteinA , YarmushJM , SchianodiColaJ , WeinbergJ . Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;169(2):184-8. KalavaA , WeinbergJ , JayakumarM , YarmushJM , SchianodiColaJJ . Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. In: http://www.asaabstracts.com/strands/asaabstracts/abstract.htm;jsessionid=0507CB47FEB444D841EEF290BF35A8BF?year=2011&amp;index=13&amp;absnum=4726 (accessed 1 Febraury 2012). 2011. NCT01733212. Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. Https://clinicaltrials.gov/show/NCT01733212 2012 Nov 26. [CENTRAL: CN-02041676] ">Kalava 2013</a>; <a href="./references#CD007579-bbs2-0036" title="ISRCTN15475205. Does propofol prevent morphine-induced nausea, vomiting and itching in women who have had a Caesarean section?Http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN15475205 (first received 2019). [CENTRAL: CN-01974804] KampoS , AffulAP , MohammedS , NtimM , BuunaaimAD , AnabahTW . Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section - a randomized control trial. BMC Anesthesiology2019;19(1):177. [CENTRAL: CN-01987099] [EMBASE: 629299629] [PMID: 31521119]">Kampo 2019</a>; <a href="./references#CD007579-bbs2-0037" title="KasodekarS , DhumneS , BalkiM , CarvalhoJ . Prophylactic granisetron does not prevent nausea and vomiting during elective cesarean section under spinal anesthesia [abstract]. Anesthesiology2006;104(Suppl 1):9. ">Kasodekar 2006</a>; <a href="./references#CD007579-bbs2-0038" title="KhalaylehK , OmarAA . Comparitive antiemetic efficacy of intrathecal fentanyl and intravenous metoclopromide, during Caesarean Section under spinal anaesthesia. Journal of the Bahrain Medical Society2005;17(4):243-7. ">Khalayleh 2005</a>; <a href="./references#CD007579-bbs2-0040" title="KojuRB , CTRI/2015/01/005362. Prophylactic administration of ondansetron in prevention of intrathecal morphine induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section. http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=10813 (07 January 2015). KojuRB , GurungBS , DongolY . Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section. BMC Anesthesiology2015;15:18. ">Koju 2015</a>; <a href="./references#CD007579-bbs2-0041" title="KotelkoDM , RottmanRL , WrightWC , StoneJJ , YamashiroAY , RosenblattRM . Transderm SCOP decreases post-cesarean nausea and vomiting in patients receiving epidural morphine. Anesthesiology1988;69:A666. KotelkoDM , RottmanRL , WrightWC , StoneJJ , YamashiroAY , RosenblattRM . Transdermal scopolamine decreases nausea and vomiting following cesarean section in patients receiving epidural morphine. Anesthesiology1989;71:675-8. ">Kotelko 1989</a>; <a href="./references#CD007579-bbs2-0043" title="LevinD , CohenS , MellenderS , MohiuddinA , ZhaoR , KissG , et al. Transcutaneous P6 acupoint electrical stimulation prevents both nausea and vomiting during elective cesarean section under combined spinal-epidural: a randomized control clinical trial. Anesthesia and Analgesia2018;126(4):421-2. [CENTRAL: CN-01789975] [EMBASE: 626090330]LevinD , CohenS , MellenderS , ShahU , KangP , MohiuddinA , et al. Effectiveness of p6 stimulation for reduction of nausea and vomiting during caesarean section under combined spinal-epidural anaesthesia: a randomised controlled trial. Turkish Journal of Anaesthesiology and Reanimation2019;47(2):120-7. [CENTRAL: CN-02089475] LevinD , CohenS , MohiuddinA , NaftalovichR , KangP , MellenderS , et al. How does acupressure point P6 stimulation compare to pharmacological therapy in reduction of nausea and vomiting during cesarean section with neuraxial anesthesia? Randomized control trial. Regional Anesthesia and Pain Medicine2017;42(6):no pagination. [CENTRAL: CN-01441790] [EMBASE: 619777950]">Levin 2019</a>; <a href="./references#CD007579-bbs2-0044" title="LiJZ , LiXZ , WangMS , LiJP , ShiF , YuHF . [Effects of transcutaneous electrical stimulation of auricular Shenmen point on postoperative nausea and vomiting and patient-controlled epidural analgesia in cesarean section]. [Chinese]. Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal]2012;92(27):1892-5. ">Li 2012</a>; <a href="./references#CD007579-bbs2-0048" title="LussosS , BaderA , ThornhillM , DattaS . The antiemetic efficacy of prophylactic metoclopramide for cesarean delivery. Anesthesiology1991;75:A1081. LussosSA , BaderAM , ThornhillML , DattaS . The antiemetic efficacy and safety of prophylactic metoclopramide for elective cesarean delivery during spinal anesthesia. Regional Anesthesia1992;17:126-30. ">Lussos 1992</a>; <a href="./references#CD007579-bbs2-0049" title="MandellG , DewanDM , HowardG , FloydHM . The effectiveness of low dose droperidol in controlling nausea and vomiting during epidural anesthesia for cesarean section. Anesthesiology1986;65:391. MandellGL , DewanDM , HowardG , FloydHM . The effectiveness of low dose droperidol in controlling nausea and vomiting during epidural anesthesia for cesarean section. International Journal of Obstetric Anesthesia1992;1(2):65-8. ">Mandell 1992</a>; <a href="./references#CD007579-bbs2-0050" title="MaranhaoMV , CoelhoVV , IvoCM , MaranhaoMH , AmaralEB . A comparative study between metoclopramide and droperidol in the control of nausea and vomit in patients subjected to spinal blockade during cesarean section [Estudo comparativo entre a metoclopramida e o droperidol no controle de nauseas e vomitos na operacao cesariana em gestantes submetidas a bloqueio subaracnoideo]. Revista Brasileira de Anestesiologia1988;38(4):245-9. ">Maranhao 1988</a>; <a href="./references#CD007579-bbs2-0052" title="MohammadiSS , JabbarzadehS , MovafeghA . Efficacy of granisetron on prevention of shivering, nausea and vomiting during cesarean delivery under spinal anesthesia: a randomized double-blinded clinical trial. Journal of Obstetric Anaesthesia and Critical Care2015;5(1):22-6. ">Mohammadi 2015</a>; <a href="./references#CD007579-bbs2-0053" title="MokiniZ , FabbriE , Dell'AttiI , Di MartinoR , D'EttorreM , PetriniF . A randomized, controlled, double blind trial on the incidence of nausea and vomiting with prophylactic subhypnotic propofol vs metoclopramide and in combination therapy in cesarean section with subarachnoid anesthesia. European Journal of Anaesthesiology2014;31:192. NCT01781377. Prophylactic subhypnotic propofol for nausea and vomiting during for cesarean section under subarachnoid anesthesia. Https://clinicaltrials.gov/show/NCT01781377 (first received 2013 Jan 25). [CENTRAL: CN-01540221] ">Mokini 2014</a>; <a href="./references#CD007579-bbs2-0054" title="MukherjeeS , RudraA , MandelM , KumarP . Optimum dose of propofol for prevention of emetic episodes during caesarean delivery: an evaluation. Journal of Anaesthesia and Clinical Pharmacology2006;22(2):139-43. ">Mukherjee 2006</a>; <a href="./references#CD007579-bbs2-0055" title="MunnurU , TranC , ZambareSN , Lozano-GorenaM , SureshMS . Post operative nausea and vomiting following cesarean section with intrathecal morphine. Anesthesiology2008;109:A1113. ">Munnur 2008</a>; <a href="./references#CD007579-bbs2-0056" title="NiuK , LiuH , Chen R-W, Fang Q-W, WenH , Guo S-M, et al. Use of propofol for prevention of post-delivery nausea during cesarean section: a double-blind, randomized, placebo-controlled trial. Journal of Anesthesia2018;32(5):748-55. [CENTRAL: CN-02000278] [EMBASE: 623932583] [PMID: 30209576]">Niu 2018</a>; <a href="./references#CD007579-bbs2-0057" title="NorooziniaH , MahooriA , HasaniE , Gerami-FahimM , SepehrvandN . The effect of acupressure on nausea and vomiting after cesarean section under spinal anesthesia. Acta Medica Iranica2013;51(3):163-7. ">Noroozinia 2013</a>; <a href="./references#CD007579-bbs2-0058" title="NortcliffeSA , BuggyDJ . Prophylaxis of nausea and vomiting after spinal morphine analgesia for caesarean section: comparison between cyclizine, dexamethasone, and placebo [abstract]. British Journal of Anaesthesia2001;87(4):657P. NortcliffeSA , ShahJ , BuggyDJ . Prevention of postoperative nausea and vomiting after spinal morphine for caesarean section: comparison of cyclizine, dexamethasone and placebo. British Journal of Anaesthesia2003;90(5):665-70. ">Nortcliffe 2003</a>; <a href="./references#CD007579-bbs2-0059" title="PanPH , MooreCH . Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for cesarean section patients under epidural anesthesia. Anesthesia and Analgesia1996;83(5):982-6. ">Pan 1996</a>; <a href="./references#CD007579-bbs2-0060" title="PanP , MooreC , FragnetoR , RossV , JustisG . Is antiemetic prophylaxis cost-effective for cesarean section patients [abstract]. Anesthesiology2000;93(3A):A1092. PanPH , MooreC , FragnetoR , RossV , JustisG . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesiology2000;92 Suppl:A40. PanPH , MooreCH . Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. Journal of Clinical Anesthesia2001;13(6):430-5. PanPH , MooreCM . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesia and Analgesia2000;90 Suppl:S295. ">Pan 2001</a>; <a href="./references#CD007579-bbs2-0061" title="PanAK , RudraA . Prophylactic single dose intravenous administration of ondansetron in the prevention of postoperative emetic symptoms during spinal anaesthesia for caesarean delivery. Indian Journal of Anaesthesia2003;47(3):178-80. ">Pan 2003</a>; <a href="./references#CD007579-bbs2-0062" title="ISRCTN57227250. Prevention of nausea and vomiting comparing ondansetron and dexamethasone versus placebo in cesarean section under regional anesthesia. http://www.isrctn.com/ISRCTN57227250 (7 July 2016). [CENTRAL: CN-01812416] Parra-GuizaR , MelendezHJ , OchoaME . Prophylactic efficacy of ondansetron and dexamethasone in nausea and vomit in patients undergoing cesarean section with neuraxial opioids. Controlled clinical trial. Medicas UIS2018;31(1):31-8. [DOI: 10.18273/revmed.v31n1-2018004]">Parra‐Guiza 2018</a>; <a href="./references#CD007579-bbs2-0064" title="PeixotoAJ , CelichMF , ZardoL , Peixoto FilhoAJ . Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine. European Journal of Anaesthesiology2006;23(8):670-5. ">Peixoto 2006</a>; <a href="./references#CD007579-bbs2-0066" title="RasooliS , MoslemiF , KhakiA . Effect of sub hypnotic doses of propofol and midazolam for nausea and vomiting during spinal anesthesia for cesarean section. Anesthesiology and Pain Medicine2014;4(4):e19384. ">Rasooli 2014</a>; <a href="./references#CD007579-bbs2-0067" title="RudraA , HalderR , SenA , KunduS . Efficacy of low dose propofol for control of emetic episodes during caesarean delivery with spinal anaesthesia. Indian Journal of Anaesthesia2004;48(1):31-4. ">Rudra 2004a</a>; <a href="./references#CD007579-bbs2-0068" title="SahooT , SenDasguptaC , GoswamiA , HazraA . Reduction in spinal-induced hypotension with ondansetron in parturients undergoing caesarean section: A double-blind randomised, placebo-controlled study. International Journal of Obstetric Anesthesia2012;21(1):24-8. ">Sahoo 2012</a>; <a href="./references#CD007579-bbs2-0070" title="KjaerK . Dexamethasone for the prevention of post-operative nausea and vomiting in patients undergoing cesarean sections. https://clinicaltrials.gov/ct2/show/results/NCT01734161 (27 November 2012). [CENTRAL: CN-01538899] SelzerA , PryorKO , TangelV , O'ConnellK , KjaerK . The effect of intravenous dexamethasone on postoperative nausea and vomiting after Cesarean delivery with intrathecal morphine: a randomized-controlled trial [Effet de la dexamethasone intraveineuse sur les nausees et vomissements postoperatoires apres un accouchement par cesarienne avec morphine intrathecale: un essai randomise controle]. Canadian Journal of Anesthesia2020;67:817-26. [CENTRAL: CN-02072818] [EMBASE: 2004140352] [PMID: 31989472]SelzerAR , PickJ , AbramovitzS , GadallaF , DarwichA , KjaerK . The effect of a single dose of intravenous dexamethasone on nausea and vomiting when administered prior to intrathecal morphine for cesarean section: a randomized, placebo-controlled, double-blinded trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 47th Annual Meeting; 2015 May 13-17; Colorado, USA. 2015:T-03. ">Selzer 2020</a>; <a href="./references#CD007579-bbs2-0071" title="ShabanaAM , NasrES , MoawadHE . Effect of ketamine on intraoperative nausea and vomiting during elective caesarean section under spinal anaesthesia: a placebo-controlled prospective randomized double blinded study. Egyptian Journal of Anaesthesia2012;28(2):169-74. ">Shabana 2012</a>; <a href="./references#CD007579-bbs2-0072" title="ShenYJ , YinYQ , ZhangYJ , ZhuQ , ZhangJH , ZhaoW , et al. Efficacy of intravenous scopolamine for preventing postoperative nausea and vomiting after cesarean section. Acta Academiae Medicinae Sinicae2012;34(1):32-7. ">Shen 2012</a>; <a href="./references#CD007579-bbs2-0073" title="SteinDJ , BirnbachDJ , DanzerBI , KurodaMM , GrunebaumA , ThysDM . Acupressure versus intravenous metoclopramide to prevent nausea and vomiting during spinal anesthesia for cesarean section. Anesthesia and Analgesia1997;84(2):342-5. ">Stein 1997</a>; <a href="./references#CD007579-bbs2-0074" title="TarhanO , CanbayO , CelebiN , UzunS , SahinA , CoskunF , et al. Subhypnotic doses of midazolam prevent nausea and vomiting during spinal anesthesia for cesarean section. Minerva Anestesiologica2007;73(12):629-33. ">Tarhan 2007</a>; <a href="./references#CD007579-bbs2-0075" title="TkachenkoR , PyasetskaN . The efficiency of intrathecal dexamethasone for spinal anaesthesia in elective caesarean section. Regional Anesthesia and Pain Medicine2019;44(10):A192. [CENTRAL: CN-01999210] [EMBASE: 629475510]">Tkachenko 2019</a>; <a href="./references#CD007579-bbs2-0076" title="TzengJI , WangJJ , HoST , TangCS , LiuYC , LeeSC . Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline. British Journal of Anaesthesia2000;85(6):865-8. ">Tzeng 2000</a>; <a href="./references#CD007579-bbs2-0077" title="TCTR20160216003. Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. http://www.clinicaltrials.in.th/index.php?tp=regtrials&amp;menu=trialsearch&amp;smenu=fulltext&amp;task=search&amp;task2=view1&amp;id=1734 (16 February 2016). [CENTRAL: CN-01882139] UerpairojkitK , ChesohA , BudcharoentongD . Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. Anesthesia and Analgesia2016;123(3 Suppl):286-7. [CENTRAL: CN-01783979] [EMBASE: 612648638]UerpairojkitK , ChesohA , BudcharoentongD . Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. Chotmaihet Thangphaet [Journal of the Medical Association of Thailand]2017;100(12):1283-9. [CENTRAL: CN-01451211] [EMBASE: 620181091]">Uerpairojkit 2017</a>; <a href="./references#CD007579-bbs2-0078" title="UreD , JamesKS , McNeillM , BoothJV . Glycopyrrolate reduces nausea during spinal anaesthesia for caesarean section without affecting neonatal outcome. British Journal of Anaesthesia1999;82(2):277-9. ">Ure 1999</a>; <a href="./references#CD007579-bbs2-0079" title="VoigtM , FrohlichCW , HuttelC , KrankeP , MennenJ , BoessneckO , et al. Prophylaxis of intra- and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. Medical Science Monitor2013;19:993-1000. ">Voigt 2013</a>; <a href="./references#CD007579-bbs2-0080" title="WangJJ , HoST , WongCS , TzengJI , LiuHS , GerLP . Dexamethasone prophylaxis of nausea and vomiting after epidural morphine for post-cesarean analgesia. Canadian Journal of Anaesthesia2001;48(2):185-90. ">Wang 2001</a>; <a href="./references#CD007579-bbs2-0082" title="WuJI , LoY , ChiaYY , LiuK , FongWP , YangLC , et al. Prevention of postoperative nausea and vomiting after intrathecal morphine for cesarean section: a randomized comparison of dexamethasone, droperidol, and a combination. International Journal of Obstetric Anesthesia2007;16(2):122-7. ">Wu 2007</a>; <a href="./references#CD007579-bbs2-0084" title="ZeraatiH , ShahinfarJ , HesariSI , MasrorniyaM , NasimiF . The effect of ginger extract on the incidence and severity of nausea and vomiting after cesarean section under spinal anesthesia. Anesthesiology and Pain Medicine2016;6(5):e38943. [CENTRAL: CN-01760273] [EMBASE: 612722027] [PMID: 27847700]">Zeraati 2016</a>). </p> <p>Fifteen studies are included but do not contribute data to the meta‐analysis because the data were either presented in a graphical format only, or there was no information on the number of women in each outcome group (<a href="./references#CD007579-bbs2-0007" title="BirnbachDJ , SteinDJ , SaundersTA , GrunebaumA , KitainEM . Prophylactic use of acupressure for the prevention of nausea and vomiting during spinal anesthesia for cesarean section. Anesthesiology1993;79:A1020. ">Birnbach 1993</a>; <a href="./references#CD007579-bbs2-0009" title="BooneJB , GaoGG , ClarkCP , ChaudhuriS , ChaudhuriK . Dolasetron for prevention of perioperative nausea and vomiting during cesarean section under regional anesthesia [abstract]. Anesthesiology2002;96 Suppl:A1069. ">Boone 2002</a>; ; <a href="./references#CD007579-bbs2-0032" title="ImbeloniLE , SantosJM , SantosMM . Prophylactic use of metoclopramide for control of nausea and vomiting during epidural anesthesia for cesarean section [Uso profilatico da metoclopramida no controle de nauseas e vomitos durante anestesia peridural para cesariana]. Revista Brasileira de Anestesiologia1986;36(4):295-8. ">Imbeloni 1986</a>; <a href="./references#CD007579-bbs2-0034" title="JangDG , ChangWY , YoonSY , KimKB . Epidural butorphanol reduces the side effects from epidural morphine after cesarean section. Korean Journal of Anesthesiology1997;33(2):297-303. ">Jang 1997</a>; <a href="./references#CD007579-bbs2-0039" title="KimMO , SuhKS . A comparison of the antiemetic effect of ondansetron and metoclopramide on nausea and vomiting associated with epidural buprenorphine. Korean Journal of Anesthesiology1999;37(4):656-61. ">Kim 1999</a>; <a href="./references#CD007579-bbs2-0042" title="LeeYW , HongJY , YoonHJ , KimSM . Could emesis from epidural anesthesia for a cesarean section be controlled by prophylactic low-dose granisetron?Korean Journal of Anesthesiology2002;43(6):s13-9. ">Lee 2002</a>; <a href="./references#CD007579-bbs2-0045" title="LimTJ , ChiuJW , TanHM . Transcutaneous acupoint electrical stimulation for prevention of perioperative nausea and vomiting during cesarean section with spinal anesthesia [abstract]. Anesthesiology2001;95 Suppl:A1078. ">Lim 2001a</a>; <a href="./references#CD007579-bbs2-0046" title="LimTJ , LimE , ChiuJW , TanHM . Perioperative antiemetic efficacy of dexamethasone 4mg in cesarean section under spinal anaesthesia [abstract]. Anesthesiology2001;95 Suppl:A466. ">Lim 2001b</a>; <a href="./references#CD007579-bbs2-0047" title="LiuY , WangM , LiQ , WangL , LiJ . Impacts of transcutaneous acupoint electric stimulation on the postoperative nausea and vomiting and plasma 5-ht concentration after cesarean section. Chinese Acupuncture &amp; Moxibustion2015;35(10):1039-43. ">Liu 2015a</a>; <a href="./references#CD007579-bbs2-0051" title="ModirH , MoshiriE , KamaliA , ShokrpourM , ShamsN . Prophylatic efficacy of dexamethasone, ketamine and dexmedetomidine against intra- and postoperative nausea and vomiting under spinal anesthesia. Formosan Journal of Surgery2019;52(1):17-23. [CENTRAL: CN-01790839] [EMBASE: 626475964]">Modir 2019</a>; <a href="./references#CD007579-bbs2-0063" title="PazokiS , ModirH , KamaliA , ZamaniA , ShahidaniM . Ondansetron 8 mg and 4 mg with normal saline against post-operative headache and nausea/vomiting after spinal anesthesia: a randomized double-blind trial. Medical Gas Research2018;8(2):48-53. [CENTRAL: CN-01617025] [EMBASE: 622985422]">Pazoki 2018</a>; <a href="./references#CD007579-bbs2-0065" title="QuineyNF , MurphyPG . The effect of pretreatment with glycopyrrolate on emetic and hypotensive problems during caesarean section conducted under spinal anaesthesia [abstract]. International Journal of Obstetric Anesthesia1995;4:66-7. ">Quiney 1995</a>; <a href="./references#CD007579-bbs2-0069" title="SanansilpV , AreewatanaS , TonsukchaiN . Droperidol and the side effects of epidural morphine after cesarean section. Anesthesia &amp; Analgesia1998;86(3):532-7. ">Sanansilp 1998</a>; <a href="./references#CD007579-bbs2-0081" title="WeissMD , DiazF , ZuberiF , MilmanB , PasrichaS . Subhypnotic doses of propofol for prevention of postoperative pruritus and nausea in cesarean section patients given spinal opioids. Anesthesiology1995;83(3A):A960. ">Weiss 1995</a>; <a href="./references#CD007579-bbs2-0083" title="YazigiA , ChalhoubV , Madi-JebaraS , HaddadF , HayekG . Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritis after cesarean delivery with intrathecal sufentanil-morphine. Journal of Clinical Anesthesia2002;14:183-6. ">Yazigi 2002</a>). We have written to these authors requesting further information. </p> <section id="CD007579-sec-0060"> <h5 class="title">Multi‐arm studies</h5> <p>There are 41 multi‐arm studies, 31 are three‐arm studies (<a href="./references#CD007579-bbs2-0002" title="AbdollahpourA , AzadiR , BandariR , MirmohammadkhaniM . Effects of adding midazolam and sufentanil to intrathecal bupivacaine on analgesia quality and postoperative complications in elective cesarean section. Anesthesiology and Pain Medicine2015;5(4):e23565. ">Abdollahpour 2015</a>; <a href="./references#CD007579-bbs2-0005" title="ApiliogullariS , DumanA , GokF . Prophylactic dimenhydrinate (dramamine) is effective in the treatment of nausea-vomiting with intrathecal morphine [abstract]. Regional Anesthesia and Pain Medicine2007;32(5 Suppl):87. ">Apiliogullari 2007</a>; <a href="./references#CD007579-bbs2-0006" title="BaciarelloM , CorniniA , ZasaM , PedronaP , ScrofaniG , VenutiFS , et al. Intrathecal atropine to prevent postoperative nausea and vomiting after cesarean section: a randomized, controlled trial. Minerva Anestesiologica2011;77(8):781-8. ">Baciarello 2011</a>; <a href="./references#CD007579-bbs2-0007" title="BirnbachDJ , SteinDJ , SaundersTA , GrunebaumA , KitainEM . Prophylactic use of acupressure for the prevention of nausea and vomiting during spinal anesthesia for cesarean section. Anesthesiology1993;79:A1020. ">Birnbach 1993</a>; <a href="./references#CD007579-bbs2-0016" title="ChoiDH , KimSC , SimWS . Prevention of nausea and vomiting during spinal or epidural anesthesia for cesarean section - the efficacy of metoclopramide and droperidol. Korean Journal of Anesthesiology1999;37(6):1054-9. ">Choi 1999</a>; <a href="./references#CD007579-bbs2-0018" title="Direkvand-MoghadamA , KhosraviA . Effect of acupressure on post-operative nausea and vomiting in cesarean section: a randomised controlled trial. Journal of Clinical and Diagnostic Research2013;7(10):2247-9. IRCT201111146575N4. Comparing the effect of acupressure and metoclopramide on nausea and vomiting in women with spinal anesthesia for cesarean. http://en.irct.ir/trial/7020 (21 December 2011). [CENTRAL: CN-01849415] ">Direkvand‐Moghadam 2013</a>; <a href="./references#CD007579-bbs2-0020" title="ApiliogullariS , GokF , CanpolatA , SoysalS , ToyH , SukanF . Comparison of prophylactic dimenhydrinate and metoclopramide for prevention of nausea-vomiting caused by intrathecal opioids in parturients undergoing caesarean delivery. Regional Anesthesia and Pain Medicine2008;33(5 Suppl 1):131. DumanA , ApiliogullariS , GokF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine in cesarean delivery. Nobel Medicus2010;6(3):13-9. DumanA , ApiliogullariS , GookF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine for cesarean delivery. Data on file. ">Duman 2010</a>; <a href="./references#CD007579-bbs2-0021" title="El-DeebAM , AhmadyMS . Effect of acupuncture on nausea and/or vomiting during and after cesarean section in comparison with ondansetron. Journal of Anesthesia2011;25(5):698-703. ">El‐Deeb 2011a</a>; <a href="./references#CD007579-bbs2-0022" title="Garcia-MiguelFJ , MontanoE , Mart-VicenteV , FuentesAL , AlsinaFJ , San JoseJA . Prophylaxis against intraoperative nausea and vomiting during spinal anesthesia for cesarean section: a comparative study of ondansetron versus metoclopramide. Internet Journal of Anesthesiology2000;4(2). ">Garcia‐Miguel 2000</a>; <a href="./references#CD007579-bbs2-0024" title="HabibAS , GeorgeRB , McKeenDM , WhiteWD , ItukUS , MegallaSA , et al. Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. Obstetrics and Gynecology2013;121(3):615-23. NCT01216410. Prevention of intraoperative nausea and vomiting during cesarean section. Https://clinicaltrials.gov/show/NCT01216410 (first received 2010 Oct 6). [CENTRAL: CN-02025773] ">Habib 2013</a>; <a href="./references#CD007579-bbs2-0026" title="HarnettMJ , O'RourkeN , WalshM , CarabuenaJM , SegalS . Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery. Anesthesia and Analgesia2007;105(3):764-9. ">Harnett 2007</a>; <a href="./references#CD007579-bbs2-0027" title="HassaneinA , MahmoudE . Effect of low dose ketamine versus dexamethasone on intraoperative nausea and vomiting during cesarean section under spinal anesthesia. Egyptian Journal of Anaesthesia2015;31(1):59-63. ">Hassanein 2015</a>; <a href="./references#CD007579-bbs2-0036" title="ISRCTN15475205. Does propofol prevent morphine-induced nausea, vomiting and itching in women who have had a Caesarean section?Http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN15475205 (first received 2019). [CENTRAL: CN-01974804] KampoS , AffulAP , MohammedS , NtimM , BuunaaimAD , AnabahTW . Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section - a randomized control trial. BMC Anesthesiology2019;19(1):177. [CENTRAL: CN-01987099] [EMBASE: 629299629] [PMID: 31521119]">Kampo 2019</a>; <a href="./references#CD007579-bbs2-0038" title="KhalaylehK , OmarAA . Comparitive antiemetic efficacy of intrathecal fentanyl and intravenous metoclopromide, during Caesarean Section under spinal anaesthesia. Journal of the Bahrain Medical Society2005;17(4):243-7. ">Khalayleh 2005</a>; <a href="./references#CD007579-bbs2-0043" title="LevinD , CohenS , MellenderS , MohiuddinA , ZhaoR , KissG , et al. Transcutaneous P6 acupoint electrical stimulation prevents both nausea and vomiting during elective cesarean section under combined spinal-epidural: a randomized control clinical trial. Anesthesia and Analgesia2018;126(4):421-2. [CENTRAL: CN-01789975] [EMBASE: 626090330]LevinD , CohenS , MellenderS , ShahU , KangP , MohiuddinA , et al. Effectiveness of p6 stimulation for reduction of nausea and vomiting during caesarean section under combined spinal-epidural anaesthesia: a randomised controlled trial. Turkish Journal of Anaesthesiology and Reanimation2019;47(2):120-7. [CENTRAL: CN-02089475] LevinD , CohenS , MohiuddinA , NaftalovichR , KangP , MellenderS , et al. How does acupressure point P6 stimulation compare to pharmacological therapy in reduction of nausea and vomiting during cesarean section with neuraxial anesthesia? Randomized control trial. Regional Anesthesia and Pain Medicine2017;42(6):no pagination. [CENTRAL: CN-01441790] [EMBASE: 619777950]">Levin 2019</a>; <a href="./references#CD007579-bbs2-0044" title="LiJZ , LiXZ , WangMS , LiJP , ShiF , YuHF . [Effects of transcutaneous electrical stimulation of auricular Shenmen point on postoperative nausea and vomiting and patient-controlled epidural analgesia in cesarean section]. [Chinese]. Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal]2012;92(27):1892-5. ">Li 2012</a>; <a href="./references#CD007579-bbs2-0050" title="MaranhaoMV , CoelhoVV , IvoCM , MaranhaoMH , AmaralEB . A comparative study between metoclopramide and droperidol in the control of nausea and vomit in patients subjected to spinal blockade during cesarean section [Estudo comparativo entre a metoclopramida e o droperidol no controle de nauseas e vomitos na operacao cesariana em gestantes submetidas a bloqueio subaracnoideo]. Revista Brasileira de Anestesiologia1988;38(4):245-9. ">Maranhao 1988</a>; <a href="./references#CD007579-bbs2-0051" title="ModirH , MoshiriE , KamaliA , ShokrpourM , ShamsN . Prophylatic efficacy of dexamethasone, ketamine and dexmedetomidine against intra- and postoperative nausea and vomiting under spinal anesthesia. Formosan Journal of Surgery2019;52(1):17-23. [CENTRAL: CN-01790839] [EMBASE: 626475964]">Modir 2019</a>; <a href="./references#CD007579-bbs2-0055" title="MunnurU , TranC , ZambareSN , Lozano-GorenaM , SureshMS . Post operative nausea and vomiting following cesarean section with intrathecal morphine. Anesthesiology2008;109:A1113. ">Munnur 2008</a>; <a href="./references#CD007579-bbs2-0058" title="NortcliffeSA , BuggyDJ . Prophylaxis of nausea and vomiting after spinal morphine analgesia for caesarean section: comparison between cyclizine, dexamethasone, and placebo [abstract]. British Journal of Anaesthesia2001;87(4):657P. NortcliffeSA , ShahJ , BuggyDJ . Prevention of postoperative nausea and vomiting after spinal morphine for caesarean section: comparison of cyclizine, dexamethasone and placebo. British Journal of Anaesthesia2003;90(5):665-70. ">Nortcliffe 2003</a>; <a href="./references#CD007579-bbs2-0059" title="PanPH , MooreCH . Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for cesarean section patients under epidural anesthesia. Anesthesia and Analgesia1996;83(5):982-6. ">Pan 1996</a>; <a href="./references#CD007579-bbs2-0060" title="PanP , MooreC , FragnetoR , RossV , JustisG . Is antiemetic prophylaxis cost-effective for cesarean section patients [abstract]. Anesthesiology2000;93(3A):A1092. PanPH , MooreC , FragnetoR , RossV , JustisG . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesiology2000;92 Suppl:A40. PanPH , MooreCH . Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. Journal of Clinical Anesthesia2001;13(6):430-5. PanPH , MooreCM . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesia and Analgesia2000;90 Suppl:S295. ">Pan 2001</a>; <a href="./references#CD007579-bbs2-0062" title="ISRCTN57227250. Prevention of nausea and vomiting comparing ondansetron and dexamethasone versus placebo in cesarean section under regional anesthesia. http://www.isrctn.com/ISRCTN57227250 (7 July 2016). [CENTRAL: CN-01812416] Parra-GuizaR , MelendezHJ , OchoaME . Prophylactic efficacy of ondansetron and dexamethasone in nausea and vomit in patients undergoing cesarean section with neuraxial opioids. Controlled clinical trial. Medicas UIS2018;31(1):31-8. [DOI: 10.18273/revmed.v31n1-2018004]">Parra‐Guiza 2018</a>; <a href="./references#CD007579-bbs2-0063" title="PazokiS , ModirH , KamaliA , ZamaniA , ShahidaniM . Ondansetron 8 mg and 4 mg with normal saline against post-operative headache and nausea/vomiting after spinal anesthesia: a randomized double-blind trial. Medical Gas Research2018;8(2):48-53. [CENTRAL: CN-01617025] [EMBASE: 622985422]">Pazoki 2018</a>; <a href="./references#CD007579-bbs2-0064" title="PeixotoAJ , CelichMF , ZardoL , Peixoto FilhoAJ . Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine. European Journal of Anaesthesiology2006;23(8):670-5. ">Peixoto 2006</a>; <a href="./references#CD007579-bbs2-0066" title="RasooliS , MoslemiF , KhakiA . Effect of sub hypnotic doses of propofol and midazolam for nausea and vomiting during spinal anesthesia for cesarean section. Anesthesiology and Pain Medicine2014;4(4):e19384. ">Rasooli 2014</a>; <a href="./references#CD007579-bbs2-0069" title="SanansilpV , AreewatanaS , TonsukchaiN . Droperidol and the side effects of epidural morphine after cesarean section. Anesthesia &amp; Analgesia1998;86(3):532-7. ">Sanansilp 1998</a>; <a href="./references#CD007579-bbs2-0073" title="SteinDJ , BirnbachDJ , DanzerBI , KurodaMM , GrunebaumA , ThysDM . Acupressure versus intravenous metoclopramide to prevent nausea and vomiting during spinal anesthesia for cesarean section. Anesthesia and Analgesia1997;84(2):342-5. ">Stein 1997</a>; <a href="./references#CD007579-bbs2-0074" title="TarhanO , CanbayO , CelebiN , UzunS , SahinA , CoskunF , et al. Subhypnotic doses of midazolam prevent nausea and vomiting during spinal anesthesia for cesarean section. Minerva Anestesiologica2007;73(12):629-33. ">Tarhan 2007</a>; <a href="./references#CD007579-bbs2-0075" title="TkachenkoR , PyasetskaN . The efficiency of intrathecal dexamethasone for spinal anaesthesia in elective caesarean section. Regional Anesthesia and Pain Medicine2019;44(10):A192. [CENTRAL: CN-01999210] [EMBASE: 629475510]">Tkachenko 2019</a>; <a href="./references#CD007579-bbs2-0076" title="TzengJI , WangJJ , HoST , TangCS , LiuYC , LeeSC . Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline. British Journal of Anaesthesia2000;85(6):865-8. ">Tzeng 2000</a>; <a href="./references#CD007579-bbs2-0079" title="VoigtM , FrohlichCW , HuttelC , KrankeP , MennenJ , BoessneckO , et al. Prophylaxis of intra- and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. Medical Science Monitor2013;19:993-1000. ">Voigt 2013</a>) and 10 studies are four‐arm studies (<a href="./references#CD007579-bbs2-0004" title="AhnHJ , KimYA , ChoiDH . The effects of sedation using propofol TCI on the satisfaction level and side effects of parturients during regional anesthesia for a cesarean section. Korean Journal of Anesthesiology2002;43(1):66-72. ">Ahn 2002</a>; <a href="./references#CD007579-bbs2-0008" title="BiswasBN , RudraA , DasSK , NathS , BiswasSC . A comparative study of glycopyrrolate, dexamethasone and metoclopramide in control of post-operative nausea and vomiting after spinal anaesthesia for caesarean delivery. Indian Journal of Anaesthesia2003;47(3):198-200. ">Biswas 2003</a>; <a href="./references#CD007579-bbs2-0013" title="CharuluxanananS , KyokongO , SomboonviboonW , NarasethakamolA , PromlokP . Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesthesia and Analgesia2003;96(6):1789-93. ">Charuluxananan 2003</a>; <a href="./references#CD007579-bbs2-0042" title="LeeYW , HongJY , YoonHJ , KimSM . Could emesis from epidural anesthesia for a cesarean section be controlled by prophylactic low-dose granisetron?Korean Journal of Anesthesiology2002;43(6):s13-9. ">Lee 2002</a>; <a href="./references#CD007579-bbs2-0053" title="MokiniZ , FabbriE , Dell'AttiI , Di MartinoR , D'EttorreM , PetriniF . A randomized, controlled, double blind trial on the incidence of nausea and vomiting with prophylactic subhypnotic propofol vs metoclopramide and in combination therapy in cesarean section with subarachnoid anesthesia. European Journal of Anaesthesiology2014;31:192. NCT01781377. Prophylactic subhypnotic propofol for nausea and vomiting during for cesarean section under subarachnoid anesthesia. Https://clinicaltrials.gov/show/NCT01781377 (first received 2013 Jan 25). [CENTRAL: CN-01540221] ">Mokini 2014</a>; <a href="./references#CD007579-bbs2-0054" title="MukherjeeS , RudraA , MandelM , KumarP . Optimum dose of propofol for prevention of emetic episodes during caesarean delivery: an evaluation. Journal of Anaesthesia and Clinical Pharmacology2006;22(2):139-43. ">Mukherjee 2006</a>; <a href="./references#CD007579-bbs2-0072" title="ShenYJ , YinYQ , ZhangYJ , ZhuQ , ZhangJH , ZhaoW , et al. Efficacy of intravenous scopolamine for preventing postoperative nausea and vomiting after cesarean section. Acta Academiae Medicinae Sinicae2012;34(1):32-7. ">Shen 2012</a>; <a href="./references#CD007579-bbs2-0079" title="VoigtM , FrohlichCW , HuttelC , KrankeP , MennenJ , BoessneckO , et al. Prophylaxis of intra- and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. Medical Science Monitor2013;19:993-1000. ">Voigt 2013</a>; <a href="./references#CD007579-bbs2-0080" title="WangJJ , HoST , WongCS , TzengJI , LiuHS , GerLP . Dexamethasone prophylaxis of nausea and vomiting after epidural morphine for post-cesarean analgesia. Canadian Journal of Anaesthesia2001;48(2):185-90. ">Wang 2001</a>; <a href="./references#CD007579-bbs2-0082" title="WuJI , LoY , ChiaYY , LiuK , FongWP , YangLC , et al. Prevention of postoperative nausea and vomiting after intrathecal morphine for cesarean section: a randomized comparison of dexamethasone, droperidol, and a combination. International Journal of Obstetric Anesthesia2007;16(2):122-7. ">Wu 2007</a>). Where two or more arms of a study fell within the same comparison, we treated the data as described in the <a href="#CD007579-sec-0043">Unit of analysis issues</a>. </p> <p>Of the multi‐arm studies which provided data, 18 compared more than one drug against placebo but the drugs were in different categories and so in different comparisons (<a href="./references#CD007579-bbs2-0008" title="BiswasBN , RudraA , DasSK , NathS , BiswasSC . A comparative study of glycopyrrolate, dexamethasone and metoclopramide in control of post-operative nausea and vomiting after spinal anaesthesia for caesarean delivery. Indian Journal of Anaesthesia2003;47(3):198-200. ">Biswas 2003</a>; <a href="./references#CD007579-bbs2-0016" title="ChoiDH , KimSC , SimWS . Prevention of nausea and vomiting during spinal or epidural anesthesia for cesarean section - the efficacy of metoclopramide and droperidol. Korean Journal of Anesthesiology1999;37(6):1054-9. ">Choi 1999</a>; <a href="./references#CD007579-bbs2-0018" title="Direkvand-MoghadamA , KhosraviA . Effect of acupressure on post-operative nausea and vomiting in cesarean section: a randomised controlled trial. Journal of Clinical and Diagnostic Research2013;7(10):2247-9. IRCT201111146575N4. Comparing the effect of acupressure and metoclopramide on nausea and vomiting in women with spinal anesthesia for cesarean. http://en.irct.ir/trial/7020 (21 December 2011). [CENTRAL: CN-01849415] ">Direkvand‐Moghadam 2013</a>; <a href="./references#CD007579-bbs2-0020" title="ApiliogullariS , GokF , CanpolatA , SoysalS , ToyH , SukanF . Comparison of prophylactic dimenhydrinate and metoclopramide for prevention of nausea-vomiting caused by intrathecal opioids in parturients undergoing caesarean delivery. Regional Anesthesia and Pain Medicine2008;33(5 Suppl 1):131. DumanA , ApiliogullariS , GokF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine in cesarean delivery. Nobel Medicus2010;6(3):13-9. DumanA , ApiliogullariS , GookF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine for cesarean delivery. Data on file. ">Duman 2010</a>; <a href="./references#CD007579-bbs2-0021" title="El-DeebAM , AhmadyMS . Effect of acupuncture on nausea and/or vomiting during and after cesarean section in comparison with ondansetron. Journal of Anesthesia2011;25(5):698-703. ">El‐Deeb 2011a</a>; <a href="./references#CD007579-bbs2-0022" title="Garcia-MiguelFJ , MontanoE , Mart-VicenteV , FuentesAL , AlsinaFJ , San JoseJA . Prophylaxis against intraoperative nausea and vomiting during spinal anesthesia for cesarean section: a comparative study of ondansetron versus metoclopramide. Internet Journal of Anesthesiology2000;4(2). ">Garcia‐Miguel 2000</a>; <a href="./references#CD007579-bbs2-0026" title="HarnettMJ , O'RourkeN , WalshM , CarabuenaJM , SegalS . Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery. Anesthesia and Analgesia2007;105(3):764-9. ">Harnett 2007</a>; <a href="./references#CD007579-bbs2-0027" title="HassaneinA , MahmoudE . Effect of low dose ketamine versus dexamethasone on intraoperative nausea and vomiting during cesarean section under spinal anesthesia. Egyptian Journal of Anaesthesia2015;31(1):59-63. ">Hassanein 2015</a>; <a href="./references#CD007579-bbs2-0036" title="ISRCTN15475205. Does propofol prevent morphine-induced nausea, vomiting and itching in women who have had a Caesarean section?Http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN15475205 (first received 2019). [CENTRAL: CN-01974804] KampoS , AffulAP , MohammedS , NtimM , BuunaaimAD , AnabahTW . Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section - a randomized control trial. BMC Anesthesiology2019;19(1):177. [CENTRAL: CN-01987099] [EMBASE: 629299629] [PMID: 31521119]">Kampo 2019</a>; <a href="./references#CD007579-bbs2-0058" title="NortcliffeSA , BuggyDJ . Prophylaxis of nausea and vomiting after spinal morphine analgesia for caesarean section: comparison between cyclizine, dexamethasone, and placebo [abstract]. British Journal of Anaesthesia2001;87(4):657P. NortcliffeSA , ShahJ , BuggyDJ . Prevention of postoperative nausea and vomiting after spinal morphine for caesarean section: comparison of cyclizine, dexamethasone and placebo. British Journal of Anaesthesia2003;90(5):665-70. ">Nortcliffe 2003</a>; <a href="./references#CD007579-bbs2-0059" title="PanPH , MooreCH . Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for cesarean section patients under epidural anesthesia. Anesthesia and Analgesia1996;83(5):982-6. ">Pan 1996</a>; <a href="./references#CD007579-bbs2-0060" title="PanP , MooreC , FragnetoR , RossV , JustisG . Is antiemetic prophylaxis cost-effective for cesarean section patients [abstract]. Anesthesiology2000;93(3A):A1092. PanPH , MooreC , FragnetoR , RossV , JustisG . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesiology2000;92 Suppl:A40. PanPH , MooreCH . Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. Journal of Clinical Anesthesia2001;13(6):430-5. PanPH , MooreCM . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesia and Analgesia2000;90 Suppl:S295. ">Pan 2001</a>; <a href="./references#CD007579-bbs2-0062" title="ISRCTN57227250. Prevention of nausea and vomiting comparing ondansetron and dexamethasone versus placebo in cesarean section under regional anesthesia. http://www.isrctn.com/ISRCTN57227250 (7 July 2016). [CENTRAL: CN-01812416] Parra-GuizaR , MelendezHJ , OchoaME . Prophylactic efficacy of ondansetron and dexamethasone in nausea and vomit in patients undergoing cesarean section with neuraxial opioids. Controlled clinical trial. Medicas UIS2018;31(1):31-8. [DOI: 10.18273/revmed.v31n1-2018004]">Parra‐Guiza 2018</a>; <a href="./references#CD007579-bbs2-0064" title="PeixotoAJ , CelichMF , ZardoL , Peixoto FilhoAJ . Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine. European Journal of Anaesthesiology2006;23(8):670-5. ">Peixoto 2006</a>; <a href="./references#CD007579-bbs2-0072" title="ShenYJ , YinYQ , ZhangYJ , ZhuQ , ZhangJH , ZhaoW , et al. Efficacy of intravenous scopolamine for preventing postoperative nausea and vomiting after cesarean section. Acta Academiae Medicinae Sinicae2012;34(1):32-7. ">Shen 2012</a>; <a href="./references#CD007579-bbs2-0073" title="SteinDJ , BirnbachDJ , DanzerBI , KurodaMM , GrunebaumA , ThysDM . Acupressure versus intravenous metoclopramide to prevent nausea and vomiting during spinal anesthesia for cesarean section. Anesthesia and Analgesia1997;84(2):342-5. ">Stein 1997</a>; <a href="./references#CD007579-bbs2-0076" title="TzengJI , WangJJ , HoST , TangCS , LiuYC , LeeSC . Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline. British Journal of Anaesthesia2000;85(6):865-8. ">Tzeng 2000</a>; <a href="./references#CD007579-bbs2-0082" title="WuJI , LoY , ChiaYY , LiuK , FongWP , YangLC , et al. Prevention of postoperative nausea and vomiting after intrathecal morphine for cesarean section: a randomized comparison of dexamethasone, droperidol, and a combination. International Journal of Obstetric Anesthesia2007;16(2):122-7. ">Wu 2007</a>). Six multi‐arm studies providing data included arms with one of our excluded drugs or a combination of drugs, so data from these arms were excluded (<a href="./references#CD007579-bbs2-0002" title="AbdollahpourA , AzadiR , BandariR , MirmohammadkhaniM . Effects of adding midazolam and sufentanil to intrathecal bupivacaine on analgesia quality and postoperative complications in elective cesarean section. Anesthesiology and Pain Medicine2015;5(4):e23565. ">Abdollahpour 2015</a>; <a href="./references#CD007579-bbs2-0024" title="HabibAS , GeorgeRB , McKeenDM , WhiteWD , ItukUS , MegallaSA , et al. Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. Obstetrics and Gynecology2013;121(3):615-23. NCT01216410. Prevention of intraoperative nausea and vomiting during cesarean section. Https://clinicaltrials.gov/show/NCT01216410 (first received 2010 Oct 6). [CENTRAL: CN-02025773] ">Habib 2013</a>; <a href="./references#CD007579-bbs2-0038" title="KhalaylehK , OmarAA . Comparitive antiemetic efficacy of intrathecal fentanyl and intravenous metoclopromide, during Caesarean Section under spinal anaesthesia. Journal of the Bahrain Medical Society2005;17(4):243-7. ">Khalayleh 2005</a>; <a href="./references#CD007579-bbs2-0043" title="LevinD , CohenS , MellenderS , MohiuddinA , ZhaoR , KissG , et al. Transcutaneous P6 acupoint electrical stimulation prevents both nausea and vomiting during elective cesarean section under combined spinal-epidural: a randomized control clinical trial. Anesthesia and Analgesia2018;126(4):421-2. [CENTRAL: CN-01789975] [EMBASE: 626090330]LevinD , CohenS , MellenderS , ShahU , KangP , MohiuddinA , et al. Effectiveness of p6 stimulation for reduction of nausea and vomiting during caesarean section under combined spinal-epidural anaesthesia: a randomised controlled trial. Turkish Journal of Anaesthesiology and Reanimation2019;47(2):120-7. [CENTRAL: CN-02089475] LevinD , CohenS , MohiuddinA , NaftalovichR , KangP , MellenderS , et al. How does acupressure point P6 stimulation compare to pharmacological therapy in reduction of nausea and vomiting during cesarean section with neuraxial anesthesia? Randomized control trial. Regional Anesthesia and Pain Medicine2017;42(6):no pagination. [CENTRAL: CN-01441790] [EMBASE: 619777950]">Levin 2019</a>; <a href="./references#CD007579-bbs2-0044" title="LiJZ , LiXZ , WangMS , LiJP , ShiF , YuHF . [Effects of transcutaneous electrical stimulation of auricular Shenmen point on postoperative nausea and vomiting and patient-controlled epidural analgesia in cesarean section]. [Chinese]. Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal]2012;92(27):1892-5. ">Li 2012</a>; <a href="./references#CD007579-bbs2-0079" title="VoigtM , FrohlichCW , HuttelC , KrankeP , MennenJ , BoessneckO , et al. Prophylaxis of intra- and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. Medical Science Monitor2013;19:993-1000. ">Voigt 2013</a>). Seven multi‐arm studies providing data looked at different concentrations of the same drug or different routes of administration and we adjusted the placebo data accordingly (<a href="./references#CD007579-bbs2-0004" title="AhnHJ , KimYA , ChoiDH . The effects of sedation using propofol TCI on the satisfaction level and side effects of parturients during regional anesthesia for a cesarean section. Korean Journal of Anesthesiology2002;43(1):66-72. ">Ahn 2002</a>; <a href="./references#CD007579-bbs2-0005" title="ApiliogullariS , DumanA , GokF . Prophylactic dimenhydrinate (dramamine) is effective in the treatment of nausea-vomiting with intrathecal morphine [abstract]. Regional Anesthesia and Pain Medicine2007;32(5 Suppl):87. ">Apiliogullari 2007</a>; <a href="./references#CD007579-bbs2-0006" title="BaciarelloM , CorniniA , ZasaM , PedronaP , ScrofaniG , VenutiFS , et al. Intrathecal atropine to prevent postoperative nausea and vomiting after cesarean section: a randomized, controlled trial. Minerva Anestesiologica2011;77(8):781-8. ">Baciarello 2011</a>; <a href="./references#CD007579-bbs2-0042" title="LeeYW , HongJY , YoonHJ , KimSM . Could emesis from epidural anesthesia for a cesarean section be controlled by prophylactic low-dose granisetron?Korean Journal of Anesthesiology2002;43(6):s13-9. ">Lee 2002</a>; <a href="./references#CD007579-bbs2-0054" title="MukherjeeS , RudraA , MandelM , KumarP . Optimum dose of propofol for prevention of emetic episodes during caesarean delivery: an evaluation. Journal of Anaesthesia and Clinical Pharmacology2006;22(2):139-43. ">Mukherjee 2006</a>; <a href="./references#CD007579-bbs2-0075" title="TkachenkoR , PyasetskaN . The efficiency of intrathecal dexamethasone for spinal anaesthesia in elective caesarean section. Regional Anesthesia and Pain Medicine2019;44(10):A192. [CENTRAL: CN-01999210] [EMBASE: 629475510]">Tkachenko 2019</a>; <a href="./references#CD007579-bbs2-0080" title="WangJJ , HoST , WongCS , TzengJI , LiuHS , GerLP . Dexamethasone prophylaxis of nausea and vomiting after epidural morphine for post-cesarean analgesia. Canadian Journal of Anaesthesia2001;48(2):185-90. ">Wang 2001</a>). Four multi‐arm studies looked at different drugs from the same category and so were in the same comparison and here we adjusted the placebo data accordingly (<a href="./references#CD007579-bbs2-0050" title="MaranhaoMV , CoelhoVV , IvoCM , MaranhaoMH , AmaralEB . A comparative study between metoclopramide and droperidol in the control of nausea and vomit in patients subjected to spinal blockade during cesarean section [Estudo comparativo entre a metoclopramida e o droperidol no controle de nauseas e vomitos na operacao cesariana em gestantes submetidas a bloqueio subaracnoideo]. Revista Brasileira de Anestesiologia1988;38(4):245-9. ">Maranhao 1988</a>; <a href="./references#CD007579-bbs2-0055" title="MunnurU , TranC , ZambareSN , Lozano-GorenaM , SureshMS . Post operative nausea and vomiting following cesarean section with intrathecal morphine. Anesthesiology2008;109:A1113. ">Munnur 2008</a>; <a href="./references#CD007579-bbs2-0066" title="RasooliS , MoslemiF , KhakiA . Effect of sub hypnotic doses of propofol and midazolam for nausea and vomiting during spinal anesthesia for cesarean section. Anesthesiology and Pain Medicine2014;4(4):e19384. ">Rasooli 2014</a>; <a href="./references#CD007579-bbs2-0074" title="TarhanO , CanbayO , CelebiN , UzunS , SahinA , CoskunF , et al. Subhypnotic doses of midazolam prevent nausea and vomiting during spinal anesthesia for cesarean section. Minerva Anestesiologica2007;73(12):629-33. ">Tarhan 2007</a>). One four‐arm study looked at two drugs from different categories and for one of these drugs looked at two doses, the placebo data was dealt with accordingly (<a href="./references#CD007579-bbs2-0013" title="CharuluxanananS , KyokongO , SomboonviboonW , NarasethakamolA , PromlokP . Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesthesia and Analgesia2003;96(6):1789-93. ">Charuluxananan 2003</a>) and another four‐arm study one arm was excluded as it was a combination of drugs and the other two arms were drugs in different categories (<a href="./references#CD007579-bbs2-0053" title="MokiniZ , FabbriE , Dell'AttiI , Di MartinoR , D'EttorreM , PetriniF . A randomized, controlled, double blind trial on the incidence of nausea and vomiting with prophylactic subhypnotic propofol vs metoclopramide and in combination therapy in cesarean section with subarachnoid anesthesia. European Journal of Anaesthesiology2014;31:192. NCT01781377. Prophylactic subhypnotic propofol for nausea and vomiting during for cesarean section under subarachnoid anesthesia. Https://clinicaltrials.gov/show/NCT01781377 (first received 2013 Jan 25). [CENTRAL: CN-01540221] ">Mokini 2014</a>). Four of the multi‐arm studies provided no data that we could use in this review (<a href="./references#CD007579-bbs2-0007" title="BirnbachDJ , SteinDJ , SaundersTA , GrunebaumA , KitainEM . Prophylactic use of acupressure for the prevention of nausea and vomiting during spinal anesthesia for cesarean section. Anesthesiology1993;79:A1020. ">Birnbach 1993</a>; <a href="./references#CD007579-bbs2-0063" title="PazokiS , ModirH , KamaliA , ZamaniA , ShahidaniM . Ondansetron 8 mg and 4 mg with normal saline against post-operative headache and nausea/vomiting after spinal anesthesia: a randomized double-blind trial. Medical Gas Research2018;8(2):48-53. [CENTRAL: CN-01617025] [EMBASE: 622985422]">Pazoki 2018</a>; <a href="./references#CD007579-bbs2-0069" title="SanansilpV , AreewatanaS , TonsukchaiN . Droperidol and the side effects of epidural morphine after cesarean section. Anesthesia &amp; Analgesia1998;86(3):532-7. ">Sanansilp 1998</a>; <a href="./references#CD007579-bbs2-0051" title="ModirH , MoshiriE , KamaliA , ShokrpourM , ShamsN . Prophylatic efficacy of dexamethasone, ketamine and dexmedetomidine against intra- and postoperative nausea and vomiting under spinal anesthesia. Formosan Journal of Surgery2019;52(1):17-23. [CENTRAL: CN-01790839] [EMBASE: 626475964]">Modir 2019</a>). </p> </section> <section id="CD007579-sec-0061"> <h5 class="title">Populations</h5> <p>The included studies covered women undergoing elective and emergency caesarean sections under regional anaesthesia, with either spinal or epidural anaesthesia. Most studies reported women in American Society of Anesthesiologists physical status classification (ASA) Grade 1 to 2, and so generally with no medical problems (<a href="./references#CD007579-sec-0184" title="">Characteristics of included studies</a>) </p> </section> <section id="CD007579-sec-0062"> <h5 class="title">Interventions</h5> <p>The studies covered drugs in seven different classes of drugs. For 5‐HT3 antagonists (e.g. ondansetron, granisetron) there were 21 studies involving providing data on 2686 women; for dopamine antagonists (e.g. metoclopramide, droperidol) there were 20 studies providing data on 1880 women; for corticosteroids (e.g. dexamethasone) there were 12 studies providing data on 1182 women; for antihistamines (e.g. dimenhydrinate, cyclizine) there were four studies providing data on 514 women; for anticholinergics (e.g. glycopyrrolate, scopolamine) there were six studies providing data on 787 women; for sedatives (e.g. propofol, midazolam) there were 13 studies providing data on 1265 women; and for opioid antagonists/partial agonists (nalbuphine) there were two studies providing data on 197 women. Ten studies on acupressure/acupuncture provided data on 1401 women and two studies on ginger which provided data on 365 women (<a href="./references#CD007579-sec-0184" title="">Characteristics of included studies</a>). </p> </section> <section id="CD007579-sec-0063"> <h5 class="title">Outcomes</h5> <p>Most studies reported intraoperative nausea, intraoperative vomiting, postoperative nausea and postoperative vomiting separately, but a few reported combines nausea and vomiting both intraoperative and postoperative. Some studies reported looking for side effects/adverse effects such as hypotension, itching, dizziness. Few studies looked at women's satisfaction (<a href="./references#CD007579-sec-0184" title="">Characteristics of included studies</a>). </p> </section> <section id="CD007579-sec-0064"> <h5 class="title">Settings</h5> <p>The 84 studies were undertaken in a wide range of countries across the world (see <a href="./references#CD007579-sec-0184" title="">Characteristics of included studies</a>): </p> <p>Americas (24 studies) ‐ USA 18 studies, South America four studies (including one from Columbia and two from Brazil), Canada two studies; </p> <p>Asia (24 studies) ‐ India five studies, China five studies, Nepal one study, Thailand three studies, Taiwan three studies; South Korea five studies, Singapore two studies; </p> <p>Middle East (14 studies) ‐ Iran 10 studies, Lebanon one study, Turkey three studies;</p> <p>UK/Europe (10 studies) ‐ UK four studies, Germany one study, Ireland one study, Italy one study, Spain two studies; Ukraine one study; </p> <p>Africa (seven studies) ‐ Egypt six studies, Ghana one study.</p> <p>For two studies, there was no information provided on the setting, and three studies were conducted across multiple countries (e.g. USA and UK). </p> </section> <section id="CD007579-sec-0065"> <h5 class="title">Dates of included studies</h5> <p>Fifty‐nine studies did not report the dates over which their studies were undertaken. The studies which reported dates covered 2001 to 2017 and publication dates range from 1987 to 2020 (<a href="./references#CD007579-sec-0184" title="">Characteristics of included studies</a>). </p> </section> <section id="CD007579-sec-0066"> <h5 class="title">Funding sources of included studies</h5> <p>Seventy‐one studies did not report funding sources. Of the studies reporting this information, two studies reported commercial company funding (<a href="./references#CD007579-bbs2-0003" title="AbouleishEI , RashidS , HaqueS , GiezentannerA , JoyntonP , ChuangAZ . Ondansetron versus placebo for the control of nausea and vomiting during caesarean section under spinal anaesthesia. Anaesthesia1999;54:479-82. ">Abouleish 1999</a>; <a href="./references#CD007579-bbs2-0019" title="DuggalKN , DouglasMJ , PeterEA , MerrickPM . Acupressure for intrathecal narcotic-induced nausea and vomiting after caesarean section. International Journal of Obstetric Anesthesia1998;7(4):231-6. ">Duggal 1998</a>), one study specifically reported no commercial funding (<a href="./references#CD007579-bbs2-0014" title="CherianVT , SmithI . Prophylactic ondansetron does not improve patient satisfaction in women using PCA after caesarean section. British Journal of Anaesthesia2001;87(3):502-4. ">Cherian 2001</a>), nine studies reported finding from universities, hospitals and public funding bodies (<a href="./references#CD007579-bbs2-0002" title="AbdollahpourA , AzadiR , BandariR , MirmohammadkhaniM . Effects of adding midazolam and sufentanil to intrathecal bupivacaine on analgesia quality and postoperative complications in elective cesarean section. Anesthesiology and Pain Medicine2015;5(4):e23565. ">Abdollahpour 2015</a>; <a href="./references#CD007579-bbs2-0011" title="CardosoMM , LeiteAO , SantosEA , GozzaniJL , MathiasLA . Effect of dexamethasone on prevention of postoperative nausea, vomiting and pain after caesarean section: a randomised, placebo-controlled, double-blind trial. European Journal of Anaesthesiology2013;30:102-5. ">Cardoso 2013</a>; <a href="./references#CD007579-bbs2-0018" title="Direkvand-MoghadamA , KhosraviA . Effect of acupressure on post-operative nausea and vomiting in cesarean section: a randomised controlled trial. Journal of Clinical and Diagnostic Research2013;7(10):2247-9. IRCT201111146575N4. Comparing the effect of acupressure and metoclopramide on nausea and vomiting in women with spinal anesthesia for cesarean. http://en.irct.ir/trial/7020 (21 December 2011). [CENTRAL: CN-01849415] ">Direkvand‐Moghadam 2013</a>;<a href="./references#CD007579-bbs2-0019" title="DuggalKN , DouglasMJ , PeterEA , MerrickPM . Acupressure for intrathecal narcotic-induced nausea and vomiting after caesarean section. International Journal of Obstetric Anesthesia1998;7(4):231-6. ">Duggal 1998</a>; <a href="./references#CD007579-bbs2-0051" title="ModirH , MoshiriE , KamaliA , ShokrpourM , ShamsN . Prophylatic efficacy of dexamethasone, ketamine and dexmedetomidine against intra- and postoperative nausea and vomiting under spinal anesthesia. Formosan Journal of Surgery2019;52(1):17-23. [CENTRAL: CN-01790839] [EMBASE: 626475964]">Modir 2019</a>; <a href="./references#CD007579-bbs2-0062" title="ISRCTN57227250. Prevention of nausea and vomiting comparing ondansetron and dexamethasone versus placebo in cesarean section under regional anesthesia. http://www.isrctn.com/ISRCTN57227250 (7 July 2016). [CENTRAL: CN-01812416] Parra-GuizaR , MelendezHJ , OchoaME . Prophylactic efficacy of ondansetron and dexamethasone in nausea and vomit in patients undergoing cesarean section with neuraxial opioids. Controlled clinical trial. Medicas UIS2018;31(1):31-8. [DOI: 10.18273/revmed.v31n1-2018004]">Parra‐Guiza 2018</a>; <a href="./references#CD007579-bbs2-0063" title="PazokiS , ModirH , KamaliA , ZamaniA , ShahidaniM . Ondansetron 8 mg and 4 mg with normal saline against post-operative headache and nausea/vomiting after spinal anesthesia: a randomized double-blind trial. Medical Gas Research2018;8(2):48-53. [CENTRAL: CN-01617025] [EMBASE: 622985422]">Pazoki 2018</a>; <a href="./references#CD007579-bbs2-0070" title="KjaerK . Dexamethasone for the prevention of post-operative nausea and vomiting in patients undergoing cesarean sections. https://clinicaltrials.gov/ct2/show/results/NCT01734161 (27 November 2012). [CENTRAL: CN-01538899] SelzerA , PryorKO , TangelV , O'ConnellK , KjaerK . The effect of intravenous dexamethasone on postoperative nausea and vomiting after Cesarean delivery with intrathecal morphine: a randomized-controlled trial [Effet de la dexamethasone intraveineuse sur les nausees et vomissements postoperatoires apres un accouchement par cesarienne avec morphine intrathecale: un essai randomise controle]. Canadian Journal of Anesthesia2020;67:817-26. [CENTRAL: CN-02072818] [EMBASE: 2004140352] [PMID: 31989472]SelzerAR , PickJ , AbramovitzS , GadallaF , DarwichA , KjaerK . The effect of a single dose of intravenous dexamethasone on nausea and vomiting when administered prior to intrathecal morphine for cesarean section: a randomized, placebo-controlled, double-blinded trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 47th Annual Meeting; 2015 May 13-17; Colorado, USA. 2015:T-03. ">Selzer 2020</a>; <a href="./references#CD007579-bbs2-0084" title="ZeraatiH , ShahinfarJ , HesariSI , MasrorniyaM , NasimiF . The effect of ginger extract on the incidence and severity of nausea and vomiting after cesarean section under spinal anesthesia. Anesthesiology and Pain Medicine2016;6(5):e38943. [CENTRAL: CN-01760273] [EMBASE: 612722027] [PMID: 27847700]">Zeraati 2016</a>), and two studies reported specifically that they had no funding (<a href="./references#CD007579-bbs2-0036" title="ISRCTN15475205. Does propofol prevent morphine-induced nausea, vomiting and itching in women who have had a Caesarean section?Http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN15475205 (first received 2019). [CENTRAL: CN-01974804] KampoS , AffulAP , MohammedS , NtimM , BuunaaimAD , AnabahTW . Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section - a randomized control trial. BMC Anesthesiology2019;19(1):177. [CENTRAL: CN-01987099] [EMBASE: 629299629] [PMID: 31521119]">Kampo 2019</a>; <a href="./references#CD007579-bbs2-0043" title="LevinD , CohenS , MellenderS , MohiuddinA , ZhaoR , KissG , et al. Transcutaneous P6 acupoint electrical stimulation prevents both nausea and vomiting during elective cesarean section under combined spinal-epidural: a randomized control clinical trial. Anesthesia and Analgesia2018;126(4):421-2. [CENTRAL: CN-01789975] [EMBASE: 626090330]LevinD , CohenS , MellenderS , ShahU , KangP , MohiuddinA , et al. Effectiveness of p6 stimulation for reduction of nausea and vomiting during caesarean section under combined spinal-epidural anaesthesia: a randomised controlled trial. Turkish Journal of Anaesthesiology and Reanimation2019;47(2):120-7. [CENTRAL: CN-02089475] LevinD , CohenS , MohiuddinA , NaftalovichR , KangP , MellenderS , et al. How does acupressure point P6 stimulation compare to pharmacological therapy in reduction of nausea and vomiting during cesarean section with neuraxial anesthesia? Randomized control trial. Regional Anesthesia and Pain Medicine2017;42(6):no pagination. [CENTRAL: CN-01441790] [EMBASE: 619777950]">Levin 2019</a>). </p> </section> <section id="CD007579-sec-0067"> <h5 class="title">Declarations of interest of authors of included studies</h5> <p>Seventy‐three studies did not report on declarations of interest of the authors. Eleven studies reported no conflict of interest for their authors (<a href="./references#CD007579-bbs2-0001" title="Abdel-AleemM , OsmanA , MorsyK . Effect of coadministration of dexamethasone with intrathecal morphine on postoperative outcomes after cesarean delivery. International Journal of Gynecology and Obstetrics2012;116(2):158-61. ">Abdel‐Aleem 2012</a>; <a href="./references#CD007579-bbs2-0003" title="AbouleishEI , RashidS , HaqueS , GiezentannerA , JoyntonP , ChuangAZ . Ondansetron versus placebo for the control of nausea and vomiting during caesarean section under spinal anaesthesia. Anaesthesia1999;54:479-82. ">Abouleish 1999</a>; <a href="./references#CD007579-bbs2-0011" title="CardosoMM , LeiteAO , SantosEA , GozzaniJL , MathiasLA . Effect of dexamethasone on prevention of postoperative nausea, vomiting and pain after caesarean section: a randomised, placebo-controlled, double-blind trial. European Journal of Anaesthesiology2013;30:102-5. ">Cardoso 2013</a>;<a href="./references#CD007579-bbs2-0036" title="ISRCTN15475205. Does propofol prevent morphine-induced nausea, vomiting and itching in women who have had a Caesarean section?Http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN15475205 (first received 2019). [CENTRAL: CN-01974804] KampoS , AffulAP , MohammedS , NtimM , BuunaaimAD , AnabahTW . Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section - a randomized control trial. BMC Anesthesiology2019;19(1):177. [CENTRAL: CN-01987099] [EMBASE: 629299629] [PMID: 31521119]">Kampo 2019</a>; <a href="./references#CD007579-bbs2-0040" title="KojuRB , CTRI/2015/01/005362. Prophylactic administration of ondansetron in prevention of intrathecal morphine induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section. http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=10813 (07 January 2015). KojuRB , GurungBS , DongolY . Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section. BMC Anesthesiology2015;15:18. ">Koju 2015</a>; <a href="./references#CD007579-bbs2-0043" title="LevinD , CohenS , MellenderS , MohiuddinA , ZhaoR , KissG , et al. Transcutaneous P6 acupoint electrical stimulation prevents both nausea and vomiting during elective cesarean section under combined spinal-epidural: a randomized control clinical trial. Anesthesia and Analgesia2018;126(4):421-2. [CENTRAL: CN-01789975] [EMBASE: 626090330]LevinD , CohenS , MellenderS , ShahU , KangP , MohiuddinA , et al. Effectiveness of p6 stimulation for reduction of nausea and vomiting during caesarean section under combined spinal-epidural anaesthesia: a randomised controlled trial. Turkish Journal of Anaesthesiology and Reanimation2019;47(2):120-7. [CENTRAL: CN-02089475] LevinD , CohenS , MohiuddinA , NaftalovichR , KangP , MellenderS , et al. How does acupressure point P6 stimulation compare to pharmacological therapy in reduction of nausea and vomiting during cesarean section with neuraxial anesthesia? Randomized control trial. Regional Anesthesia and Pain Medicine2017;42(6):no pagination. [CENTRAL: CN-01441790] [EMBASE: 619777950]">Levin 2019</a>; <a href="./references#CD007579-bbs2-0056" title="NiuK , LiuH , Chen R-W, Fang Q-W, WenH , Guo S-M, et al. Use of propofol for prevention of post-delivery nausea during cesarean section: a double-blind, randomized, placebo-controlled trial. Journal of Anesthesia2018;32(5):748-55. [CENTRAL: CN-02000278] [EMBASE: 623932583] [PMID: 30209576]">Niu 2018</a>; <a href="./references#CD007579-bbs2-0062" title="ISRCTN57227250. Prevention of nausea and vomiting comparing ondansetron and dexamethasone versus placebo in cesarean section under regional anesthesia. http://www.isrctn.com/ISRCTN57227250 (7 July 2016). [CENTRAL: CN-01812416] Parra-GuizaR , MelendezHJ , OchoaME . Prophylactic efficacy of ondansetron and dexamethasone in nausea and vomit in patients undergoing cesarean section with neuraxial opioids. Controlled clinical trial. Medicas UIS2018;31(1):31-8. [DOI: 10.18273/revmed.v31n1-2018004]">Parra‐Guiza 2018</a>; <a href="./references#CD007579-bbs2-0070" title="KjaerK . Dexamethasone for the prevention of post-operative nausea and vomiting in patients undergoing cesarean sections. https://clinicaltrials.gov/ct2/show/results/NCT01734161 (27 November 2012). [CENTRAL: CN-01538899] SelzerA , PryorKO , TangelV , O'ConnellK , KjaerK . The effect of intravenous dexamethasone on postoperative nausea and vomiting after Cesarean delivery with intrathecal morphine: a randomized-controlled trial [Effet de la dexamethasone intraveineuse sur les nausees et vomissements postoperatoires apres un accouchement par cesarienne avec morphine intrathecale: un essai randomise controle]. Canadian Journal of Anesthesia2020;67:817-26. [CENTRAL: CN-02072818] [EMBASE: 2004140352] [PMID: 31989472]SelzerAR , PickJ , AbramovitzS , GadallaF , DarwichA , KjaerK . The effect of a single dose of intravenous dexamethasone on nausea and vomiting when administered prior to intrathecal morphine for cesarean section: a randomized, placebo-controlled, double-blinded trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 47th Annual Meeting; 2015 May 13-17; Colorado, USA. 2015:T-03. ">Selzer 2020</a>; <a href="./references#CD007579-bbs2-0077" title="TCTR20160216003. Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. http://www.clinicaltrials.in.th/index.php?tp=regtrials&amp;menu=trialsearch&amp;smenu=fulltext&amp;task=search&amp;task2=view1&amp;id=1734 (16 February 2016). [CENTRAL: CN-01882139] UerpairojkitK , ChesohA , BudcharoentongD . Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. Anesthesia and Analgesia2016;123(3 Suppl):286-7. [CENTRAL: CN-01783979] [EMBASE: 612648638]UerpairojkitK , ChesohA , BudcharoentongD . Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. Chotmaihet Thangphaet [Journal of the Medical Association of Thailand]2017;100(12):1283-9. [CENTRAL: CN-01451211] [EMBASE: 620181091]">Uerpairojkit 2017</a>; <a href="./references#CD007579-bbs2-0079" title="VoigtM , FrohlichCW , HuttelC , KrankeP , MennenJ , BoessneckO , et al. Prophylaxis of intra- and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. Medical Science Monitor2013;19:993-1000. ">Voigt 2013</a>). </p> </section> <section id="CD007579-sec-0068"> <h5 class="title">Elective versus emergency caesarean sections</h5> <p>Of all our included studies, the vast majority were specifically restricted to elective caesarean sections. Only one study mentioned including both elective and emergency caesareans but they did not present the data separately (<a href="./references#CD007579-bbs2-0010" title="CabaF , BernalL , PallaresJA , EchevarriaM , RodriguezR . Prophylaxis for intraoperative nausea and vomiting with subhypnotic doses of propofol during intradural anaesthesia for caesarean section [Profilaxis de nauseas y vomitos intraoperatorios con dosis subhipnoticas de propofol durante anestesia intradural en cesareas]. Revista Espanola de Anestesiologia y Reanimacion1997;44(Suppl 1):122. [CENTRAL: CN-00400431] CabaF , EchevarriaM , Bernal-DavalosL , Pallares-GonzalezJA , Rodriguez-RodriguezR . Prophylaxis for intraoperative nausea and vomiting with nonhypnotic doses of propofol during intradural anesthesia for cesarean delivery [Profilaxis de las nauseas y los vomitos intraoperatorios con dosis subhipnoticas de propofol durante la anestesia intradural en cesareas]. Revista Espanola De Anestesiologia y Reanimacion1997;44:262-6. ">Caba 1997</a>). One other study specifically included only women undergoing emergency caesarean section (<a href="./references#CD007579-bbs2-0030" title="HuangWP . Clinical observation of using Metoclopramide to relieve dragging reaction during baby deliver in caesarean operation. Chinese Journal of Anaesthesiology1992;12(1):33. ">Huang 1992</a>). Most of the remaining studies did not mention whether they included elective or emergency caesareans. We have, therefore, not been able to consider the subgroup comparison of elective versus emergency caesarean section. </p> </section> </section> <section id="CD007579-sec-0069"> <h4 class="title">Excluded studies</h4> <section id="CD007579-sec-0070"> <h5 class="title">Excluded studies</h5> <p>We have excluded a total of 236 studies (269 reports). The excluded studies are listed in the reference section under excluded studies and the table <a href="./references#CD007579-sec-0185" title="">Characteristics of excluded studies</a> states the reasons for exclusion from this review. Studies were excluded for a wide variety of reasons. Some studies were excluded for multiple reasons. Many studies that were excluded, assessed interventions for reducing the risk of aspiration pneumonitis at caesarean section rather than reducing the risk of nausea and vomiting, as the search strategy included both these circumstances in the original protocol, which remains part of the aspiration pneumonitis review (<a href="./references#CD007579-bbs2-0383" title="ParanjothyS , LiuE , BrownH , ThomasJ . Drugs at caesarean section for preventing nausea, vomiting and aspiration pneumonitis. Cochrane Database of Systematic Reviews2004, Issue 4. Art. No: CD004943. [DOI: 10.1002/14651858.CD004943]">Paranjothy 2004</a>). Fifty‐four studies looking at aspiration prophylaxis and are included in the review of interventions for reducing aspiration prophylaxis at caesarean section (<a href="./references#CD007579-bbs2-0377" title="ParanjothyS , GriffithsJD , BroughtonHK , GyteGM , BrownHC , ThomasJ . Interventions at caesarean section for reducing the risk of aspiration pneumonitis. Cochrane Database of Systematic Reviews2014, Issue 2. Art. No: CD004943. [DOI: 10.1002/14651858.CD004943.pub4]">Paranjothy 2014</a>). Seven studies (<a href="./references#CD007579-bbs2-0154" title="Editors. Retraction. Granisetron prevents nausea and vomiting during spinal anaesthesia for caesarean section. Acta Anaesthesiologica Scandinavica2013;57(4):535. FujiiY , TanakaH , ToyookaH . Granisetron prevents nausea and vomiting during spinal anaesthesia for caesarean section. Acta Anaesthesiologica Scandinavica1998;42(3):312-5. ">Fujii 1998a</a>; <a href="./references#CD007579-bbs2-0155" title="Editors. Retraction. Prevention of nausea and vomiting with granisetron, droperidol and metoclopramide during and after spinal anaesthesia for caesarean section: a randomized, doubleblind, placebo-controlled trial. Acta Anaesthesiologica Scandinavica2013;57(4):537. FujiiY , TanakaH , ToyookaH . Prevention of nausea and vomiting with granisetron, droperidol and metoclopramide during and after spinal anaesthesia for caesarean section: a randomized, double-blind, placebo-controlled trial. Acta Anaesthesiologica Scandinavica1998;42(8):921-5. ">Fujii 1998b</a>; <a href="./references#CD007579-bbs2-0156" title="FujiiY , SaitohY , TanakaH , ToyookaH . Granisetron/dexamethasone combination for reducing nausea and vomiting during and after spinal anesthesia for cesarean section. Anesthesia and Analgesia1999;88(6):1346-50. FujiiY , SaitohY , TanakaH , ToyookaH . Granisetron/dexamethasone combination for reducing nausea and vomiting during and after spinal anesthesia for cesarean section. Anesthesia and Analgesia 1999;88:1346-50. Retraction. Anesthesia and Analgesia2013;116(3):744. ">Fujii 1999</a>; <a href="./references#CD007579-bbs2-0157" title='Editors. Notice of retraction: "dexamethasone for the prevention of nausea and vomiting after dilatation and curettage: a randomized controlled trial" (fujii and uemura) and "dose-range effects of propofol for reducing emetic symptoms during cesarean delivery" (fujii and numazaki). Obstetrics and Gynecology2013;121(6):1362. FujiiY , NumazakiM . Dose-range effects of propofol for reducing emetic symptoms during cesarean delivery. Obstetrics &amp; Gynecology2002;99:75-9. '>Fujii 2002</a>; <a href="./references#CD007579-bbs2-0158" title="FujiiY , NumazakiM . RETRACTED: Randomized, double-blind comparison of subhypnotic-dose propofol alone and combined with dexamethasone for emesis in parturients undergoing cesarean delivery. Clinical Therapeutics2004;26(8):1286-91. ">Fujii 2004</a>; <a href="./references#CD007579-bbs2-0236" title="GibbsN . Editor's note: notice of retraction. Anaesthesia and Intensive Care2013;41(2):275. NumazakiM , FujiiY . Subhypnotic dose of propofol for the prevention of nausea and vomiting during spinal anaesthesia for caesarean section. Anaesthesia and Intensive Care2000;28:262-5. ">Numazaki 2000</a>; <a href="./references#CD007579-bbs2-0237" title='Editors. Retraction notice to "reduction of emetic symptoms during cesarean delivery with antiemetics: propofol at subhypnotic dose versus traditional antiemetics" (j clin anesth 2003;15:423-27). Journal of Clinical Anesthesia2013;25(4):353. NumazakiM , FujiiY . Reduction of emetic symptoms during cesarean delivery with antiemetics: propofol at subhypnotic dose versus traditional antiemetics. Journal of Clinical Anesthesia2003;15:423-7. '>Numazaki 2003</a>) were excluded following investigation into research authenticity (<a href="./references#CD007579-bbs2-0362" title="Carlisle, JB. The analysis of 168 randomised controlled trials to test data integrity. Anaesthesia2012;67:512-37. [DOI: 10.1111/j.1365-2044.2012.07128.x]">Carlisle 2012</a>). </p> <p>Although our review assesses interventions for prevention (rather than treatment) of nausea and vomiting, our current search would identify treatment studies too. There were only three randomised controlled trials (RCTs) identified which specifically assessed interventions for treatment (rather than prevention) of nausea and vomiting (<a href="./references#CD007579-bbs2-0147" title="FazelN , PejhanA , TaghizadehM , TabarayiY , RivadehF , FarkhondehL . The effect of anethum graveolens L. oil consumption on the intensity of nausea after cesarean section. Iranian Journal of Obstetrics, Gynecology and Infertility2017;20(7):18-24. [CENTRAL: CN-01440150] [EMBASE: 619421387]">Fazel 2017</a>; <a href="./references#CD007579-bbs2-0200" title="KimuraM , OkamotoT , SukagoshiH , SatoJ , SaitoS . Effect of flurbiprofen, metoclopramide and droperidol for nausea and emesis during cesarean section under spinal anesthesia. Journal of Anesthesia2011;25(5):692-7. ">Kimura 2011</a>; <a href="./references#CD007579-bbs2-0208" title="LaneB , CannellaK , BowenC , CopelanD , NteffG , BarnesK , et al. Examination of the effectiveness of peppermint aromatherapy on nausea in women post C-section. Journal of Holistic Nursing2012;30(2):90-104. ">Lane 2012</a>). Four studies were excluded because the women had their caesarean sections with general anaesthesia (<a href="./references#CD007579-bbs2-0085" title="AbadiF , IRCT20171015036784N3. The effect of acupressure on anxiety before cesarean section and nausea, vomiting and pain after cesarean section in woman admitted to hospital. http://en.irct.ir/trial/27409 (29 January 2018). ">Abadi 2018</a>; <a href="./references#CD007579-bbs2-0181" title="HuseyinogcluU , UlkerK . Preoperative use of 10-mg metoclopramide and 50-mg dimenhydrinate in the prophylaxis of postoperative nausea and vomiting in elective caesarean births: a prospective randomized clinical study. Journal of Obstetrics and Gynecology of India2016;66(4):252-8. ">Huseyinogclu 2016</a>; <a href="./references#CD007579-bbs2-0183" title="HussainM , IshaqN , YusafA . Comparison of acid reducing properties of tramadol and ranitidine given before caesarean section under general anaesthesia. Pakistan Journal of Medical and Health Sciences2014;8(1):129-32. ">Hussain 2014</a>; <a href="./references#CD007579-bbs2-0204" title="KocamanogluIS , BarisS , KarakayaD , SenerB , TurA , CetinkayaM . Effects of granisetron with droperidol or dexamethasone on prevention of postoperative nausea and vomiting after general anesthesia for cesarean section. Methods and Findings in Experimental and Clinical Pharmacology2005;27(7):489-93. ">Kocamanoglu 2005</a>). </p> <p>One hundred and seven studies were excluded because they studied aspects of anaesthesia other than interventions given for the prevention of nausea and vomiting. Many studies assessed antiemetic medication but were focused on the haemodynamic effects of the medication, or the quality and duration of anaesthesia (rather than the antiemetic effect). Some studies examined other medication such as analgesics, antidepressants or anticonvulsants, again not focused on their antiemetic effects. Some other studies compared different surgical techniques, or other interventions such as supplemental oxygen, intravenous fluids or prolonged fasting. These were also outside the inclusion criteria for our review (<a href="./references#CD007579-sec-0185" title="">Characteristics of excluded studies</a>). </p> <p>Fifty studies were excluded as they compared different treatments, or combinations of treatments, without a placebo or control group. </p> <p>Thirteen studies were excluded as they were deemed not to be an RCT (<a href="./references#CD007579-bbs2-0100" title="AtkinsonRE , ThomasT , NicholasAD , AndersonI . An antacid comparison trial. Anaesthesia1980;35:1126-30. ">Atkinson 1980</a>; <a href="./references#CD007579-bbs2-0109" title="BoschiS , DiMMG , PignaA , RossiR . The effect of ranitidine on gastric ph and volume in patients undergoing cesarean section: Possible relationship to Mendelson's syndrome. Current Therapeutic Research, Clinical and Experimental1984;35(4):654-62. ">Boschi 1984</a>; <a href="./references#CD007579-bbs2-0111" title="Brock-UtneJG , RoutC , MoodleyJ , MayatN . Influence of preoperative gastric aspiration on the volume and pH of gastric contents in obstetric patients undergoing caesarean section. British Journal of Anaesthesia1989;62:397-401. ">Brock‐Utne 1989</a>; <a href="./references#CD007579-bbs2-0120" title="ChenHM , ChangFY , HsuCT . Effect of acupressure on nausea, vomiting, anxiety and pain among post-cesarean section women in Taiwan. Kaohsiung Journal of Medical Sciences2005;21(8):341-50. ">Chen 2005</a>; <a href="./references#CD007579-bbs2-0125" title="ColmanRD , FrankM , LoughnanBA , CohenDG , CattermoleR . Use of i.m. ranitidine for the prophylaxis of aspiration pneumonitis in obstetrics. British Journal of Anaesthesia1988;61:720-9. ">Colman 1988</a>; <a href="./references#CD007579-bbs2-0131" title="DattaS , AlperMH , OstheimerGW , WeissJB . Method of ephedrine administration and nausea and hypotension during spinal anesthesia for cesarean section. Anesthesiology1982;56:68-70. ">Datta 1982</a>; <a href="./references#CD007579-bbs2-0134" title="DewanDM , WheelerAS , James FMIII , FloydHM , RhyneL . Antacid anticholinergic regimens in patients undergoing elective caesarean section. Canadian Anaesthetists Society Journal1982;29:27-30. ">Dewan 1982</a>; <a href="./references#CD007579-bbs2-0137" title="DundeeJW , HoweJP , MooreJ , McCaugheyW . Effect of cimetidine on gastric pH in women undergoing elective caesarean section [proceedings]. British Journal of Clinical Pharmacology1979;8:391P-2P. ">Dundee 1979</a>; <a href="./references#CD007579-bbs2-0147" title="FazelN , PejhanA , TaghizadehM , TabarayiY , RivadehF , FarkhondehL . The effect of anethum graveolens L. oil consumption on the intensity of nausea after cesarean section. Iranian Journal of Obstetrics, Gynecology and Infertility2017;20(7):18-24. [CENTRAL: CN-01440150] [EMBASE: 619421387]">Fazel 2017</a>; <a href="./references#CD007579-bbs2-0260" title="QvistN , StormK . Cimethidine pre-anesthetic - a prophylactic method against Mendelson's syndrome in cesarean section. Acta Obstetricia et Gynecologica Scandinavica1983;62:157-9. ">Qvist 1983</a>; <a href="./references#CD007579-bbs2-0278" title="SantosA , DattaS . Prophylactic use of droperidol for control of nausea and vomiting during spinal anesthesia for cesarean section. Anesthesia and Analgesia1984;63:85-7. ">Santos 1984</a>; <a href="./references#CD007579-bbs2-0292" title="SultanP , ElkomyM , PeltzG , ClavijoC , WuM , GalinkinJL , et al. Pharmacokinetics of ondansetron in non-pregnant and pregnant women. International Journal of Obstetric Anesthesia2014;23(Suppl 1):S9. ">Sultan 2014</a>; <a href="./references#CD007579-bbs2-0295" title="TanakaM , BalkiM , ParkesR , CarvalhoJ . ED95 of phenylephrine to prevent hypotension and nausea/vomiting after spinal anesthesia for cesarean section [abstract]. Anesthesiology2007;106(Suppl 1):55. ">Tanaka 2007</a>). </p> <p>Seven studies were excluded as the publications had been retracted since our previous review was published. </p> </section> </section> </section> <section id="CD007579-sec-0071"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall risk of bias is reported in <a href="#CD007579-fig-0002">Figure 2</a> and <a href="#CD007579-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD007579-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD007579-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <div class="figure" id="CD007579-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007579-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD007579-sec-0072"> <h4 class="title">Allocation</h4> <p>Of the 84 studies included in the review, random sequence generation was judged to be of low risk of bias in 38 studies, with 46 studies being judged of unclear risk. Many studies simply stated that "patients were randomised" without providing any further details. </p> <p>Allocation concealment was generally poorly described. It was judged to be of low risk of bias in five studies and of unclear risk in 79 studies. There were only five studies where both sequence generation and allocation concealment were judged to be of low risk (<a href="./references#CD007579-bbs2-0001" title="Abdel-AleemM , OsmanA , MorsyK . Effect of coadministration of dexamethasone with intrathecal morphine on postoperative outcomes after cesarean delivery. International Journal of Gynecology and Obstetrics2012;116(2):158-61. ">Abdel‐Aleem 2012</a>; <a href="./references#CD007579-bbs2-0013" title="CharuluxanananS , KyokongO , SomboonviboonW , NarasethakamolA , PromlokP . Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesthesia and Analgesia2003;96(6):1789-93. ">Charuluxananan 2003</a>; <a href="./references#CD007579-bbs2-0014" title="CherianVT , SmithI . Prophylactic ondansetron does not improve patient satisfaction in women using PCA after caesarean section. British Journal of Anaesthesia2001;87(3):502-4. ">Cherian 2001</a>; <a href="./references#CD007579-bbs2-0074" title="TarhanO , CanbayO , CelebiN , UzunS , SahinA , CoskunF , et al. Subhypnotic doses of midazolam prevent nausea and vomiting during spinal anesthesia for cesarean section. Minerva Anestesiologica2007;73(12):629-33. ">Tarhan 2007</a>; <a href="./references#CD007579-bbs2-0077" title="TCTR20160216003. Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. http://www.clinicaltrials.in.th/index.php?tp=regtrials&amp;menu=trialsearch&amp;smenu=fulltext&amp;task=search&amp;task2=view1&amp;id=1734 (16 February 2016). [CENTRAL: CN-01882139] UerpairojkitK , ChesohA , BudcharoentongD . Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. Anesthesia and Analgesia2016;123(3 Suppl):286-7. [CENTRAL: CN-01783979] [EMBASE: 612648638]UerpairojkitK , ChesohA , BudcharoentongD . Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. Chotmaihet Thangphaet [Journal of the Medical Association of Thailand]2017;100(12):1283-9. [CENTRAL: CN-01451211] [EMBASE: 620181091]">Uerpairojkit 2017</a>). </p> </section> <section id="CD007579-sec-0073"> <h4 class="title">Blinding</h4> <p>Blinding was assessed in more detail in this updated review. Blinding was sometimes described poorly, with many studies simply describing a "double blind" design. </p> <p>We judged blinding of participants and clinicians as of low risk of bias in 30 studies,and of unclear bias in 50studies. Blinding was considered at high risk of bias in four studies because the treating anaesthetist was likely not blinded to the study drug (<a href="./references#CD007579-bbs2-0018" title="Direkvand-MoghadamA , KhosraviA . Effect of acupressure on post-operative nausea and vomiting in cesarean section: a randomised controlled trial. Journal of Clinical and Diagnostic Research2013;7(10):2247-9. IRCT201111146575N4. Comparing the effect of acupressure and metoclopramide on nausea and vomiting in women with spinal anesthesia for cesarean. http://en.irct.ir/trial/7020 (21 December 2011). [CENTRAL: CN-01849415] ">Direkvand‐Moghadam 2013</a>; <a href="./references#CD007579-bbs2-0053" title="MokiniZ , FabbriE , Dell'AttiI , Di MartinoR , D'EttorreM , PetriniF . A randomized, controlled, double blind trial on the incidence of nausea and vomiting with prophylactic subhypnotic propofol vs metoclopramide and in combination therapy in cesarean section with subarachnoid anesthesia. European Journal of Anaesthesiology2014;31:192. NCT01781377. Prophylactic subhypnotic propofol for nausea and vomiting during for cesarean section under subarachnoid anesthesia. Https://clinicaltrials.gov/show/NCT01781377 (first received 2013 Jan 25). [CENTRAL: CN-01540221] ">Mokini 2014</a>; <a href="./references#CD007579-bbs2-0066" title="RasooliS , MoslemiF , KhakiA . Effect of sub hypnotic doses of propofol and midazolam for nausea and vomiting during spinal anesthesia for cesarean section. Anesthesiology and Pain Medicine2014;4(4):e19384. ">Rasooli 2014</a>; <a href="./references#CD007579-bbs2-0067" title="RudraA , HalderR , SenA , KunduS . Efficacy of low dose propofol for control of emetic episodes during caesarean delivery with spinal anaesthesia. Indian Journal of Anaesthesia2004;48(1):31-4. ">Rudra 2004a</a>). In all these studies, it seemed some effort at blinding the treating clinician could have been made. </p> <p>Blinding of outcome assessors was variably described, with 36 studies judged to be of low risk and 46 studies judged to be of unclear risk. Two studies were considered to be of high risk of bias in this regard (<a href="./references#CD007579-bbs2-0004" title="AhnHJ , KimYA , ChoiDH . The effects of sedation using propofol TCI on the satisfaction level and side effects of parturients during regional anesthesia for a cesarean section. Korean Journal of Anesthesiology2002;43(1):66-72. ">Ahn 2002</a>; <a href="./references#CD007579-bbs2-0053" title="MokiniZ , FabbriE , Dell'AttiI , Di MartinoR , D'EttorreM , PetriniF . A randomized, controlled, double blind trial on the incidence of nausea and vomiting with prophylactic subhypnotic propofol vs metoclopramide and in combination therapy in cesarean section with subarachnoid anesthesia. European Journal of Anaesthesiology2014;31:192. NCT01781377. Prophylactic subhypnotic propofol for nausea and vomiting during for cesarean section under subarachnoid anesthesia. Https://clinicaltrials.gov/show/NCT01781377 (first received 2013 Jan 25). [CENTRAL: CN-01540221] ">Mokini 2014</a>). </p> </section> <section id="CD007579-sec-0074"> <h4 class="title">Incomplete outcome data</h4> <p>Incomplete outcome data were addressed adequately and so at low risk of bias in 47 studies. In 34 studies, it was judged to be of unclear bias, and at high risk of bias in three studies (<a href="./references#CD007579-bbs2-0006" title="BaciarelloM , CorniniA , ZasaM , PedronaP , ScrofaniG , VenutiFS , et al. Intrathecal atropine to prevent postoperative nausea and vomiting after cesarean section: a randomized, controlled trial. Minerva Anestesiologica2011;77(8):781-8. ">Baciarello 2011</a>; <a href="./references#CD007579-bbs2-0011" title="CardosoMM , LeiteAO , SantosEA , GozzaniJL , MathiasLA . Effect of dexamethasone on prevention of postoperative nausea, vomiting and pain after caesarean section: a randomised, placebo-controlled, double-blind trial. European Journal of Anaesthesiology2013;30:102-5. ">Cardoso 2013</a>; <a href="./references#CD007579-bbs2-0020" title="ApiliogullariS , GokF , CanpolatA , SoysalS , ToyH , SukanF . Comparison of prophylactic dimenhydrinate and metoclopramide for prevention of nausea-vomiting caused by intrathecal opioids in parturients undergoing caesarean delivery. Regional Anesthesia and Pain Medicine2008;33(5 Suppl 1):131. DumanA , ApiliogullariS , GokF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine in cesarean delivery. Nobel Medicus2010;6(3):13-9. DumanA , ApiliogullariS , GookF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine for cesarean delivery. Data on file. ">Duman 2010</a>). In these three studies, data on a significant number of participants were excluded and we were unable to be re‐include on an intention‐to‐treat basis. </p> </section> <section id="CD007579-sec-0075"> <h4 class="title">Selective reporting</h4> <p>As we were generally not able to assess study protocols, 76 studies were judged to be unclear about selective reporting bias with just one study assessed as low risk (<a href="./references#CD007579-bbs2-0035" title="KalavaA , DarjiSJ , KalsteinA , YarmushJM , SchianodiColaJ , WeinbergJ . Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;169(2):184-8. KalavaA , WeinbergJ , JayakumarM , YarmushJM , SchianodiColaJJ . Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. In: http://www.asaabstracts.com/strands/asaabstracts/abstract.htm;jsessionid=0507CB47FEB444D841EEF290BF35A8BF?year=2011&amp;index=13&amp;absnum=4726 (accessed 1 Febraury 2012). 2011. NCT01733212. Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. Https://clinicaltrials.gov/show/NCT01733212 2012 Nov 26. [CENTRAL: CN-02041676] ">Kalava 2013</a>).. However, seven studies were judged to show a high risk of bias (<a href="./references#CD007579-bbs2-0004" title="AhnHJ , KimYA , ChoiDH . The effects of sedation using propofol TCI on the satisfaction level and side effects of parturients during regional anesthesia for a cesarean section. Korean Journal of Anesthesiology2002;43(1):66-72. ">Ahn 2002</a>; <a href="./references#CD007579-bbs2-0012" title="CarvalhoJC , NairGS , DowneyK , BalkiM . Prophylactic dimenhydrinate does not reduce nausea and vomiting during cesarean section delivery under spinal anesthesia: a randomized, double-blind, placebo-controlled trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 42nd Annual Meeting; 2010 May 12-16, San Antonio, USA. 2010. NCT00791960. Prophylactic dimenhydrinate for intraoperative nausea and vomiting. Https://clinicaltrials.gov/show/NCT00791960 (first received 2008 Nov 13). [CENTRAL: CN-01485523] ">Carvalho 2010</a>; <a href="./references#CD007579-bbs2-0031" title="IbrahimAS , AlyMG , ThabetME , AbdelazizMR . Effect of adding nalbuphine to intrathecal bupivacaine with morphine on postoperative nausea and vomiting and pruritus after elective cesarean delivery: a randomized double blinded study. Minerva Anestesiologica2019;85(3):255-62. [CENTRAL: CN-01939130] [EMBASE: 2001726956] [PMID: 29856176]">Ibrahim 2019</a>; <a href="./references#CD007579-bbs2-0034" title="JangDG , ChangWY , YoonSY , KimKB . Epidural butorphanol reduces the side effects from epidural morphine after cesarean section. Korean Journal of Anesthesiology1997;33(2):297-303. ">Jang 1997</a>; <a href="./references#CD007579-bbs2-0070" title="KjaerK . Dexamethasone for the prevention of post-operative nausea and vomiting in patients undergoing cesarean sections. https://clinicaltrials.gov/ct2/show/results/NCT01734161 (27 November 2012). [CENTRAL: CN-01538899] SelzerA , PryorKO , TangelV , O'ConnellK , KjaerK . The effect of intravenous dexamethasone on postoperative nausea and vomiting after Cesarean delivery with intrathecal morphine: a randomized-controlled trial [Effet de la dexamethasone intraveineuse sur les nausees et vomissements postoperatoires apres un accouchement par cesarienne avec morphine intrathecale: un essai randomise controle]. Canadian Journal of Anesthesia2020;67:817-26. [CENTRAL: CN-02072818] [EMBASE: 2004140352] [PMID: 31989472]SelzerAR , PickJ , AbramovitzS , GadallaF , DarwichA , KjaerK . The effect of a single dose of intravenous dexamethasone on nausea and vomiting when administered prior to intrathecal morphine for cesarean section: a randomized, placebo-controlled, double-blinded trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 47th Annual Meeting; 2015 May 13-17; Colorado, USA. 2015:T-03. ">Selzer 2020</a>; <a href="./references#CD007579-bbs2-0075" title="TkachenkoR , PyasetskaN . The efficiency of intrathecal dexamethasone for spinal anaesthesia in elective caesarean section. Regional Anesthesia and Pain Medicine2019;44(10):A192. [CENTRAL: CN-01999210] [EMBASE: 629475510]">Tkachenko 2019</a>; <a href="./references#CD007579-bbs2-0079" title="VoigtM , FrohlichCW , HuttelC , KrankeP , MennenJ , BoessneckO , et al. Prophylaxis of intra- and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. Medical Science Monitor2013;19:993-1000. ">Voigt 2013</a>), generally because they did not report outcomes which were pre‐specified in the study methods. </p> </section> <section id="CD007579-sec-0076"> <h4 class="title">Other potential sources of bias</h4> <p>Thirty‐six studies were judged to be free of other potential sources of bias, with 46 being unclear. Two studies were judged to be at high risk of bias (<a href="./references#CD007579-bbs2-0024" title="HabibAS , GeorgeRB , McKeenDM , WhiteWD , ItukUS , MegallaSA , et al. Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. Obstetrics and Gynecology2013;121(3):615-23. NCT01216410. Prevention of intraoperative nausea and vomiting during cesarean section. Https://clinicaltrials.gov/show/NCT01216410 (first received 2010 Oct 6). [CENTRAL: CN-02025773] ">Habib 2013</a>; <a href="./references#CD007579-bbs2-0027" title="HassaneinA , MahmoudE . Effect of low dose ketamine versus dexamethasone on intraoperative nausea and vomiting during cesarean section under spinal anesthesia. Egyptian Journal of Anaesthesia2015;31(1):59-63. ">Hassanein 2015</a>). One study was conducted at two different centres. There seemed to be many differences in practice between the two centres and the study seemed poorly controlled (<a href="./references#CD007579-bbs2-0024" title="HabibAS , GeorgeRB , McKeenDM , WhiteWD , ItukUS , MegallaSA , et al. Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. Obstetrics and Gynecology2013;121(3):615-23. NCT01216410. Prevention of intraoperative nausea and vomiting during cesarean section. Https://clinicaltrials.gov/show/NCT01216410 (first received 2010 Oct 6). [CENTRAL: CN-02025773] ">Habib 2013</a>). Another study included an unspecified number of women undergoing additional surgical procedures (such as tubal ligation (<a href="./references#CD007579-bbs2-0027" title="HassaneinA , MahmoudE . Effect of low dose ketamine versus dexamethasone on intraoperative nausea and vomiting during cesarean section under spinal anesthesia. Egyptian Journal of Anaesthesia2015;31(1):59-63. ">Hassanein 2015</a>). </p> </section> </section> <section id="CD007579-sec-0077"> <h3 class="title" id="CD007579-sec-0077">Effects of interventions</h3> <p>See: <a href="./full#CD007579-tbl-0001"><b>Summary of findings 1</b> 5‐HT3 antagonists compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</a>; <a href="./full#CD007579-tbl-0002"><b>Summary of findings 2</b> Dopamine antagonists compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</a>; <a href="./full#CD007579-tbl-0003"><b>Summary of findings 3</b> Corticosteroids compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</a>; <a href="./full#CD007579-tbl-0004"><b>Summary of findings 4</b> Antihistamines compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</a>; <a href="./full#CD007579-tbl-0005"><b>Summary of findings 5</b> Anticholinergics compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</a>; <a href="./full#CD007579-tbl-0006"><b>Summary of findings 6</b> Sedatives compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</a>; <a href="./full#CD007579-tbl-0007"><b>Summary of findings 7</b> Opioid antagonists compared to placebo for preventing nausea and vomiting</a>; <a href="./full#CD007579-tbl-0008"><b>Summary of findings 8</b> Acupressure/acupuncture compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</a>; <a href="./full#CD007579-tbl-0009"><b>Summary of findings 9</b> Ginger compared to placebo for preventing nausea and vomiting</a> </p> <section id="CD007579-sec-0078"> <h4 class="title">1) 5‐HT<sub>3</sub> receptor antagonists versus placebo (25 studies, 3942 women, Comparison 1) </h4> <p>Whilst 25 studies assessed this comparison, only 21 provided usable data on outcomes involving 2686 women (<a href="./references#CD007579-bbs2-0003" title="AbouleishEI , RashidS , HaqueS , GiezentannerA , JoyntonP , ChuangAZ . Ondansetron versus placebo for the control of nausea and vomiting during caesarean section under spinal anaesthesia. Anaesthesia1999;54:479-82. ">Abouleish 1999</a>; <a href="./references#CD007579-bbs2-0013" title="CharuluxanananS , KyokongO , SomboonviboonW , NarasethakamolA , PromlokP . Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesthesia and Analgesia2003;96(6):1789-93. ">Charuluxananan 2003</a>; <a href="./references#CD007579-bbs2-0014" title="CherianVT , SmithI . Prophylactic ondansetron does not improve patient satisfaction in women using PCA after caesarean section. British Journal of Anaesthesia2001;87(3):502-4. ">Cherian 2001</a>; <a href="./references#CD007579-bbs2-0017" title="DasguptaM , BiswasBN , ChatterjeeS , MazumderP , BhanjaM . Randomized, placebo-controlled trial of granisetron for control of nausea and vomiting during cesarean delivery under spinal anesthesia. Journal of Obstetrics and Gynecology of India2012;62(4):419-23. ">Dasgupta 2012</a>; <a href="./references#CD007579-bbs2-0021" title="El-DeebAM , AhmadyMS . Effect of acupuncture on nausea and/or vomiting during and after cesarean section in comparison with ondansetron. Journal of Anesthesia2011;25(5):698-703. ">El‐Deeb 2011a</a>; <a href="./references#CD007579-bbs2-0022" title="Garcia-MiguelFJ , MontanoE , Mart-VicenteV , FuentesAL , AlsinaFJ , San JoseJA . Prophylaxis against intraoperative nausea and vomiting during spinal anesthesia for cesarean section: a comparative study of ondansetron versus metoclopramide. Internet Journal of Anesthesiology2000;4(2). ">Garcia‐Miguel 2000</a>; <a href="./references#CD007579-bbs2-0026" title="HarnettMJ , O'RourkeN , WalshM , CarabuenaJM , SegalS . Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery. Anesthesia and Analgesia2007;105(3):764-9. ">Harnett 2007</a>; <a href="./references#CD007579-bbs2-0037" title="KasodekarS , DhumneS , BalkiM , CarvalhoJ . Prophylactic granisetron does not prevent nausea and vomiting during elective cesarean section under spinal anesthesia [abstract]. Anesthesiology2006;104(Suppl 1):9. ">Kasodekar 2006</a>; <a href="./references#CD007579-bbs2-0040" title="KojuRB , CTRI/2015/01/005362. Prophylactic administration of ondansetron in prevention of intrathecal morphine induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section. http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=10813 (07 January 2015). KojuRB , GurungBS , DongolY . Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section. BMC Anesthesiology2015;15:18. ">Koju 2015</a>; <a href="./references#CD007579-bbs2-0052" title="MohammadiSS , JabbarzadehS , MovafeghA . Efficacy of granisetron on prevention of shivering, nausea and vomiting during cesarean delivery under spinal anesthesia: a randomized double-blinded clinical trial. Journal of Obstetric Anaesthesia and Critical Care2015;5(1):22-6. ">Mohammadi 2015</a>; <a href="./references#CD007579-bbs2-0055" title="MunnurU , TranC , ZambareSN , Lozano-GorenaM , SureshMS . Post operative nausea and vomiting following cesarean section with intrathecal morphine. Anesthesiology2008;109:A1113. ">Munnur 2008</a>; <a href="./references#CD007579-bbs2-0059" title="PanPH , MooreCH . Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for cesarean section patients under epidural anesthesia. Anesthesia and Analgesia1996;83(5):982-6. ">Pan 1996</a>; <a href="./references#CD007579-bbs2-0060" title="PanP , MooreC , FragnetoR , RossV , JustisG . Is antiemetic prophylaxis cost-effective for cesarean section patients [abstract]. Anesthesiology2000;93(3A):A1092. PanPH , MooreC , FragnetoR , RossV , JustisG . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesiology2000;92 Suppl:A40. PanPH , MooreCH . Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. Journal of Clinical Anesthesia2001;13(6):430-5. PanPH , MooreCM . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesia and Analgesia2000;90 Suppl:S295. ">Pan 2001</a>; <a href="./references#CD007579-bbs2-0061" title="PanAK , RudraA . Prophylactic single dose intravenous administration of ondansetron in the prevention of postoperative emetic symptoms during spinal anaesthesia for caesarean delivery. Indian Journal of Anaesthesia2003;47(3):178-80. ">Pan 2003</a>; <a href="./references#CD007579-bbs2-0062" title="ISRCTN57227250. Prevention of nausea and vomiting comparing ondansetron and dexamethasone versus placebo in cesarean section under regional anesthesia. http://www.isrctn.com/ISRCTN57227250 (7 July 2016). [CENTRAL: CN-01812416] Parra-GuizaR , MelendezHJ , OchoaME . Prophylactic efficacy of ondansetron and dexamethasone in nausea and vomit in patients undergoing cesarean section with neuraxial opioids. Controlled clinical trial. Medicas UIS2018;31(1):31-8. [DOI: 10.18273/revmed.v31n1-2018004]">Parra‐Guiza 2018</a>; <a href="./references#CD007579-bbs2-0064" title="PeixotoAJ , CelichMF , ZardoL , Peixoto FilhoAJ . Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine. European Journal of Anaesthesiology2006;23(8):670-5. ">Peixoto 2006</a>, <a href="./references#CD007579-bbs2-0068" title="SahooT , SenDasguptaC , GoswamiA , HazraA . Reduction in spinal-induced hypotension with ondansetron in parturients undergoing caesarean section: A double-blind randomised, placebo-controlled study. International Journal of Obstetric Anesthesia2012;21(1):24-8. ">Sahoo 2012</a>; <a href="./references#CD007579-bbs2-0072" title="ShenYJ , YinYQ , ZhangYJ , ZhuQ , ZhangJH , ZhaoW , et al. Efficacy of intravenous scopolamine for preventing postoperative nausea and vomiting after cesarean section. Acta Academiae Medicinae Sinicae2012;34(1):32-7. ">Shen 2012</a>; <a href="./references#CD007579-bbs2-0077" title="TCTR20160216003. Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. http://www.clinicaltrials.in.th/index.php?tp=regtrials&amp;menu=trialsearch&amp;smenu=fulltext&amp;task=search&amp;task2=view1&amp;id=1734 (16 February 2016). [CENTRAL: CN-01882139] UerpairojkitK , ChesohA , BudcharoentongD . Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. Anesthesia and Analgesia2016;123(3 Suppl):286-7. [CENTRAL: CN-01783979] [EMBASE: 612648638]UerpairojkitK , ChesohA , BudcharoentongD . Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. Chotmaihet Thangphaet [Journal of the Medical Association of Thailand]2017;100(12):1283-9. [CENTRAL: CN-01451211] [EMBASE: 620181091]">Uerpairojkit 2017</a>; <a href="./references#CD007579-bbs2-0079" title="VoigtM , FrohlichCW , HuttelC , KrankeP , MennenJ , BoessneckO , et al. Prophylaxis of intra- and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. Medical Science Monitor2013;19:993-1000. ">Voigt 2013</a>; <a href="./references#CD007579-bbs2-0083" title="YazigiA , ChalhoubV , Madi-JebaraS , HaddadF , HayekG . Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritis after cesarean delivery with intrathecal sufentanil-morphine. Journal of Clinical Anesthesia2002;14:183-6. ">Yazigi 2002</a>). Four studies provided no data which could be included in our analyses (<a href="./references#CD007579-bbs2-0009" title="BooneJB , GaoGG , ClarkCP , ChaudhuriS , ChaudhuriK . Dolasetron for prevention of perioperative nausea and vomiting during cesarean section under regional anesthesia [abstract]. Anesthesiology2002;96 Suppl:A1069. ">Boone 2002</a>; <a href="./references#CD007579-bbs2-0042" title="LeeYW , HongJY , YoonHJ , KimSM . Could emesis from epidural anesthesia for a cesarean section be controlled by prophylactic low-dose granisetron?Korean Journal of Anesthesiology2002;43(6):s13-9. ">Lee 2002</a>; <a href="./references#CD007579-bbs2-0063" title="PazokiS , ModirH , KamaliA , ZamaniA , ShahidaniM . Ondansetron 8 mg and 4 mg with normal saline against post-operative headache and nausea/vomiting after spinal anesthesia: a randomized double-blind trial. Medical Gas Research2018;8(2):48-53. [CENTRAL: CN-01617025] [EMBASE: 622985422]">Pazoki 2018</a>; <a href="./references#CD007579-bbs2-0083" title="YazigiA , ChalhoubV , Madi-JebaraS , HaddadF , HayekG . Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritis after cesarean delivery with intrathecal sufentanil-morphine. Journal of Clinical Anesthesia2002;14:183-6. ">Yazigi 2002</a>). Of the studies that provided data, 17 studied ondansetron (<a href="./references#CD007579-bbs2-0003" title="AbouleishEI , RashidS , HaqueS , GiezentannerA , JoyntonP , ChuangAZ . Ondansetron versus placebo for the control of nausea and vomiting during caesarean section under spinal anaesthesia. Anaesthesia1999;54:479-82. ">Abouleish 1999</a>; <a href="./references#CD007579-bbs2-0013" title="CharuluxanananS , KyokongO , SomboonviboonW , NarasethakamolA , PromlokP . Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesthesia and Analgesia2003;96(6):1789-93. ">Charuluxananan 2003</a>; <a href="./references#CD007579-bbs2-0014" title="CherianVT , SmithI . Prophylactic ondansetron does not improve patient satisfaction in women using PCA after caesarean section. British Journal of Anaesthesia2001;87(3):502-4. ">Cherian 2001</a>; <a href="./references#CD007579-bbs2-0021" title="El-DeebAM , AhmadyMS . Effect of acupuncture on nausea and/or vomiting during and after cesarean section in comparison with ondansetron. Journal of Anesthesia2011;25(5):698-703. ">El‐Deeb 2011a</a>; <a href="./references#CD007579-bbs2-0022" title="Garcia-MiguelFJ , MontanoE , Mart-VicenteV , FuentesAL , AlsinaFJ , San JoseJA . Prophylaxis against intraoperative nausea and vomiting during spinal anesthesia for cesarean section: a comparative study of ondansetron versus metoclopramide. Internet Journal of Anesthesiology2000;4(2). ">Garcia‐Miguel 2000</a>; <a href="./references#CD007579-bbs2-0026" title="HarnettMJ , O'RourkeN , WalshM , CarabuenaJM , SegalS . Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery. Anesthesia and Analgesia2007;105(3):764-9. ">Harnett 2007</a>; <a href="./references#CD007579-bbs2-0040" title="KojuRB , CTRI/2015/01/005362. Prophylactic administration of ondansetron in prevention of intrathecal morphine induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section. http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=10813 (07 January 2015). KojuRB , GurungBS , DongolY . Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section. BMC Anesthesiology2015;15:18. ">Koju 2015</a>; <a href="./references#CD007579-bbs2-0055" title="MunnurU , TranC , ZambareSN , Lozano-GorenaM , SureshMS . Post operative nausea and vomiting following cesarean section with intrathecal morphine. Anesthesiology2008;109:A1113. ">Munnur 2008</a>; <a href="./references#CD007579-bbs2-0059" title="PanPH , MooreCH . Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for cesarean section patients under epidural anesthesia. Anesthesia and Analgesia1996;83(5):982-6. ">Pan 1996</a>; <a href="./references#CD007579-bbs2-0060" title="PanP , MooreC , FragnetoR , RossV , JustisG . Is antiemetic prophylaxis cost-effective for cesarean section patients [abstract]. Anesthesiology2000;93(3A):A1092. PanPH , MooreC , FragnetoR , RossV , JustisG . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesiology2000;92 Suppl:A40. PanPH , MooreCH . Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. Journal of Clinical Anesthesia2001;13(6):430-5. PanPH , MooreCM . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesia and Analgesia2000;90 Suppl:S295. ">Pan 2001</a>; <a href="./references#CD007579-bbs2-0061" title="PanAK , RudraA . Prophylactic single dose intravenous administration of ondansetron in the prevention of postoperative emetic symptoms during spinal anaesthesia for caesarean delivery. Indian Journal of Anaesthesia2003;47(3):178-80. ">Pan 2003</a>; <a href="./references#CD007579-bbs2-0062" title="ISRCTN57227250. Prevention of nausea and vomiting comparing ondansetron and dexamethasone versus placebo in cesarean section under regional anesthesia. http://www.isrctn.com/ISRCTN57227250 (7 July 2016). [CENTRAL: CN-01812416] Parra-GuizaR , MelendezHJ , OchoaME . Prophylactic efficacy of ondansetron and dexamethasone in nausea and vomit in patients undergoing cesarean section with neuraxial opioids. Controlled clinical trial. Medicas UIS2018;31(1):31-8. [DOI: 10.18273/revmed.v31n1-2018004]">Parra‐Guiza 2018</a>; <a href="./references#CD007579-bbs2-0064" title="PeixotoAJ , CelichMF , ZardoL , Peixoto FilhoAJ . Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine. European Journal of Anaesthesiology2006;23(8):670-5. ">Peixoto 2006</a>, <a href="./references#CD007579-bbs2-0068" title="SahooT , SenDasguptaC , GoswamiA , HazraA . Reduction in spinal-induced hypotension with ondansetron in parturients undergoing caesarean section: A double-blind randomised, placebo-controlled study. International Journal of Obstetric Anesthesia2012;21(1):24-8. ">Sahoo 2012</a>; <a href="./references#CD007579-bbs2-0072" title="ShenYJ , YinYQ , ZhangYJ , ZhuQ , ZhangJH , ZhaoW , et al. Efficacy of intravenous scopolamine for preventing postoperative nausea and vomiting after cesarean section. Acta Academiae Medicinae Sinicae2012;34(1):32-7. ">Shen 2012</a>; <a href="./references#CD007579-bbs2-0077" title="TCTR20160216003. Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. http://www.clinicaltrials.in.th/index.php?tp=regtrials&amp;menu=trialsearch&amp;smenu=fulltext&amp;task=search&amp;task2=view1&amp;id=1734 (16 February 2016). [CENTRAL: CN-01882139] UerpairojkitK , ChesohA , BudcharoentongD . Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. Anesthesia and Analgesia2016;123(3 Suppl):286-7. [CENTRAL: CN-01783979] [EMBASE: 612648638]UerpairojkitK , ChesohA , BudcharoentongD . Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial. Chotmaihet Thangphaet [Journal of the Medical Association of Thailand]2017;100(12):1283-9. [CENTRAL: CN-01451211] [EMBASE: 620181091]">Uerpairojkit 2017</a>; <a href="./references#CD007579-bbs2-0083" title="YazigiA , ChalhoubV , Madi-JebaraS , HaddadF , HayekG . Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritis after cesarean delivery with intrathecal sufentanil-morphine. Journal of Clinical Anesthesia2002;14:183-6. ">Yazigi 2002</a>), five examined granisetron (<a href="./references#CD007579-bbs2-0017" title="DasguptaM , BiswasBN , ChatterjeeS , MazumderP , BhanjaM . Randomized, placebo-controlled trial of granisetron for control of nausea and vomiting during cesarean delivery under spinal anesthesia. Journal of Obstetrics and Gynecology of India2012;62(4):419-23. ">Dasgupta 2012</a>; <a href="./references#CD007579-bbs2-0037" title="KasodekarS , DhumneS , BalkiM , CarvalhoJ . Prophylactic granisetron does not prevent nausea and vomiting during elective cesarean section under spinal anesthesia [abstract]. Anesthesiology2006;104(Suppl 1):9. ">Kasodekar 2006</a>; <a href="./references#CD007579-bbs2-0042" title="LeeYW , HongJY , YoonHJ , KimSM . Could emesis from epidural anesthesia for a cesarean section be controlled by prophylactic low-dose granisetron?Korean Journal of Anesthesiology2002;43(6):s13-9. ">Lee 2002</a>; <a href="./references#CD007579-bbs2-0052" title="MohammadiSS , JabbarzadehS , MovafeghA . Efficacy of granisetron on prevention of shivering, nausea and vomiting during cesarean delivery under spinal anesthesia: a randomized double-blinded clinical trial. Journal of Obstetric Anaesthesia and Critical Care2015;5(1):22-6. ">Mohammadi 2015</a>; <a href="./references#CD007579-bbs2-0055" title="MunnurU , TranC , ZambareSN , Lozano-GorenaM , SureshMS . Post operative nausea and vomiting following cesarean section with intrathecal morphine. Anesthesiology2008;109:A1113. ">Munnur 2008</a>) and one studied tropisotron (<a href="./references#CD007579-bbs2-0079" title="VoigtM , FrohlichCW , HuttelC , KrankeP , MennenJ , BoessneckO , et al. Prophylaxis of intra- and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. Medical Science Monitor2013;19:993-1000. ">Voigt 2013</a>). </p> <p>The studies which provided data were undertaken in: USA (six studies); Egypt (two studies); India (two studies); Iran (one study); Iran (one study); Spain (one study); Thailand (one study); and UK (one study). </p> <p>Of the 21 studies providing data, only three were judged to have had both adequate sequence generation and allocation concealment (<a href="./references#CD007579-bbs2-0003" title="AbouleishEI , RashidS , HaqueS , GiezentannerA , JoyntonP , ChuangAZ . Ondansetron versus placebo for the control of nausea and vomiting during caesarean section under spinal anaesthesia. Anaesthesia1999;54:479-82. ">Abouleish 1999</a>; <a href="./references#CD007579-bbs2-0013" title="CharuluxanananS , KyokongO , SomboonviboonW , NarasethakamolA , PromlokP . Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesthesia and Analgesia2003;96(6):1789-93. ">Charuluxananan 2003</a>; <a href="./references#CD007579-bbs2-0014" title="CherianVT , SmithI . Prophylactic ondansetron does not improve patient satisfaction in women using PCA after caesarean section. British Journal of Anaesthesia2001;87(3):502-4. ">Cherian 2001</a>). The remaining are unclear. Five studies were considered to have adequate and well‐described blinding (<a href="./references#CD007579-bbs2-0017" title="DasguptaM , BiswasBN , ChatterjeeS , MazumderP , BhanjaM . Randomized, placebo-controlled trial of granisetron for control of nausea and vomiting during cesarean delivery under spinal anesthesia. Journal of Obstetrics and Gynecology of India2012;62(4):419-23. ">Dasgupta 2012</a>; <a href="./references#CD007579-bbs2-0052" title="MohammadiSS , JabbarzadehS , MovafeghA . Efficacy of granisetron on prevention of shivering, nausea and vomiting during cesarean delivery under spinal anesthesia: a randomized double-blinded clinical trial. Journal of Obstetric Anaesthesia and Critical Care2015;5(1):22-6. ">Mohammadi 2015</a>; <a href="./references#CD007579-bbs2-0059" title="PanPH , MooreCH . Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for cesarean section patients under epidural anesthesia. Anesthesia and Analgesia1996;83(5):982-6. ">Pan 1996</a>; <a href="./references#CD007579-bbs2-0060" title="PanP , MooreC , FragnetoR , RossV , JustisG . Is antiemetic prophylaxis cost-effective for cesarean section patients [abstract]. Anesthesiology2000;93(3A):A1092. PanPH , MooreC , FragnetoR , RossV , JustisG . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesiology2000;92 Suppl:A40. PanPH , MooreCH . Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. Journal of Clinical Anesthesia2001;13(6):430-5. PanPH , MooreCM . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesia and Analgesia2000;90 Suppl:S295. ">Pan 2001</a>; <a href="./references#CD007579-bbs2-0064" title="PeixotoAJ , CelichMF , ZardoL , Peixoto FilhoAJ . Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine. European Journal of Anaesthesiology2006;23(8):670-5. ">Peixoto 2006</a>). The remainder are unclear in at least one element (<i>see</i><a href="#CD007579-fig-0002">Figure 2</a> and <a href="#CD007579-fig-0003">Figure 3</a>). </p> <section id="CD007579-sec-0079"> <h5 class="title">Primary outcomes</h5> <section id="CD007579-sec-0080"> <h6 class="title">Intraoperative nausea</h6> <p>5‐HT<sub>3</sub> antagonists may reduce the number of women having intraoperative nausea (average risk ratio (RR) 0.55, 95% confidence interval (CI) 0.42 to 0.71), 12 studies, 1419 women, random‐effects (T<sup>2</sup> = 0.11; Chi<sup>2</sup> P = 0.0009; I<sup>2</sup> = 65%), <a href="./references#CD007579-fig-0004" title="">Analysis 1.1</a>). The certainty of the evidence was low, downgraded for serious risk of bias and serious inconsistency (<a href="./full#CD007579-tbl-0001">summary of findings Table 1</a>). </p> <p>In a subgroup analysis by drug and dose, there was significant difference in treatment effect between the subgroups (Chi² = 7.72, P = 0.05, I² = 61.1%). </p> <p>The sensitivity analysis left only one study (with 81 women) at low risk of bias across selection and attrition bias and this showed no reduction and a wide CI crossing the line of no difference (average RR 1.11, 95% CI 0.45 to 2.79). </p> </section> <section id="CD007579-sec-0081"> <h6 class="title">Intraoperative vomiting</h6> <p>5‐HT<sub>3</sub> antagonists may lead to a reduction in the number of women having intraoperative vomiting, but the results are very uncertain (average RR 0.46, 95% CI 0.29 to 0.73, 11 studies, 1414 women, random‐effects (T² = 0.27, Chi² P = 0.008, I² = 58%), <a href="./references#CD007579-fig-0005" title="">Analysis 1.2</a>).The certainty of the evidence is very low, downgraded for serious risk of bias, serious inconsistency and some evidence of publication bias (<a href="./full#CD007579-tbl-0001">summary of findings Table 1</a>). </p> <p>In the subgroup analysis by dose of drug, there was no evidence of differences in treatment effect between the subgroups (Chi² = 4.33, P = 0.22, I² = 32.2%). </p> <p>The sensitivity analysis left only one study (with 81 women) at low risk of bias across selection and attrition bias, it showed a similar result to the main analysis but a wider CI (RR 0.38, 95% CI 0.18 to 0.81). </p> </section> <section id="CD007579-sec-0082"> <h6 class="title">Postoperative nausea</h6> <p>5‐HT<sub>3</sub> antagonists probably reduce the number of women having postoperative nausea (average RR 0.40, 95% CI 0.30 to 0.54, 10 studies, 1340 women, random‐effects (T² = 0.09, Chi² P = 0.10, I² = 37%) (<a href="./references#CD007579-fig-0006" title="">Analysis 1.3</a>). The certainty of the evidence was moderate, downgraded for serious risk of bias (<a href="./full#CD007579-tbl-0001">summary of findings Table 1</a>). </p> <p>The subgroup analysis by drug and dose did not identify any heterogeneity (Chi² = 0.15, df = 3 (P = 0.99), I² = 0%). </p> <p>The sensitivity analysis left only two studies (with 338 women) at low risk of bias across selection and attrition bias and this showed similar finding, with a wider CI (average RR 0.56, 95% CI 0.38 to 0.83). </p> </section> <section id="CD007579-sec-0083"> <h6 class="title">Postoperative vomiting</h6> <p>5‐HT<sub>3</sub> antagonists may reduce the number of women having postoperative vomiting (average RR 0.47, 95% CI 0.31 to 0.69, 10 studies, 1450 women, random‐effects (T² = 0.13, Chi² P = 0.10, I² = 37%), <a href="./references#CD007579-fig-0007" title="">Analysis 1.4</a>). The certainty of the evidence was low, downgraded for serious risk of bias and some evidence of publication bias (<a href="./full#CD007579-tbl-0001">summary of findings Table 1</a>). </p> <p>The subgroup analysis by drug and dose did not identify any differences (Chi² = 1.15, df = 3 (P = 0.76), I² = 0%). </p> <p>The sensitivity analysis left only two studies (with 338 women) at low risk of bias across selection and attrition bias and this showed a wider CI crossing the line of no difference (average RR 0.94, 95% CI 0.53 to 1.67). </p> </section> </section> <section id="CD007579-sec-0084"> <h5 class="title">Secondary outcomes</h5> <section id="CD007579-sec-0085"> <h6 class="title">Intraoperative nausea + vomiting</h6> <p>Only one small study (<a href="./references#CD007579-bbs2-0079" title="VoigtM , FrohlichCW , HuttelC , KrankeP , MennenJ , BoessneckO , et al. Prophylaxis of intra- and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. Medical Science Monitor2013;19:993-1000. ">Voigt 2013</a>) looked at this outcome and so there are insufficient data to make any judgement (<a href="./references#CD007579-fig-0008" title="">Analysis 1.5</a>). </p> </section> <section id="CD007579-sec-0086"> <h6 class="title">Postoperative nausea + vomiting</h6> <p>5HT<sub>3</sub> antagonists may reduce the number of women having postoperative nausea plus vomiting (RR 0.57, 95% CI 0.41 to 0.80, five studies, 576 women), however, the certainty of the evidence is low due to unclear risk of bias on most aspects including selection and attrition bias. (<a href="./references#CD007579-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD007579-sec-0087"> <h6 class="title">Maternal satisfaction</h6> <p>We identified two differing results in women's satisfaction between the 5‐HT<sub>3</sub> receptor antagonist ondansetron and placebo. One study showed a benefit from the ondansetron (RR 1.99, 95%CI 1.35 to 2.94, 1 study, 105 women) (<a href="./references#CD007579-bbs2-0060" title="PanP , MooreC , FragnetoR , RossV , JustisG . Is antiemetic prophylaxis cost-effective for cesarean section patients [abstract]. Anesthesiology2000;93(3A):A1092. PanPH , MooreC , FragnetoR , RossV , JustisG . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesiology2000;92 Suppl:A40. PanPH , MooreCH . Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. Journal of Clinical Anesthesia2001;13(6):430-5. PanPH , MooreCM . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesia and Analgesia2000;90 Suppl:S295. ">Pan 2001</a>), and the other showed no difference (RR 0.98, 95% CI 0.82 to 1.16, 1 study 81 women) (<a href="./references#CD007579-bbs2-0014" title="CherianVT , SmithI . Prophylactic ondansetron does not improve patient satisfaction in women using PCA after caesarean section. British Journal of Anaesthesia2001;87(3):502-4. ">Cherian 2001</a>) (<a href="./references#CD007579-fig-0010" title="">Analysis 1.7</a>). </p> </section> <section id="CD007579-sec-0088"> <h6 class="title">Adverse effects and side effects</h6> <p>There were no events in the one study involving 100 women that assessed a composite outcome of adverse effects. There was no indication of adverse effects for a number of outcome measures: headaches/dizziness (average RR 1.04, 95% CI 0.60 to 1.79, 4 studies, 433 women, <a href="./references#CD007579-fig-0012" title="">Analysis 1.9</a>); hypotension (average RR 1.22, 95% CI 0.72 to 2.08, 3 studies 290 women, <a href="./references#CD007579-fig-0013" title="">Analysis 1.10</a>); and pruritis/itching (RR 0.85, 95% CI 0.69 to 1.05, 4 studies 488 women, ,<a href="./references#CD007579-fig-0014" title="">Analysis 1.11</a>); dry mouth (RR 0.75, 95% CI 0.17 to 3.22, 1 study, 130 women, <a href="./references#CD007579-fig-0015" title="">Analysis 1.12</a>); drowsiness/sedation (RR 3.94, 95% CI 0.45 to 34.63, 2 studies, 170 women, <a href="./references#CD007579-fig-0016" title="">Analysis 1.13</a>). . </p> <p>Rescue antiemetics used: 5HT<sub>3</sub> antagonist ondansetron may reduce the use of rescue antiemetics (RR 0.32, 95% CI 0.11 to 0.93, 1 study, 158 women, <a href="./references#CD007579-fig-0017" title="">Analysis 1.14</a>) but more data are needed. </p> </section> </section> </section> <section id="CD007579-sec-0089"> <h4 class="title">2) Dopamine antagonists versus placebo (24 studies, 2965 women, Comparison 2)</h4> <p>Twenty‐four studies compared dopamine antagonists with placebo, of which 20 studies provided data for analysis involving 1880 women (<a href="./references#CD007579-bbs2-0008" title="BiswasBN , RudraA , DasSK , NathS , BiswasSC . A comparative study of glycopyrrolate, dexamethasone and metoclopramide in control of post-operative nausea and vomiting after spinal anaesthesia for caesarean delivery. Indian Journal of Anaesthesia2003;47(3):198-200. ">Biswas 2003</a>; <a href="./references#CD007579-bbs2-0015" title="ChestnutDH , BatesJN , ChoiWW , VandewalkerGE . Administration of metoclopramide for prevention of nausea and vomiting during regional anesthesia for cesarean section: a randomized, double blind, placebo controlled study. Anesthesiology1986;65:390. ChestnutDH , VandewalkerGE , OwenCL , BatesJN , ChoiWW . Administration of metoclopramide for prevention of nausea and vomiting during epidural anesthesia for elective cesarean section. Anesthesiology1987;66:563-6. ">Chestnut 1987</a>; <a href="./references#CD007579-bbs2-0016" title="ChoiDH , KimSC , SimWS . Prevention of nausea and vomiting during spinal or epidural anesthesia for cesarean section - the efficacy of metoclopramide and droperidol. Korean Journal of Anesthesiology1999;37(6):1054-9. ">Choi 1999</a>; <a href="./references#CD007579-bbs2-0018" title="Direkvand-MoghadamA , KhosraviA . Effect of acupressure on post-operative nausea and vomiting in cesarean section: a randomised controlled trial. Journal of Clinical and Diagnostic Research2013;7(10):2247-9. IRCT201111146575N4. Comparing the effect of acupressure and metoclopramide on nausea and vomiting in women with spinal anesthesia for cesarean. http://en.irct.ir/trial/7020 (21 December 2011). [CENTRAL: CN-01849415] ">Direkvand‐Moghadam 2013</a>; <a href="./references#CD007579-bbs2-0020" title="ApiliogullariS , GokF , CanpolatA , SoysalS , ToyH , SukanF . Comparison of prophylactic dimenhydrinate and metoclopramide for prevention of nausea-vomiting caused by intrathecal opioids in parturients undergoing caesarean delivery. Regional Anesthesia and Pain Medicine2008;33(5 Suppl 1):131. DumanA , ApiliogullariS , GokF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine in cesarean delivery. Nobel Medicus2010;6(3):13-9. DumanA , ApiliogullariS , GookF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine for cesarean delivery. Data on file. ">Duman 2010</a>; <a href="./references#CD007579-bbs2-0022" title="Garcia-MiguelFJ , MontanoE , Mart-VicenteV , FuentesAL , AlsinaFJ , San JoseJA . Prophylaxis against intraoperative nausea and vomiting during spinal anesthesia for cesarean section: a comparative study of ondansetron versus metoclopramide. Internet Journal of Anesthesiology2000;4(2). ">Garcia‐Miguel 2000</a>; <a href="./references#CD007579-bbs2-0024" title="HabibAS , GeorgeRB , McKeenDM , WhiteWD , ItukUS , MegallaSA , et al. Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. Obstetrics and Gynecology2013;121(3):615-23. NCT01216410. Prevention of intraoperative nausea and vomiting during cesarean section. Https://clinicaltrials.gov/show/NCT01216410 (first received 2010 Oct 6). [CENTRAL: CN-02025773] ">Habib 2013</a>; <a href="./references#CD007579-bbs2-0030" title="HuangWP . Clinical observation of using Metoclopramide to relieve dragging reaction during baby deliver in caesarean operation. Chinese Journal of Anaesthesiology1992;12(1):33. ">Huang 1992</a>; <a href="./references#CD007579-bbs2-0036" title="ISRCTN15475205. Does propofol prevent morphine-induced nausea, vomiting and itching in women who have had a Caesarean section?Http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN15475205 (first received 2019). [CENTRAL: CN-01974804] KampoS , AffulAP , MohammedS , NtimM , BuunaaimAD , AnabahTW . Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section - a randomized control trial. BMC Anesthesiology2019;19(1):177. [CENTRAL: CN-01987099] [EMBASE: 629299629] [PMID: 31521119]">Kampo 2019</a>; <a href="./references#CD007579-bbs2-0038" title="KhalaylehK , OmarAA . Comparitive antiemetic efficacy of intrathecal fentanyl and intravenous metoclopromide, during Caesarean Section under spinal anaesthesia. Journal of the Bahrain Medical Society2005;17(4):243-7. ">Khalayleh 2005</a>; <a href="./references#CD007579-bbs2-0048" title="LussosS , BaderA , ThornhillM , DattaS . The antiemetic efficacy of prophylactic metoclopramide for cesarean delivery. Anesthesiology1991;75:A1081. LussosSA , BaderAM , ThornhillML , DattaS . The antiemetic efficacy and safety of prophylactic metoclopramide for elective cesarean delivery during spinal anesthesia. Regional Anesthesia1992;17:126-30. ">Lussos 1992</a>; <a href="./references#CD007579-bbs2-0049" title="MandellG , DewanDM , HowardG , FloydHM . The effectiveness of low dose droperidol in controlling nausea and vomiting during epidural anesthesia for cesarean section. Anesthesiology1986;65:391. MandellGL , DewanDM , HowardG , FloydHM . The effectiveness of low dose droperidol in controlling nausea and vomiting during epidural anesthesia for cesarean section. International Journal of Obstetric Anesthesia1992;1(2):65-8. ">Mandell 1992</a>; <a href="./references#CD007579-bbs2-0050" title="MaranhaoMV , CoelhoVV , IvoCM , MaranhaoMH , AmaralEB . A comparative study between metoclopramide and droperidol in the control of nausea and vomit in patients subjected to spinal blockade during cesarean section [Estudo comparativo entre a metoclopramida e o droperidol no controle de nauseas e vomitos na operacao cesariana em gestantes submetidas a bloqueio subaracnoideo]. Revista Brasileira de Anestesiologia1988;38(4):245-9. ">Maranhao 1988</a>; <a href="./references#CD007579-bbs2-0053" title="MokiniZ , FabbriE , Dell'AttiI , Di MartinoR , D'EttorreM , PetriniF . A randomized, controlled, double blind trial on the incidence of nausea and vomiting with prophylactic subhypnotic propofol vs metoclopramide and in combination therapy in cesarean section with subarachnoid anesthesia. European Journal of Anaesthesiology2014;31:192. NCT01781377. Prophylactic subhypnotic propofol for nausea and vomiting during for cesarean section under subarachnoid anesthesia. Https://clinicaltrials.gov/show/NCT01781377 (first received 2013 Jan 25). [CENTRAL: CN-01540221] ">Mokini 2014</a>; <a href="./references#CD007579-bbs2-0059" title="PanPH , MooreCH . Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for cesarean section patients under epidural anesthesia. Anesthesia and Analgesia1996;83(5):982-6. ">Pan 1996</a>; <a href="./references#CD007579-bbs2-0060" title="PanP , MooreC , FragnetoR , RossV , JustisG . Is antiemetic prophylaxis cost-effective for cesarean section patients [abstract]. Anesthesiology2000;93(3A):A1092. PanPH , MooreC , FragnetoR , RossV , JustisG . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesiology2000;92 Suppl:A40. PanPH , MooreCH . Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. Journal of Clinical Anesthesia2001;13(6):430-5. PanPH , MooreCM . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesia and Analgesia2000;90 Suppl:S295. ">Pan 2001</a>; <a href="./references#CD007579-bbs2-0064" title="PeixotoAJ , CelichMF , ZardoL , Peixoto FilhoAJ . Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine. European Journal of Anaesthesiology2006;23(8):670-5. ">Peixoto 2006</a>; <a href="./references#CD007579-bbs2-0073" title="SteinDJ , BirnbachDJ , DanzerBI , KurodaMM , GrunebaumA , ThysDM . Acupressure versus intravenous metoclopramide to prevent nausea and vomiting during spinal anesthesia for cesarean section. Anesthesia and Analgesia1997;84(2):342-5. ">Stein 1997</a>; <a href="./references#CD007579-bbs2-0076" title="TzengJI , WangJJ , HoST , TangCS , LiuYC , LeeSC . Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline. British Journal of Anaesthesia2000;85(6):865-8. ">Tzeng 2000</a>; <a href="./references#CD007579-bbs2-0082" title="WuJI , LoY , ChiaYY , LiuK , FongWP , YangLC , et al. Prevention of postoperative nausea and vomiting after intrathecal morphine for cesarean section: a randomized comparison of dexamethasone, droperidol, and a combination. International Journal of Obstetric Anesthesia2007;16(2):122-7. ">Wu 2007</a>). Four studies provided no data which could be included in our analyses (<a href="./references#CD007579-bbs2-0007" title="BirnbachDJ , SteinDJ , SaundersTA , GrunebaumA , KitainEM . Prophylactic use of acupressure for the prevention of nausea and vomiting during spinal anesthesia for cesarean section. Anesthesiology1993;79:A1020. ">Birnbach 1993</a>; <a href="./references#CD007579-bbs2-0032" title="ImbeloniLE , SantosJM , SantosMM . Prophylactic use of metoclopramide for control of nausea and vomiting during epidural anesthesia for cesarean section [Uso profilatico da metoclopramida no controle de nauseas e vomitos durante anestesia peridural para cesariana]. Revista Brasileira de Anestesiologia1986;36(4):295-8. ">Imbeloni 1986</a>; <a href="./references#CD007579-bbs2-0039" title="KimMO , SuhKS . A comparison of the antiemetic effect of ondansetron and metoclopramide on nausea and vomiting associated with epidural buprenorphine. Korean Journal of Anesthesiology1999;37(4):656-61. ">Kim 1999</a>; <a href="./references#CD007579-bbs2-0069" title="SanansilpV , AreewatanaS , TonsukchaiN . Droperidol and the side effects of epidural morphine after cesarean section. Anesthesia &amp; Analgesia1998;86(3):532-7. ">Sanansilp 1998</a>). Of the studies providing data, 15 studied metoclopramide (<a href="./references#CD007579-bbs2-0008" title="BiswasBN , RudraA , DasSK , NathS , BiswasSC . A comparative study of glycopyrrolate, dexamethasone and metoclopramide in control of post-operative nausea and vomiting after spinal anaesthesia for caesarean delivery. Indian Journal of Anaesthesia2003;47(3):198-200. ">Biswas 2003</a>; <a href="./references#CD007579-bbs2-0015" title="ChestnutDH , BatesJN , ChoiWW , VandewalkerGE . Administration of metoclopramide for prevention of nausea and vomiting during regional anesthesia for cesarean section: a randomized, double blind, placebo controlled study. Anesthesiology1986;65:390. ChestnutDH , VandewalkerGE , OwenCL , BatesJN , ChoiWW . Administration of metoclopramide for prevention of nausea and vomiting during epidural anesthesia for elective cesarean section. Anesthesiology1987;66:563-6. ">Chestnut 1987</a>; <a href="./references#CD007579-bbs2-0016" title="ChoiDH , KimSC , SimWS . Prevention of nausea and vomiting during spinal or epidural anesthesia for cesarean section - the efficacy of metoclopramide and droperidol. Korean Journal of Anesthesiology1999;37(6):1054-9. ">Choi 1999</a>; <a href="./references#CD007579-bbs2-0018" title="Direkvand-MoghadamA , KhosraviA . Effect of acupressure on post-operative nausea and vomiting in cesarean section: a randomised controlled trial. Journal of Clinical and Diagnostic Research2013;7(10):2247-9. IRCT201111146575N4. Comparing the effect of acupressure and metoclopramide on nausea and vomiting in women with spinal anesthesia for cesarean. http://en.irct.ir/trial/7020 (21 December 2011). [CENTRAL: CN-01849415] ">Direkvand‐Moghadam 2013</a>; <a href="./references#CD007579-bbs2-0020" title="ApiliogullariS , GokF , CanpolatA , SoysalS , ToyH , SukanF . Comparison of prophylactic dimenhydrinate and metoclopramide for prevention of nausea-vomiting caused by intrathecal opioids in parturients undergoing caesarean delivery. Regional Anesthesia and Pain Medicine2008;33(5 Suppl 1):131. DumanA , ApiliogullariS , GokF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine in cesarean delivery. Nobel Medicus2010;6(3):13-9. DumanA , ApiliogullariS , GookF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine for cesarean delivery. Data on file. ">Duman 2010</a>; <a href="./references#CD007579-bbs2-0022" title="Garcia-MiguelFJ , MontanoE , Mart-VicenteV , FuentesAL , AlsinaFJ , San JoseJA . Prophylaxis against intraoperative nausea and vomiting during spinal anesthesia for cesarean section: a comparative study of ondansetron versus metoclopramide. Internet Journal of Anesthesiology2000;4(2). ">Garcia‐Miguel 2000</a>; <a href="./references#CD007579-bbs2-0024" title="HabibAS , GeorgeRB , McKeenDM , WhiteWD , ItukUS , MegallaSA , et al. Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. Obstetrics and Gynecology2013;121(3):615-23. NCT01216410. Prevention of intraoperative nausea and vomiting during cesarean section. Https://clinicaltrials.gov/show/NCT01216410 (first received 2010 Oct 6). [CENTRAL: CN-02025773] ">Habib 2013</a>; <a href="./references#CD007579-bbs2-0030" title="HuangWP . Clinical observation of using Metoclopramide to relieve dragging reaction during baby deliver in caesarean operation. Chinese Journal of Anaesthesiology1992;12(1):33. ">Huang 1992</a>; <a href="./references#CD007579-bbs2-0036" title="ISRCTN15475205. Does propofol prevent morphine-induced nausea, vomiting and itching in women who have had a Caesarean section?Http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN15475205 (first received 2019). [CENTRAL: CN-01974804] KampoS , AffulAP , MohammedS , NtimM , BuunaaimAD , AnabahTW . Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section - a randomized control trial. BMC Anesthesiology2019;19(1):177. [CENTRAL: CN-01987099] [EMBASE: 629299629] [PMID: 31521119]">Kampo 2019</a>; <a href="./references#CD007579-bbs2-0038" title="KhalaylehK , OmarAA . Comparitive antiemetic efficacy of intrathecal fentanyl and intravenous metoclopromide, during Caesarean Section under spinal anaesthesia. Journal of the Bahrain Medical Society2005;17(4):243-7. ">Khalayleh 2005</a>; <a href="./references#CD007579-bbs2-0048" title="LussosS , BaderA , ThornhillM , DattaS . The antiemetic efficacy of prophylactic metoclopramide for cesarean delivery. Anesthesiology1991;75:A1081. LussosSA , BaderAM , ThornhillML , DattaS . The antiemetic efficacy and safety of prophylactic metoclopramide for elective cesarean delivery during spinal anesthesia. Regional Anesthesia1992;17:126-30. ">Lussos 1992</a>; <a href="./references#CD007579-bbs2-0050" title="MaranhaoMV , CoelhoVV , IvoCM , MaranhaoMH , AmaralEB . A comparative study between metoclopramide and droperidol in the control of nausea and vomit in patients subjected to spinal blockade during cesarean section [Estudo comparativo entre a metoclopramida e o droperidol no controle de nauseas e vomitos na operacao cesariana em gestantes submetidas a bloqueio subaracnoideo]. Revista Brasileira de Anestesiologia1988;38(4):245-9. ">Maranhao 1988</a>; <a href="./references#CD007579-bbs2-0053" title="MokiniZ , FabbriE , Dell'AttiI , Di MartinoR , D'EttorreM , PetriniF . A randomized, controlled, double blind trial on the incidence of nausea and vomiting with prophylactic subhypnotic propofol vs metoclopramide and in combination therapy in cesarean section with subarachnoid anesthesia. European Journal of Anaesthesiology2014;31:192. NCT01781377. Prophylactic subhypnotic propofol for nausea and vomiting during for cesarean section under subarachnoid anesthesia. Https://clinicaltrials.gov/show/NCT01781377 (first received 2013 Jan 25). [CENTRAL: CN-01540221] ">Mokini 2014</a>; <a href="./references#CD007579-bbs2-0060" title="PanP , MooreC , FragnetoR , RossV , JustisG . Is antiemetic prophylaxis cost-effective for cesarean section patients [abstract]. Anesthesiology2000;93(3A):A1092. PanPH , MooreC , FragnetoR , RossV , JustisG . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesiology2000;92 Suppl:A40. PanPH , MooreCH . Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. Journal of Clinical Anesthesia2001;13(6):430-5. PanPH , MooreCM . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesia and Analgesia2000;90 Suppl:S295. ">Pan 2001</a>; <a href="./references#CD007579-bbs2-0073" title="SteinDJ , BirnbachDJ , DanzerBI , KurodaMM , GrunebaumA , ThysDM . Acupressure versus intravenous metoclopramide to prevent nausea and vomiting during spinal anesthesia for cesarean section. Anesthesia and Analgesia1997;84(2):342-5. ">Stein 1997</a>). Five examined droperidol (<a href="./references#CD007579-bbs2-0049" title="MandellG , DewanDM , HowardG , FloydHM . The effectiveness of low dose droperidol in controlling nausea and vomiting during epidural anesthesia for cesarean section. Anesthesiology1986;65:391. MandellGL , DewanDM , HowardG , FloydHM . The effectiveness of low dose droperidol in controlling nausea and vomiting during epidural anesthesia for cesarean section. International Journal of Obstetric Anesthesia1992;1(2):65-8. ">Mandell 1992</a>; <a href="./references#CD007579-bbs2-0059" title="PanPH , MooreCH . Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for cesarean section patients under epidural anesthesia. Anesthesia and Analgesia1996;83(5):982-6. ">Pan 1996</a>; <a href="./references#CD007579-bbs2-0064" title="PeixotoAJ , CelichMF , ZardoL , Peixoto FilhoAJ . Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine. European Journal of Anaesthesiology2006;23(8):670-5. ">Peixoto 2006</a>; <a href="./references#CD007579-bbs2-0076" title="TzengJI , WangJJ , HoST , TangCS , LiuYC , LeeSC . Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline. British Journal of Anaesthesia2000;85(6):865-8. ">Tzeng 2000</a>; <a href="./references#CD007579-bbs2-0082" title="WuJI , LoY , ChiaYY , LiuK , FongWP , YangLC , et al. Prevention of postoperative nausea and vomiting after intrathecal morphine for cesarean section: a randomized comparison of dexamethasone, droperidol, and a combination. International Journal of Obstetric Anesthesia2007;16(2):122-7. ">Wu 2007</a>). </p> <p>The 20 studies which provided data were undertaken in: USA (seven studies); one in the USA and Canada, Taiwan (two studies); India (one study); Iran (two studies); Spain (one study); Turkey (one study); Africa (one study) South America (two studies) and two studies where the setting was not described. </p> <p>Overall, the studies were of uncertain or variable quality. Of the 20 studies which provided data, only three were judged to have had both adequate random sequence generation and allocation concealment (<a href="./references#CD007579-bbs2-0015" title="ChestnutDH , BatesJN , ChoiWW , VandewalkerGE . Administration of metoclopramide for prevention of nausea and vomiting during regional anesthesia for cesarean section: a randomized, double blind, placebo controlled study. Anesthesiology1986;65:390. ChestnutDH , VandewalkerGE , OwenCL , BatesJN , ChoiWW . Administration of metoclopramide for prevention of nausea and vomiting during epidural anesthesia for elective cesarean section. Anesthesiology1987;66:563-6. ">Chestnut 1987</a>; <a href="./references#CD007579-bbs2-0024" title="HabibAS , GeorgeRB , McKeenDM , WhiteWD , ItukUS , MegallaSA , et al. Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. Obstetrics and Gynecology2013;121(3):615-23. NCT01216410. Prevention of intraoperative nausea and vomiting during cesarean section. Https://clinicaltrials.gov/show/NCT01216410 (first received 2010 Oct 6). [CENTRAL: CN-02025773] ">Habib 2013</a>; ; <a href="./references#CD007579-bbs2-0073" title="SteinDJ , BirnbachDJ , DanzerBI , KurodaMM , GrunebaumA , ThysDM . Acupressure versus intravenous metoclopramide to prevent nausea and vomiting during spinal anesthesia for cesarean section. Anesthesia and Analgesia1997;84(2):342-5. ">Stein 1997</a>). Nine studies were judged to have had adequately described blinding (<a href="./references#CD007579-bbs2-0015" title="ChestnutDH , BatesJN , ChoiWW , VandewalkerGE . Administration of metoclopramide for prevention of nausea and vomiting during regional anesthesia for cesarean section: a randomized, double blind, placebo controlled study. Anesthesiology1986;65:390. ChestnutDH , VandewalkerGE , OwenCL , BatesJN , ChoiWW . Administration of metoclopramide for prevention of nausea and vomiting during epidural anesthesia for elective cesarean section. Anesthesiology1987;66:563-6. ">Chestnut 1987</a>; <a href="./references#CD007579-bbs2-0020" title="ApiliogullariS , GokF , CanpolatA , SoysalS , ToyH , SukanF . Comparison of prophylactic dimenhydrinate and metoclopramide for prevention of nausea-vomiting caused by intrathecal opioids in parturients undergoing caesarean delivery. Regional Anesthesia and Pain Medicine2008;33(5 Suppl 1):131. DumanA , ApiliogullariS , GokF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine in cesarean delivery. Nobel Medicus2010;6(3):13-9. DumanA , ApiliogullariS , GookF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine for cesarean delivery. Data on file. ">Duman 2010</a>; <a href="./references#CD007579-bbs2-0024" title="HabibAS , GeorgeRB , McKeenDM , WhiteWD , ItukUS , MegallaSA , et al. Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. Obstetrics and Gynecology2013;121(3):615-23. NCT01216410. Prevention of intraoperative nausea and vomiting during cesarean section. Https://clinicaltrials.gov/show/NCT01216410 (first received 2010 Oct 6). [CENTRAL: CN-02025773] ">Habib 2013</a>; ; <a href="./references#CD007579-bbs2-0059" title="PanPH , MooreCH . Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for cesarean section patients under epidural anesthesia. Anesthesia and Analgesia1996;83(5):982-6. ">Pan 1996</a>; <a href="./references#CD007579-bbs2-0060" title="PanP , MooreC , FragnetoR , RossV , JustisG . Is antiemetic prophylaxis cost-effective for cesarean section patients [abstract]. Anesthesiology2000;93(3A):A1092. PanPH , MooreC , FragnetoR , RossV , JustisG . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesiology2000;92 Suppl:A40. PanPH , MooreCH . Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. Journal of Clinical Anesthesia2001;13(6):430-5. PanPH , MooreCM . Efficacy and cost-effectiveness of prophylactic ondansetron versus metoclopramide for cesarean section patients under epidural anesthesia [abstract]. Anesthesia and Analgesia2000;90 Suppl:S295. ">Pan 2001</a>; <a href="./references#CD007579-bbs2-0064" title="PeixotoAJ , CelichMF , ZardoL , Peixoto FilhoAJ . Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine. European Journal of Anaesthesiology2006;23(8):670-5. ">Peixoto 2006</a>; <a href="./references#CD007579-bbs2-0073" title="SteinDJ , BirnbachDJ , DanzerBI , KurodaMM , GrunebaumA , ThysDM . Acupressure versus intravenous metoclopramide to prevent nausea and vomiting during spinal anesthesia for cesarean section. Anesthesia and Analgesia1997;84(2):342-5. ">Stein 1997</a>; <a href="./references#CD007579-bbs2-0076" title="TzengJI , WangJJ , HoST , TangCS , LiuYC , LeeSC . Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline. British Journal of Anaesthesia2000;85(6):865-8. ">Tzeng 2000</a>; <a href="./references#CD007579-bbs2-0082" title="WuJI , LoY , ChiaYY , LiuK , FongWP , YangLC , et al. Prevention of postoperative nausea and vomiting after intrathecal morphine for cesarean section: a randomized comparison of dexamethasone, droperidol, and a combination. International Journal of Obstetric Anesthesia2007;16(2):122-7. ">Wu 2007</a>). All the remaining being unclear (<a href="#CD007579-fig-0002">Figure 2</a>) except for one study where it seemed likely that the patient and clinicians would both have been aware of the group allocation (<a href="./references#CD007579-bbs2-0018" title="Direkvand-MoghadamA , KhosraviA . Effect of acupressure on post-operative nausea and vomiting in cesarean section: a randomised controlled trial. Journal of Clinical and Diagnostic Research2013;7(10):2247-9. IRCT201111146575N4. Comparing the effect of acupressure and metoclopramide on nausea and vomiting in women with spinal anesthesia for cesarean. http://en.irct.ir/trial/7020 (21 December 2011). [CENTRAL: CN-01849415] ">Direkvand‐Moghadam 2013</a>). study appeared at high risk of bias due to missing data, where substantial numbers of patients were excluded after randomisation and weren't able to be re‐included (<a href="./references#CD007579-bbs2-0020" title="ApiliogullariS , GokF , CanpolatA , SoysalS , ToyH , SukanF . Comparison of prophylactic dimenhydrinate and metoclopramide for prevention of nausea-vomiting caused by intrathecal opioids in parturients undergoing caesarean delivery. Regional Anesthesia and Pain Medicine2008;33(5 Suppl 1):131. DumanA , ApiliogullariS , GokF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine in cesarean delivery. Nobel Medicus2010;6(3):13-9. DumanA , ApiliogullariS , GookF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine for cesarean delivery. Data on file. ">Duman 2010</a>). </p> <section id="CD007579-sec-0090"> <h5 class="title">Primary outcomes</h5> <section id="CD007579-sec-0091"> <h6 class="title">Intraoperative nausea</h6> <p>Dopamine antagonists may reduce the number of women having intraoperative nausea but the results are very uncertain (average RR 0.38, 95% CI 0.27 to 0.52, 15 studies, 1180 women, random‐effects (T² = 0.19, Chi² P = 0.005, I² = 54%), <a href="./references#CD007579-fig-0018" title="">Analysis 2.1</a>). The certainty of the evidence was very low, downgraded for very serious risk of bias and serious inconsistency (<a href="./full#CD007579-tbl-0002">summary of findings Table 2</a>). </p> <p>In the subgroup analysis by dose and drug, there was no evidence of differences in treatment effects between the subgroups (Chi² = 0.79, df = 6 (P = 0.99), I² = 0%).. </p> <p>We could not undertake a sensitivity analysis because none of the studies providing data were at low risk of bias across selection and attrition bias. . </p> </section> <section id="CD007579-sec-0092"> <h6 class="title">Intraoperative vomiting</h6> <p>Dopamine antagonists may reduce the number of women with intraoperative vomiting (average RR 0.41, 95% CI 0.28 to 0.60, 12 studies, 942 women, random‐effects, T² = 00.02, Chi² P = 0.40, I² = 5%, <a href="./references#CD007579-fig-0019" title="">Analysis 2.2</a>). The certainty of the evidence was low, downgraded for very serious risk of bias. </p> <p>In the subgroup analysis by drug and dose, there was no evidence of differences in treatment effects between the subgroups Chi² = 2.70, df = 5 (P = 0.75), I² = 0%. </p> <p>We could not undertake a sensitivity analysis because none of the studies providing data were at low risk of bias across selection and reporting bias, and this also showed a reduced relative risk but a CI that crossed the line of no difference (average RR 0.34, 95% CI 0.10 to 1.23). </p> </section> <section id="CD007579-sec-0093"> <h6 class="title">Postoperative nausea</h6> <p>Dopamine antagonists may reduce the number of women with postoperative nausea (average RR 0.61, 95% CI 0.48 to 0.79, 7 studies, 601 women, random‐effects, T² = 0.01, Chi² P = 0.35, I² = 10%, <a href="./references#CD007579-fig-0020" title="">Analysis 2.3</a>). The certainty of the evidence is low, downgraded for very serious risk of bias (<a href="./full#CD007579-tbl-0002">summary of findings Table 2</a>). </p> <p>In the subgroup analysis by drug and dose, there was no evidence of differences in treatment effects between subgroups (Chi² = 2.84, df = 2 (P = 0.24), I² = 29.5%) </p> <p>We could not undertake a sensitivity analysis because none of the studies providing data were at low risk of bias across selective and reporting bias, </p> </section> <section id="CD007579-sec-0094"> <h6 class="title">Postoperative vomiting</h6> <p>Dopamine antagonists may lead to a reduction in the number of women having postoperative vomiting but the results are very uncertain (average RR 0.63, 95% CI 0.44 to 0.92, 9 studies, 860 women, T² = 0.13, Chi² P = 0.08, I² = 43%, <a href="./references#CD007579-fig-0021" title="">Analysis 2.4</a>). The certainty of the evidence is very low due to very serous risk of bias and some evidence of publication bias. (<a href="./full#CD007579-tbl-0002">summary of findings Table 2</a>), . These findings were broadly consistent when the individual interventions of metoclopramide and droperidol were assessed separately. </p> <p>In the subgroup analysis by type and dose of drug, there was no evidence of differences in treatment effects between subgroups (Chi² = 2.03, df = 2 (P = 0.36), I² = 1.3%). </p> <p>We could not undertake a sensitivity analysis because none of the studies providing data were at low risk of bias across selective and reporting bias. </p> </section> </section> <section id="CD007579-sec-0095"> <h5 class="title">Secondary outcomes</h5> <section id="CD007579-sec-0096"> <h6 class="title">Intraoperative nausea + vomiting</h6> <p>There is only one small study with 98 women so the findings are very uncertain (average RR 0.12, 95% CI 0.02 to 0.88, <a href="./references#CD007579-fig-0022" title="">Analysis 2.5</a>). </p> </section> <section id="CD007579-sec-0097"> <h6 class="title">Postoperative nausea + vomiting</h6> <p>There are four studies involving 450 women, so the findings are uncertain (average RR 0.23, 95% CI 0.05 to 1.02, <a href="./references#CD007579-fig-0023" title="">Analysis 2.6</a>). However, one study has a very extreme result (<a href="./references#CD007579-bbs2-0036" title="ISRCTN15475205. Does propofol prevent morphine-induced nausea, vomiting and itching in women who have had a Caesarean section?Http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN15475205 (first received 2019). [CENTRAL: CN-01974804] KampoS , AffulAP , MohammedS , NtimM , BuunaaimAD , AnabahTW . Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section - a randomized control trial. BMC Anesthesiology2019;19(1):177. [CENTRAL: CN-01987099] [EMBASE: 629299629] [PMID: 31521119]">Kampo 2019</a>). We have checked the paper and can find nothing to explain this result, so we also report the findings as well excluding these data (average (RR 0.49, 95% CI 0.32 to 0.75, 3 studies, 220 women). </p> </section> <section id="CD007579-sec-0098"> <h6 class="title">Maternal satisfaction</h6> <p>We identified no overall difference in women's satisfaction between dopamine antagonists and placebo (RR 1.42, 95% CI 0.91 to 2.21, 1 study, 102 women, <a href="./references#CD007579-fig-0024" title="">Analysis 2.7</a>). </p> </section> <section id="CD007579-sec-0099"> <h6 class="title">Adverse effects and side effects</h6> <p>Although there were no estimates of a composite outcome of adverse effects, a few studies did measure anxiety, headaches/dizziness, hypotension and pruritus. There were no differences identified (<a href="./references#CD007579-fig-0025" title="">Analysis 2.8</a>; <a href="./references#CD007579-fig-0026" title="">Analysis 2.9</a>; <a href="./references#CD007579-fig-0027" title="">Analysis 2.10</a>; <a href="./references#CD007579-fig-0030" title="">Analysis 2.13</a>). </p> </section> <section id="CD007579-sec-0100"> <h6 class="title">Subgroup analyses</h6> <p>For possible variations between individual drugs, <i>see</i><a href="./references#CD007579-fig-0018" title="">Analysis 2.1</a> to <a href="./references#CD007579-fig-0024" title="">Analysis 2.7</a>. </p> </section> </section> </section> <section id="CD007579-sec-0101"> <h4 class="title">3) Corticosteroids versus placebo (15 studies, 1830 women, Comparison 3)</h4> <p>Fifteen studies looked at corticosteroids versus placebo, of which 12 studies involving 1182 women provided data for the review. Studies compared corticosteroids against placebo, all studied dexamethasone but in various doses from 2.5 mg to 10 mg (<a href="./references#CD007579-bbs2-0001" title="Abdel-AleemM , OsmanA , MorsyK . Effect of coadministration of dexamethasone with intrathecal morphine on postoperative outcomes after cesarean delivery. International Journal of Gynecology and Obstetrics2012;116(2):158-61. ">Abdel‐Aleem 2012</a>; <a href="./references#CD007579-bbs2-0008" title="BiswasBN , RudraA , DasSK , NathS , BiswasSC . A comparative study of glycopyrrolate, dexamethasone and metoclopramide in control of post-operative nausea and vomiting after spinal anaesthesia for caesarean delivery. Indian Journal of Anaesthesia2003;47(3):198-200. ">Biswas 2003</a>; <a href="./references#CD007579-bbs2-0011" title="CardosoMM , LeiteAO , SantosEA , GozzaniJL , MathiasLA . Effect of dexamethasone on prevention of postoperative nausea, vomiting and pain after caesarean section: a randomised, placebo-controlled, double-blind trial. European Journal of Anaesthesiology2013;30:102-5. ">Cardoso 2013</a>; <a href="./references#CD007579-bbs2-0027" title="HassaneinA , MahmoudE . Effect of low dose ketamine versus dexamethasone on intraoperative nausea and vomiting during cesarean section under spinal anesthesia. Egyptian Journal of Anaesthesia2015;31(1):59-63. ">Hassanein 2015</a>; <a href="./references#CD007579-bbs2-0033" title="JaafarpourM , KhaniA , DyrekvandmoghadamA , KhajavikhanJ , SaadipourKH . The effect of dexamethasone on nausea, vomiting and pain in parturients undergoing caesarean delivery. Journal of Clinical and Diagnostic Research2008;2(3):854-8. ">Jaafarpour 2008</a>; <a href="./references#CD007579-bbs2-0058" title="NortcliffeSA , BuggyDJ . Prophylaxis of nausea and vomiting after spinal morphine analgesia for caesarean section: comparison between cyclizine, dexamethasone, and placebo [abstract]. British Journal of Anaesthesia2001;87(4):657P. NortcliffeSA , ShahJ , BuggyDJ . Prevention of postoperative nausea and vomiting after spinal morphine for caesarean section: comparison of cyclizine, dexamethasone and placebo. British Journal of Anaesthesia2003;90(5):665-70. ">Nortcliffe 2003</a>; <a href="./references#CD007579-bbs2-0062" title="ISRCTN57227250. Prevention of nausea and vomiting comparing ondansetron and dexamethasone versus placebo in cesarean section under regional anesthesia. http://www.isrctn.com/ISRCTN57227250 (7 July 2016). [CENTRAL: CN-01812416] Parra-GuizaR , MelendezHJ , OchoaME . Prophylactic efficacy of ondansetron and dexamethasone in nausea and vomit in patients undergoing cesarean section with neuraxial opioids. Controlled clinical trial. Medicas UIS2018;31(1):31-8. [DOI: 10.18273/revmed.v31n1-2018004]">Parra‐Guiza 2018</a>; <a href="./references#CD007579-bbs2-0070" title="KjaerK . Dexamethasone for the prevention of post-operative nausea and vomiting in patients undergoing cesarean sections. https://clinicaltrials.gov/ct2/show/results/NCT01734161 (27 November 2012). [CENTRAL: CN-01538899] SelzerA , PryorKO , TangelV , O'ConnellK , KjaerK . The effect of intravenous dexamethasone on postoperative nausea and vomiting after Cesarean delivery with intrathecal morphine: a randomized-controlled trial [Effet de la dexamethasone intraveineuse sur les nausees et vomissements postoperatoires apres un accouchement par cesarienne avec morphine intrathecale: un essai randomise controle]. Canadian Journal of Anesthesia2020;67:817-26. [CENTRAL: CN-02072818] [EMBASE: 2004140352] [PMID: 31989472]SelzerAR , PickJ , AbramovitzS , GadallaF , DarwichA , KjaerK . The effect of a single dose of intravenous dexamethasone on nausea and vomiting when administered prior to intrathecal morphine for cesarean section: a randomized, placebo-controlled, double-blinded trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 47th Annual Meeting; 2015 May 13-17; Colorado, USA. 2015:T-03. ">Selzer 2020</a>; <a href="./references#CD007579-bbs2-0075" title="TkachenkoR , PyasetskaN . The efficiency of intrathecal dexamethasone for spinal anaesthesia in elective caesarean section. Regional Anesthesia and Pain Medicine2019;44(10):A192. [CENTRAL: CN-01999210] [EMBASE: 629475510]">Tkachenko 2019</a>; <a href="./references#CD007579-bbs2-0076" title="TzengJI , WangJJ , HoST , TangCS , LiuYC , LeeSC . Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline. British Journal of Anaesthesia2000;85(6):865-8. ">Tzeng 2000</a>; <a href="./references#CD007579-bbs2-0080" title="WangJJ , HoST , WongCS , TzengJI , LiuHS , GerLP . Dexamethasone prophylaxis of nausea and vomiting after epidural morphine for post-cesarean analgesia. Canadian Journal of Anaesthesia2001;48(2):185-90. ">Wang 2001</a>; <a href="./references#CD007579-bbs2-0082" title="WuJI , LoY , ChiaYY , LiuK , FongWP , YangLC , et al. Prevention of postoperative nausea and vomiting after intrathecal morphine for cesarean section: a randomized comparison of dexamethasone, droperidol, and a combination. International Journal of Obstetric Anesthesia2007;16(2):122-7. ">Wu 2007</a>). Two included studies provided no data for the review (<a href="./references#CD007579-bbs2-0046" title="LimTJ , LimE , ChiuJW , TanHM . Perioperative antiemetic efficacy of dexamethasone 4mg in cesarean section under spinal anaesthesia [abstract]. Anesthesiology2001;95 Suppl:A466. ">Lim 2001b</a>; <a href="./references#CD007579-bbs2-0051" title="ModirH , MoshiriE , KamaliA , ShokrpourM , ShamsN . Prophylatic efficacy of dexamethasone, ketamine and dexmedetomidine against intra- and postoperative nausea and vomiting under spinal anesthesia. Formosan Journal of Surgery2019;52(1):17-23. [CENTRAL: CN-01790839] [EMBASE: 626475964]">Modir 2019</a>). </p> <p>The studies were undertaken in: Taiwan (three studies); Egypt (two studies); Brazil (one study); India (one study); Iran (one study), Colombia (one study), Ukraine (one study), USA (one study)and UK (one study). </p> <p>The studies were of questionable quality with only one being judged as having adequate sequence generation and allocation concealment (<a href="./references#CD007579-bbs2-0001" title="Abdel-AleemM , OsmanA , MorsyK . Effect of coadministration of dexamethasone with intrathecal morphine on postoperative outcomes after cesarean delivery. International Journal of Gynecology and Obstetrics2012;116(2):158-61. ">Abdel‐Aleem 2012</a>; ). Six had adequate blinding (<a href="./references#CD007579-bbs2-0001" title="Abdel-AleemM , OsmanA , MorsyK . Effect of coadministration of dexamethasone with intrathecal morphine on postoperative outcomes after cesarean delivery. International Journal of Gynecology and Obstetrics2012;116(2):158-61. ">Abdel‐Aleem 2012</a>; <a href="./references#CD007579-bbs2-0027" title="HassaneinA , MahmoudE . Effect of low dose ketamine versus dexamethasone on intraoperative nausea and vomiting during cesarean section under spinal anesthesia. Egyptian Journal of Anaesthesia2015;31(1):59-63. ">Hassanein 2015</a>; <a href="./references#CD007579-bbs2-0070" title="KjaerK . Dexamethasone for the prevention of post-operative nausea and vomiting in patients undergoing cesarean sections. https://clinicaltrials.gov/ct2/show/results/NCT01734161 (27 November 2012). [CENTRAL: CN-01538899] SelzerA , PryorKO , TangelV , O'ConnellK , KjaerK . The effect of intravenous dexamethasone on postoperative nausea and vomiting after Cesarean delivery with intrathecal morphine: a randomized-controlled trial [Effet de la dexamethasone intraveineuse sur les nausees et vomissements postoperatoires apres un accouchement par cesarienne avec morphine intrathecale: un essai randomise controle]. Canadian Journal of Anesthesia2020;67:817-26. [CENTRAL: CN-02072818] [EMBASE: 2004140352] [PMID: 31989472]SelzerAR , PickJ , AbramovitzS , GadallaF , DarwichA , KjaerK . The effect of a single dose of intravenous dexamethasone on nausea and vomiting when administered prior to intrathecal morphine for cesarean section: a randomized, placebo-controlled, double-blinded trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 47th Annual Meeting; 2015 May 13-17; Colorado, USA. 2015:T-03. ">Selzer 2020</a>; <a href="./references#CD007579-bbs2-0076" title="TzengJI , WangJJ , HoST , TangCS , LiuYC , LeeSC . Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline. British Journal of Anaesthesia2000;85(6):865-8. ">Tzeng 2000</a>; <a href="./references#CD007579-bbs2-0080" title="WangJJ , HoST , WongCS , TzengJI , LiuHS , GerLP . Dexamethasone prophylaxis of nausea and vomiting after epidural morphine for post-cesarean analgesia. Canadian Journal of Anaesthesia2001;48(2):185-90. ">Wang 2001</a>; <a href="./references#CD007579-bbs2-0082" title="WuJI , LoY , ChiaYY , LiuK , FongWP , YangLC , et al. Prevention of postoperative nausea and vomiting after intrathecal morphine for cesarean section: a randomized comparison of dexamethasone, droperidol, and a combination. International Journal of Obstetric Anesthesia2007;16(2):122-7. ">Wu 2007</a>). One study excluded many women after randomisation if they suffered intraoperative nausea or vomiting and this amounted to 31% of the enrolled subjects (<a href="./references#CD007579-bbs2-0001" title="Abdel-AleemM , OsmanA , MorsyK . Effect of coadministration of dexamethasone with intrathecal morphine on postoperative outcomes after cesarean delivery. International Journal of Gynecology and Obstetrics2012;116(2):158-61. ">Abdel‐Aleem 2012</a>). Another study excluded 46% of women after randomisation if they were not the first patient of the day (<a href="./references#CD007579-bbs2-0011" title="CardosoMM , LeiteAO , SantosEA , GozzaniJL , MathiasLA . Effect of dexamethasone on prevention of postoperative nausea, vomiting and pain after caesarean section: a randomised, placebo-controlled, double-blind trial. European Journal of Anaesthesiology2013;30:102-5. ">Cardoso 2013</a>). </p> <section id="CD007579-sec-0102"> <h5 class="title">Primary outcomes</h5> <section id="CD007579-sec-0103"> <h6 class="title">Intraoperative nausea</h6> <p>Dexamethasone may reduce the number of women having intraoperative nausea but the results are very uncertain (average RR 0.56, 95% CI 0.37 to 0.83, 6 studies, 609 women, random‐effects (T² = 0.12, Chi² P = 0.06, I² = 50%), <a href="./references#CD007579-fig-0031" title="">Analysis 3.1</a>), The certainty of the evidence was very low, downgraded for very serious risk of bias and serious inconsistency (<a href="./full#CD007579-tbl-0003">summary of findings Table 3</a>). </p> <p>In the subgroup analysis by dose of drug and route of administration (intravenous and intrathecal) , there was evidence of differences between the various doses and routes of administration (Chi² = 7.54, df = 2 (P = 0.02), I² = 73.5%). </p> <p>The sensitivity analysis could not be undertaken as none of the included studies were low risk for selection.and attrition bias. </p> </section> <section id="CD007579-sec-0104"> <h6 class="title">Intraoperative vomiting</h6> <p>Dexamethasone may reduce the number of women having intraoperative vomiting but the results are very uncertain (average RR 0.52, 95% CI 0.31 to 0.87, 6 studies, 609 women, random‐effects (T² = 0.00, Chi² P = 0.69, I² = 0%, <a href="./references#CD007579-fig-0032" title="">Analysis 3.2</a>). The certainty of the evidence being very low, downgraded for very serious risk of bias, and serious imprecision (<a href="./full#CD007579-tbl-0003">summary of findings Table 3</a>). </p> <p>The subgroup analysis by dose of drug and route of administration (intravenous and intrathecal showed no difference between the subgroups (Chi² = 1.80, df = 2 (P = 0.41), I² = 0%). </p> <p>The sensitivity analysis could not be undertaken as none of the included studies were low risk for selection and attrition bias. </p> </section> <section id="CD007579-sec-0105"> <h6 class="title">Postoperative nausea</h6> <p>Dexamethasone probably reduces the number of women having postoperative vomiting (average RR 0.59, 95% CI 0.49 to 0.73, 6 studies, 733 women, random‐effects (T² = 0.01, Chi² P = 0.36, I² = 9%), <a href="./references#CD007579-fig-0033" title="">Analysis 3.3</a>). The certainty of the evidence was moderate, downgraded for serious risk of bias. </p> <p>The subgroup analyses by dose of drug and route of administration (intravenous and intrathecal) showed no difference between the subgroups (Chi² = 6.87, df = 5 (P = 0.23), I² = 27.2%). </p> <p>The sensitivity analysis could not be undertaken as none of the included studies were low risk for selection.and attrition bias. . </p> </section> <section id="CD007579-sec-0106"> <h6 class="title">Postoperative vomiting</h6> <p>Dexamethasone may reduce the number of women having postoperative vomiting (average RR 0.68, 95% CI 0.49 to 0.95, 7 studies, 793 women, random‐effects (T² = 0.11, Chi² P = 0.03, I² = 52%) <a href="./references#CD007579-fig-0034" title="">Analysis 3.4</a>). The certainty of the evidence was low, downgraded for serious risk of bias and serious inconsistency (<a href="./full#CD007579-tbl-0003">summary of findings Table 3</a>). </p> <p>The subgroup analysis by dose of drug and route of administration (intravenous and intrathecal) showed some variation (Chi² = 14.65, df = 5 (P = 0.01), I² = 65.9%). </p> <p>The sensitivity analysis could not be undertaken as none of the included studies were low risk for selection.and attrition bias.. </p> </section> </section> <section id="CD007579-sec-0107"> <h5 class="title">Secondary outcomes</h5> <section id="CD007579-sec-0108"> <h6 class="title">Intraoperative nausea + vomiting</h6> <p>We identified only one study of 108 women (<a href="./references#CD007579-bbs2-0070" title="KjaerK . Dexamethasone for the prevention of post-operative nausea and vomiting in patients undergoing cesarean sections. https://clinicaltrials.gov/ct2/show/results/NCT01734161 (27 November 2012). [CENTRAL: CN-01538899] SelzerA , PryorKO , TangelV , O'ConnellK , KjaerK . The effect of intravenous dexamethasone on postoperative nausea and vomiting after Cesarean delivery with intrathecal morphine: a randomized-controlled trial [Effet de la dexamethasone intraveineuse sur les nausees et vomissements postoperatoires apres un accouchement par cesarienne avec morphine intrathecale: un essai randomise controle]. Canadian Journal of Anesthesia2020;67:817-26. [CENTRAL: CN-02072818] [EMBASE: 2004140352] [PMID: 31989472]SelzerAR , PickJ , AbramovitzS , GadallaF , DarwichA , KjaerK . The effect of a single dose of intravenous dexamethasone on nausea and vomiting when administered prior to intrathecal morphine for cesarean section: a randomized, placebo-controlled, double-blinded trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 47th Annual Meeting; 2015 May 13-17; Colorado, USA. 2015:T-03. ">Selzer 2020</a>) so the findings are very uncertain (average RR 1.65, 95% CI 0.96 to 2.84, <a href="./references#CD007579-fig-0035" title="">Analysis 3.5</a>). </p> </section> <section id="CD007579-sec-0109"> <h6 class="title">Postoperative nausea + vomiting</h6> <p>We identified only one study of 108 women (<a href="./references#CD007579-bbs2-0070" title="KjaerK . Dexamethasone for the prevention of post-operative nausea and vomiting in patients undergoing cesarean sections. https://clinicaltrials.gov/ct2/show/results/NCT01734161 (27 November 2012). [CENTRAL: CN-01538899] SelzerA , PryorKO , TangelV , O'ConnellK , KjaerK . The effect of intravenous dexamethasone on postoperative nausea and vomiting after Cesarean delivery with intrathecal morphine: a randomized-controlled trial [Effet de la dexamethasone intraveineuse sur les nausees et vomissements postoperatoires apres un accouchement par cesarienne avec morphine intrathecale: un essai randomise controle]. Canadian Journal of Anesthesia2020;67:817-26. [CENTRAL: CN-02072818] [EMBASE: 2004140352] [PMID: 31989472]SelzerAR , PickJ , AbramovitzS , GadallaF , DarwichA , KjaerK . The effect of a single dose of intravenous dexamethasone on nausea and vomiting when administered prior to intrathecal morphine for cesarean section: a randomized, placebo-controlled, double-blinded trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 47th Annual Meeting; 2015 May 13-17; Colorado, USA. 2015:T-03. ">Selzer 2020</a>) so the findings are very uncertain (RR 0.94, 95% CI 0.79 to 1.12, <a href="./references#CD007579-fig-0036" title="">Analysis 3.6</a>). </p> </section> <section id="CD007579-sec-0110"> <h6 class="title">Adverse effects and side effects</h6> <p>Although there were no estimates of a composite outcome of adverse effects, a few studies did measure hypotension and pruritis but there were insufficient data to make any firm statement about adverse effects (<a href="./references#CD007579-fig-0037" title="">Analysis 3.7</a>; to <a href="./references#CD007579-fig-0040" title="">Analysis 3.10</a>). </p> </section> </section> </section> <section id="CD007579-sec-0111"> <h4 class="title">4) Antihistamines versus placebo (4 studies, 654 women, Comparison 4)</h4> <p>Four studies compared antihistamines with placebo, all studies providing data on 514 women (<a href="./references#CD007579-bbs2-0005" title="ApiliogullariS , DumanA , GokF . Prophylactic dimenhydrinate (dramamine) is effective in the treatment of nausea-vomiting with intrathecal morphine [abstract]. Regional Anesthesia and Pain Medicine2007;32(5 Suppl):87. ">Apiliogullari 2007</a>; <a href="./references#CD007579-bbs2-0012" title="CarvalhoJC , NairGS , DowneyK , BalkiM . Prophylactic dimenhydrinate does not reduce nausea and vomiting during cesarean section delivery under spinal anesthesia: a randomized, double-blind, placebo-controlled trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 42nd Annual Meeting; 2010 May 12-16, San Antonio, USA. 2010. NCT00791960. Prophylactic dimenhydrinate for intraoperative nausea and vomiting. Https://clinicaltrials.gov/show/NCT00791960 (first received 2008 Nov 13). [CENTRAL: CN-01485523] ">Carvalho 2010</a>; <a href="./references#CD007579-bbs2-0020" title="ApiliogullariS , GokF , CanpolatA , SoysalS , ToyH , SukanF . Comparison of prophylactic dimenhydrinate and metoclopramide for prevention of nausea-vomiting caused by intrathecal opioids in parturients undergoing caesarean delivery. Regional Anesthesia and Pain Medicine2008;33(5 Suppl 1):131. DumanA , ApiliogullariS , GokF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine in cesarean delivery. Nobel Medicus2010;6(3):13-9. DumanA , ApiliogullariS , GookF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine for cesarean delivery. Data on file. ">Duman 2010</a>; <a href="./references#CD007579-bbs2-0058" title="NortcliffeSA , BuggyDJ . Prophylaxis of nausea and vomiting after spinal morphine analgesia for caesarean section: comparison between cyclizine, dexamethasone, and placebo [abstract]. British Journal of Anaesthesia2001;87(4):657P. NortcliffeSA , ShahJ , BuggyDJ . Prevention of postoperative nausea and vomiting after spinal morphine for caesarean section: comparison of cyclizine, dexamethasone and placebo. British Journal of Anaesthesia2003;90(5):665-70. ">Nortcliffe 2003</a>). </p> <p>The studies were undertaken in: Iran (one study); Turkey (one study) Canada (one study) and UK (one study). </p> <p>Only one study had adequate sequence generation (<a href="./references#CD007579-bbs2-0020" title="ApiliogullariS , GokF , CanpolatA , SoysalS , ToyH , SukanF . Comparison of prophylactic dimenhydrinate and metoclopramide for prevention of nausea-vomiting caused by intrathecal opioids in parturients undergoing caesarean delivery. Regional Anesthesia and Pain Medicine2008;33(5 Suppl 1):131. DumanA , ApiliogullariS , GokF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine in cesarean delivery. Nobel Medicus2010;6(3):13-9. DumanA , ApiliogullariS , GookF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine for cesarean delivery. Data on file. ">Duman 2010</a>). All four studies were unclear with regard to allocation concealment. Only one study had adequate blinding (<a href="./references#CD007579-bbs2-0020" title="ApiliogullariS , GokF , CanpolatA , SoysalS , ToyH , SukanF . Comparison of prophylactic dimenhydrinate and metoclopramide for prevention of nausea-vomiting caused by intrathecal opioids in parturients undergoing caesarean delivery. Regional Anesthesia and Pain Medicine2008;33(5 Suppl 1):131. DumanA , ApiliogullariS , GokF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine in cesarean delivery. Nobel Medicus2010;6(3):13-9. DumanA , ApiliogullariS , GookF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine for cesarean delivery. Data on file. ">Duman 2010</a>). Two studies were assessed as high risk of bias ‐ one due to missing data that could not be re‐included (<a href="./references#CD007579-bbs2-0020" title="ApiliogullariS , GokF , CanpolatA , SoysalS , ToyH , SukanF . Comparison of prophylactic dimenhydrinate and metoclopramide for prevention of nausea-vomiting caused by intrathecal opioids in parturients undergoing caesarean delivery. Regional Anesthesia and Pain Medicine2008;33(5 Suppl 1):131. DumanA , ApiliogullariS , GokF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine in cesarean delivery. Nobel Medicus2010;6(3):13-9. DumanA , ApiliogullariS , GookF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine for cesarean delivery. Data on file. ">Duman 2010</a>) and one due to pre‐specified outcomes not reported (<a href="./references#CD007579-bbs2-0012" title="CarvalhoJC , NairGS , DowneyK , BalkiM . Prophylactic dimenhydrinate does not reduce nausea and vomiting during cesarean section delivery under spinal anesthesia: a randomized, double-blind, placebo-controlled trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 42nd Annual Meeting; 2010 May 12-16, San Antonio, USA. 2010. NCT00791960. Prophylactic dimenhydrinate for intraoperative nausea and vomiting. Https://clinicaltrials.gov/show/NCT00791960 (first received 2008 Nov 13). [CENTRAL: CN-01485523] ">Carvalho 2010</a>). </p> <section id="CD007579-sec-0112"> <h5 class="title">Primary outcomes</h5> <section id="CD007579-sec-0113"> <h6 class="title">Intraoperative nausea</h6> <p>Antihistamines (e.g. dimenhydrinate ) may make little of no difference to intraoperative nausea (RR 0.99, 95% CI 0.47 to 2.11, 1 study, 149 women, <a href="./references#CD007579-fig-0041" title="">Analysis 4.1</a>). The certainty of the evidence was very low, downgraded for very serious risk of bias, and very serious imprecision <a href="./full#CD007579-tbl-0004">summary of findings Table 4</a>). </p> <p>It was not possible to undertake subgroup analysis as only one study assessed this outcome (<a href="./references#CD007579-bbs2-0012" title="CarvalhoJC , NairGS , DowneyK , BalkiM . Prophylactic dimenhydrinate does not reduce nausea and vomiting during cesarean section delivery under spinal anesthesia: a randomized, double-blind, placebo-controlled trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 42nd Annual Meeting; 2010 May 12-16, San Antonio, USA. 2010. NCT00791960. Prophylactic dimenhydrinate for intraoperative nausea and vomiting. Https://clinicaltrials.gov/show/NCT00791960 (first received 2008 Nov 13). [CENTRAL: CN-01485523] ">Carvalho 2010</a>). </p> <p>It was not possible to undertake sensitivity analysis as only one study (with unclear risk of selection and reporting bias) assessed this outcome (<a href="./references#CD007579-bbs2-0012" title="CarvalhoJC , NairGS , DowneyK , BalkiM . Prophylactic dimenhydrinate does not reduce nausea and vomiting during cesarean section delivery under spinal anesthesia: a randomized, double-blind, placebo-controlled trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 42nd Annual Meeting; 2010 May 12-16, San Antonio, USA. 2010. NCT00791960. Prophylactic dimenhydrinate for intraoperative nausea and vomiting. Https://clinicaltrials.gov/show/NCT00791960 (first received 2008 Nov 13). [CENTRAL: CN-01485523] ">Carvalho 2010</a>). </p> </section> <section id="CD007579-sec-0114"> <h6 class="title">Intraoperative vomiting</h6> <p>Antihistamines (e.g. dimenhydrinate ) may make little of no difference to intraoperative nausea as there were no events in the one study of 149 women looking at this outcome and the GRADE assessment of this study was very low due to very serious risk of bias and very serious imprecision (<a href="./references#CD007579-fig-0042" title="">Analysis 4.2</a>, <a href="./full#CD007579-tbl-0004">summary of findings Table 4</a>). </p> <p>It was not possible to undertake subgroup analysis as only one study assessed this outcome (<a href="./references#CD007579-bbs2-0012" title="CarvalhoJC , NairGS , DowneyK , BalkiM . Prophylactic dimenhydrinate does not reduce nausea and vomiting during cesarean section delivery under spinal anesthesia: a randomized, double-blind, placebo-controlled trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 42nd Annual Meeting; 2010 May 12-16, San Antonio, USA. 2010. NCT00791960. Prophylactic dimenhydrinate for intraoperative nausea and vomiting. Https://clinicaltrials.gov/show/NCT00791960 (first received 2008 Nov 13). [CENTRAL: CN-01485523] ">Carvalho 2010</a>). </p> <p>It was not possible to undertake sensitivity analysis as only one study (with unclear risk of selection and reporting bias) assessed this outcome (<a href="./references#CD007579-bbs2-0012" title="CarvalhoJC , NairGS , DowneyK , BalkiM . Prophylactic dimenhydrinate does not reduce nausea and vomiting during cesarean section delivery under spinal anesthesia: a randomized, double-blind, placebo-controlled trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 42nd Annual Meeting; 2010 May 12-16, San Antonio, USA. 2010. NCT00791960. Prophylactic dimenhydrinate for intraoperative nausea and vomiting. Https://clinicaltrials.gov/show/NCT00791960 (first received 2008 Nov 13). [CENTRAL: CN-01485523] ">Carvalho 2010</a>). </p> </section> <section id="CD007579-sec-0115"> <h6 class="title">Postoperative nausea</h6> <p>Antihistamines may lead to a reduction in postoperative nausea (average RR 0.44, 95% CI 0.30 to 0.64, 4 studies, 514 women, random‐effects (T² = 0.02, Chi² P = 0.34, I² = 11%), <a href="./references#CD007579-fig-0043" title="">Analysis 4.3</a>) as the certainty of the evidence is low, downgraded for very serious risk of bias. (<a href="./full#CD007579-tbl-0004">summary of findings Table 4</a>). </p> <p>In the subgroup analysis by type and dose of drug, there was no evidence of differences in treatment effects between subgroups (Chi² = 3.98, df = 3 (P = 0.26), I² = 24.6%). </p> <p>In the sensitivity analysis there were no studies with low risk of selection and attrition bias. </p> </section> <section id="CD007579-sec-0116"> <h6 class="title">Postoperative vomiting</h6> <p>Antihistamines may lead to a reduction in postoperative vomiting but the results are very uncertain (average RR 0.48, 95% CI 0.29 to 0.81, 3 studies, 333 women, random‐effects (T² = 0.00, Chi² P = 0.66, I² = 0%), <a href="./references#CD007579-fig-0044" title="">Analysis 4.4</a>), The certainty of the evidence is very low, downgraded for very serious risk of bias and serious imprecision (<a href="./full#CD007579-tbl-0004">summary of findings Table 4</a>). </p> <p>The subgroup analysis by type of drug or dose showed no difference between the subgroups (Chi² = 0.79, df = 2 (P = 0.67), I² = 0%). </p> <p>In the sensitivity analysis there were no studies with low risk of selection and attrition bias. </p> </section> </section> <section id="CD007579-sec-0117"> <h5 class="title">Secondary outcomes</h5> <p>None of the studies looked at intraoperative 'nausea + vomiting nor postoperative 'nausea + vomiting'. </p> <section id="CD007579-sec-0118"> <h6 class="title">Adverse effects and side effects</h6> <p>Although there were no estimates of a composite outcome of adverse effects, one study involving 149 women looked at hypotension (<a href="./references#CD007579-bbs2-0012" title="CarvalhoJC , NairGS , DowneyK , BalkiM . Prophylactic dimenhydrinate does not reduce nausea and vomiting during cesarean section delivery under spinal anesthesia: a randomized, double-blind, placebo-controlled trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 42nd Annual Meeting; 2010 May 12-16, San Antonio, USA. 2010. NCT00791960. Prophylactic dimenhydrinate for intraoperative nausea and vomiting. Https://clinicaltrials.gov/show/NCT00791960 (first received 2008 Nov 13). [CENTRAL: CN-01485523] ">Carvalho 2010</a>, <a href="./references#CD007579-fig-0045" title="">Analysis 4.5</a>), but there were insufficient data to make any firm statement about hypotension. </p> </section> </section> </section> <section id="CD007579-sec-0119"> <h4 class="title">5) Anticholenergics versus placebo (7 studies, 1088 women, Comparison 5)</h4> <p>Seven studies compared anticholinergics with placebo, with six of these studies (involving 787 women) reporting data that we could use in the review (<a href="./references#CD007579-bbs2-0006" title="BaciarelloM , CorniniA , ZasaM , PedronaP , ScrofaniG , VenutiFS , et al. Intrathecal atropine to prevent postoperative nausea and vomiting after cesarean section: a randomized, controlled trial. Minerva Anestesiologica2011;77(8):781-8. ">Baciarello 2011</a>; <a href="./references#CD007579-bbs2-0008" title="BiswasBN , RudraA , DasSK , NathS , BiswasSC . A comparative study of glycopyrrolate, dexamethasone and metoclopramide in control of post-operative nausea and vomiting after spinal anaesthesia for caesarean delivery. Indian Journal of Anaesthesia2003;47(3):198-200. ">Biswas 2003</a>; <a href="./references#CD007579-bbs2-0026" title="HarnettMJ , O'RourkeN , WalshM , CarabuenaJM , SegalS . Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery. Anesthesia and Analgesia2007;105(3):764-9. ">Harnett 2007</a>; <a href="./references#CD007579-bbs2-0041" title="KotelkoDM , RottmanRL , WrightWC , StoneJJ , YamashiroAY , RosenblattRM . Transderm SCOP decreases post-cesarean nausea and vomiting in patients receiving epidural morphine. Anesthesiology1988;69:A666. KotelkoDM , RottmanRL , WrightWC , StoneJJ , YamashiroAY , RosenblattRM . Transdermal scopolamine decreases nausea and vomiting following cesarean section in patients receiving epidural morphine. Anesthesiology1989;71:675-8. ">Kotelko 1989</a>; <a href="./references#CD007579-bbs2-0072" title="ShenYJ , YinYQ , ZhangYJ , ZhuQ , ZhangJH , ZhaoW , et al. Efficacy of intravenous scopolamine for preventing postoperative nausea and vomiting after cesarean section. Acta Academiae Medicinae Sinicae2012;34(1):32-7. ">Shen 2012</a>; <a href="./references#CD007579-bbs2-0078" title="UreD , JamesKS , McNeillM , BoothJV . Glycopyrrolate reduces nausea during spinal anaesthesia for caesarean section without affecting neonatal outcome. British Journal of Anaesthesia1999;82(2):277-9. ">Ure 1999</a>). One study provides no data for the review as they present data across multiple time periods and it is unclear if women have been counted multiple times (<a href="./references#CD007579-bbs2-0065" title="QuineyNF , MurphyPG . The effect of pretreatment with glycopyrrolate on emetic and hypotensive problems during caesarean section conducted under spinal anaesthesia [abstract]. International Journal of Obstetric Anesthesia1995;4:66-7. ">Quiney 1995</a>). </p> <p>The studies which provided data were undertaken in: USA (two studies); India (one study), Italy (one study), China (one study) and UK (one study). </p> <p>Two studies had adequate sequence generation (<a href="./references#CD007579-bbs2-0006" title="BaciarelloM , CorniniA , ZasaM , PedronaP , ScrofaniG , VenutiFS , et al. Intrathecal atropine to prevent postoperative nausea and vomiting after cesarean section: a randomized, controlled trial. Minerva Anestesiologica2011;77(8):781-8. ">Baciarello 2011</a>; <a href="./references#CD007579-bbs2-0026" title="HarnettMJ , O'RourkeN , WalshM , CarabuenaJM , SegalS . Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery. Anesthesia and Analgesia2007;105(3):764-9. ">Harnett 2007</a>). The other four were unclear. One study had adequate allocation concealment (<a href="./references#CD007579-bbs2-0006" title="BaciarelloM , CorniniA , ZasaM , PedronaP , ScrofaniG , VenutiFS , et al. Intrathecal atropine to prevent postoperative nausea and vomiting after cesarean section: a randomized, controlled trial. Minerva Anestesiologica2011;77(8):781-8. ">Baciarello 2011</a>) the others studies were unclear. Only one study described adequate blinding of participants and outcome assessment (<a href="./references#CD007579-bbs2-0006" title="BaciarelloM , CorniniA , ZasaM , PedronaP , ScrofaniG , VenutiFS , et al. Intrathecal atropine to prevent postoperative nausea and vomiting after cesarean section: a randomized, controlled trial. Minerva Anestesiologica2011;77(8):781-8. ">Baciarello 2011</a>). One study was judged to be at high risk of income data as 12 participants were excluded after randomisation (<a href="./references#CD007579-bbs2-0006" title="BaciarelloM , CorniniA , ZasaM , PedronaP , ScrofaniG , VenutiFS , et al. Intrathecal atropine to prevent postoperative nausea and vomiting after cesarean section: a randomized, controlled trial. Minerva Anestesiologica2011;77(8):781-8. ">Baciarello 2011</a>). </p> <section id="CD007579-sec-0120"> <h5 class="title">Primary outcomes</h5> <section id="CD007579-sec-0121"> <h6 class="title">Intraoperative nausea</h6> <p>Anticholinergics may reduce intraoperative nausea (average RR 0.67, 95% CI 0.51 to 0.87, 4 studies, 453 women, random‐effects (T² = 0.03, Chi² P = 0.13, I² = 47%), <a href="./references#CD007579-fig-0046" title="">Analysis 5.1</a>). The certainty of the evidence was low, downgraded for very serious risk of bias (<a href="./references#CD007579-fig-0046" title="">Analysis 5.1</a>). </p> <p>The subgroup analyses by type of drug or dose showed no difference between the subgroups (Chi² = 0.70, df = 1 (P = 0.40), I² = 0%). </p> <p>In the sensitivity analysis there were no studies with low risk of selection and attrition bias. </p> </section> <section id="CD007579-sec-0122"> <h6 class="title">Intraoperative vomiting</h6> <p>Anticholenergics may make little or no difference to intraoperative vomiting (average RR 0.79, 95% CI 0.40 to 1.54, 4 studies, 453 women, random‐effects (T² = 0.22, Chi² P = 0.10, I² = 52%), <a href="./references#CD007579-fig-0047" title="">Analysis 5.2</a>). The certainty of the evidence is very low, downgraded for very serious risk of bias, serious inconsistency and serious imprecision (<a href="./full#CD007579-tbl-0005">summary of findings Table 5</a>). </p> <p>These findings were persistent in the scopolamine subgroup, but not the glycopyrrolate subgroup, however, there were much smaller numbers in the glycopyrrolate subgroup. </p> <p>In a subgroup analysis by type of drug and dose, showed no difference between the subgroups (Chi² = 0.86, df = 1 (P = 0.35), I² = 0%) </p> <p>In the sensitivity analysis there were no studies with low risk of selection and attrition bias. </p> </section> <section id="CD007579-sec-0123"> <h6 class="title">Postoperative nausea</h6> <p>None of the studies assessed postoperative nausea.</p> </section> <section id="CD007579-sec-0124"> <h6 class="title">Postoperative vomiting</h6> <p>Only one study of 161 women looked at this outcome (<a href="./references#CD007579-bbs2-0026" title="HarnettMJ , O'RourkeN , WalshM , CarabuenaJM , SegalS . Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery. Anesthesia and Analgesia2007;105(3):764-9. ">Harnett 2007</a>). So we are very uncertain whether anticholinergics reduce postoperative vomiting (RR 0.55, 95% CI 0.41 to 0.74, 1 study, 161 women, (<a href="./references#CD007579-fig-0049" title="">Analysis 5.4</a>). The certainty of the evidence was low, downgraded for serious risk of bias and serious imprecision (<a href="./full#CD007579-tbl-0005">summary of findings Table 5</a>). </p> <p>There were no assessments on subgroups nor sensitivity because there was only one study.. </p> </section> </section> <section id="CD007579-sec-0125"> <h5 class="title">Secondary outcomes</h5> <p><i>Intraoperative 'nausea + vomiting'</i> </p> <p>None of the studies assessed this outcome.</p> <p><i>Postoperative 'nausea + vomiting'</i> </p> <p>Anticholinergics may reduce the number of women with postoperative nausea and vomiting (average RR 0.46, 95% CI 0.25 to 0.85, 2 studies, 334 women, <a href="./references#CD007579-fig-0051" title="">Analysis 5.6</a>) but the certainty of the evidence is very low coming from just two small studies, so overall anticholinergics may make little or no difference. </p> <section id="CD007579-sec-0126"> <h6 class="title">Adverse effects and side effects</h6> <p>Although there were no estimates of a composite outcome of adverse effects, a few studies did measure a number of adverse and side effects, including blurred vision, anxiety/disorientation and dizziness, (<a href="./references#CD007579-fig-0052" title="">Analysis 5.7</a> to <a href="./references#CD007579-fig-0058" title="">Analysis 5.13</a>) but we feel there are insufficient data to make any firm statement about adverse or side effects. </p> </section> </section> </section> <section id="CD007579-sec-0127"> <h4 class="title">6) Sedatives versus placebo (17 studies, 1730 women, Comparison 6)</h4> <p>Seventeen studies assessed sedatives versus placebo, with 13 providing analysable data on 1265 women. Most studies assessed propofol but at differing doses (<a href="./references#CD007579-bbs2-0004" title="AhnHJ , KimYA , ChoiDH . The effects of sedation using propofol TCI on the satisfaction level and side effects of parturients during regional anesthesia for a cesarean section. Korean Journal of Anesthesiology2002;43(1):66-72. ">Ahn 2002</a>; <a href="./references#CD007579-bbs2-0010" title="CabaF , BernalL , PallaresJA , EchevarriaM , RodriguezR . Prophylaxis for intraoperative nausea and vomiting with subhypnotic doses of propofol during intradural anaesthesia for caesarean section [Profilaxis de nauseas y vomitos intraoperatorios con dosis subhipnoticas de propofol durante anestesia intradural en cesareas]. Revista Espanola de Anestesiologia y Reanimacion1997;44(Suppl 1):122. [CENTRAL: CN-00400431] CabaF , EchevarriaM , Bernal-DavalosL , Pallares-GonzalezJA , Rodriguez-RodriguezR . Prophylaxis for intraoperative nausea and vomiting with nonhypnotic doses of propofol during intradural anesthesia for cesarean delivery [Profilaxis de las nauseas y los vomitos intraoperatorios con dosis subhipnoticas de propofol durante la anestesia intradural en cesareas]. Revista Espanola De Anestesiologia y Reanimacion1997;44:262-6. ">Caba 1997</a>; <a href="./references#CD007579-bbs2-0036" title="ISRCTN15475205. Does propofol prevent morphine-induced nausea, vomiting and itching in women who have had a Caesarean section?Http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN15475205 (first received 2019). [CENTRAL: CN-01974804] KampoS , AffulAP , MohammedS , NtimM , BuunaaimAD , AnabahTW . Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section - a randomized control trial. BMC Anesthesiology2019;19(1):177. [CENTRAL: CN-01987099] [EMBASE: 629299629] [PMID: 31521119]">Kampo 2019</a>; <a href="./references#CD007579-bbs2-0053" title="MokiniZ , FabbriE , Dell'AttiI , Di MartinoR , D'EttorreM , PetriniF . A randomized, controlled, double blind trial on the incidence of nausea and vomiting with prophylactic subhypnotic propofol vs metoclopramide and in combination therapy in cesarean section with subarachnoid anesthesia. European Journal of Anaesthesiology2014;31:192. NCT01781377. Prophylactic subhypnotic propofol for nausea and vomiting during for cesarean section under subarachnoid anesthesia. Https://clinicaltrials.gov/show/NCT01781377 (first received 2013 Jan 25). [CENTRAL: CN-01540221] ">Mokini 2014</a>; <a href="./references#CD007579-bbs2-0054" title="MukherjeeS , RudraA , MandelM , KumarP . Optimum dose of propofol for prevention of emetic episodes during caesarean delivery: an evaluation. Journal of Anaesthesia and Clinical Pharmacology2006;22(2):139-43. ">Mukherjee 2006</a>; <a href="./references#CD007579-bbs2-0056" title="NiuK , LiuH , Chen R-W, Fang Q-W, WenH , Guo S-M, et al. Use of propofol for prevention of post-delivery nausea during cesarean section: a double-blind, randomized, placebo-controlled trial. Journal of Anesthesia2018;32(5):748-55. [CENTRAL: CN-02000278] [EMBASE: 623932583] [PMID: 30209576]">Niu 2018</a>; <a href="./references#CD007579-bbs2-0066" title="RasooliS , MoslemiF , KhakiA . Effect of sub hypnotic doses of propofol and midazolam for nausea and vomiting during spinal anesthesia for cesarean section. Anesthesiology and Pain Medicine2014;4(4):e19384. ">Rasooli 2014</a>; <a href="./references#CD007579-bbs2-0067" title="RudraA , HalderR , SenA , KunduS . Efficacy of low dose propofol for control of emetic episodes during caesarean delivery with spinal anaesthesia. Indian Journal of Anaesthesia2004;48(1):31-4. ">Rudra 2004a</a>; <a href="./references#CD007579-bbs2-0074" title="TarhanO , CanbayO , CelebiN , UzunS , SahinA , CoskunF , et al. Subhypnotic doses of midazolam prevent nausea and vomiting during spinal anesthesia for cesarean section. Minerva Anestesiologica2007;73(12):629-33. ">Tarhan 2007</a>). Two studies assessed midazolam, two intravenous (<a href="./references#CD007579-bbs2-0066" title="RasooliS , MoslemiF , KhakiA . Effect of sub hypnotic doses of propofol and midazolam for nausea and vomiting during spinal anesthesia for cesarean section. Anesthesiology and Pain Medicine2014;4(4):e19384. ">Rasooli 2014</a>; <a href="./references#CD007579-bbs2-0074" title="TarhanO , CanbayO , CelebiN , UzunS , SahinA , CoskunF , et al. Subhypnotic doses of midazolam prevent nausea and vomiting during spinal anesthesia for cesarean section. Minerva Anestesiologica2007;73(12):629-33. ">Tarhan 2007</a>) and one intrathecal (<a href="./references#CD007579-bbs2-0002" title="AbdollahpourA , AzadiR , BandariR , MirmohammadkhaniM . Effects of adding midazolam and sufentanil to intrathecal bupivacaine on analgesia quality and postoperative complications in elective cesarean section. Anesthesiology and Pain Medicine2015;5(4):e23565. ">Abdollahpour 2015</a>). Two studies assessed ketamine (<a href="./references#CD007579-bbs2-0027" title="HassaneinA , MahmoudE . Effect of low dose ketamine versus dexamethasone on intraoperative nausea and vomiting during cesarean section under spinal anesthesia. Egyptian Journal of Anaesthesia2015;31(1):59-63. ">Hassanein 2015</a>; <a href="./references#CD007579-bbs2-0071" title="ShabanaAM , NasrES , MoawadHE . Effect of ketamine on intraoperative nausea and vomiting during elective caesarean section under spinal anaesthesia: a placebo-controlled prospective randomized double blinded study. Egyptian Journal of Anaesthesia2012;28(2):169-74. ">Shabana 2012</a>). One study provided data in graphical form only (<a href="./references#CD007579-bbs2-0081" title="WeissMD , DiazF , ZuberiF , MilmanB , PasrichaS . Subhypnotic doses of propofol for prevention of postoperative pruritus and nausea in cesarean section patients given spinal opioids. Anesthesiology1995;83(3A):A960. ">Weiss 1995</a>) and we have written to the authors to obtain the numerical data. One study provided outcome data as percentages and it was unclear how many women were in each group (<a href="./references#CD007579-bbs2-0051" title="ModirH , MoshiriE , KamaliA , ShokrpourM , ShamsN . Prophylatic efficacy of dexamethasone, ketamine and dexmedetomidine against intra- and postoperative nausea and vomiting under spinal anesthesia. Formosan Journal of Surgery2019;52(1):17-23. [CENTRAL: CN-01790839] [EMBASE: 626475964]">Modir 2019</a>). </p> <p>The studies which provided data were undertaken in: India (two studies); Iran (two studies); Korea (one study) Egypt (two studies); Spain (one study) Ghana (one study), China (one study) and Turkey (one study). One study did not specify where it was conducted. </p> <p>The 12 studies providing data appeared to be of reasonable quality with eight studies having adequate random sequence generation but only three having adequate allocation concealment. Only four of the 12 studies had adequate blinding (<a href="./references#CD007579-bbs2-0027" title="HassaneinA , MahmoudE . Effect of low dose ketamine versus dexamethasone on intraoperative nausea and vomiting during cesarean section under spinal anesthesia. Egyptian Journal of Anaesthesia2015;31(1):59-63. ">Hassanein 2015</a>; <a href="./references#CD007579-bbs2-0056" title="NiuK , LiuH , Chen R-W, Fang Q-W, WenH , Guo S-M, et al. Use of propofol for prevention of post-delivery nausea during cesarean section: a double-blind, randomized, placebo-controlled trial. Journal of Anesthesia2018;32(5):748-55. [CENTRAL: CN-02000278] [EMBASE: 623932583] [PMID: 30209576]">Niu 2018</a>; <a href="./references#CD007579-bbs2-0054" title="MukherjeeS , RudraA , MandelM , KumarP . Optimum dose of propofol for prevention of emetic episodes during caesarean delivery: an evaluation. Journal of Anaesthesia and Clinical Pharmacology2006;22(2):139-43. ">Mukherjee 2006</a>; <a href="./references#CD007579-bbs2-0074" title="TarhanO , CanbayO , CelebiN , UzunS , SahinA , CoskunF , et al. Subhypnotic doses of midazolam prevent nausea and vomiting during spinal anesthesia for cesarean section. Minerva Anestesiologica2007;73(12):629-33. ">Tarhan 2007</a>). Four studies were rated as inadequate blinding, where it was highly likely that the participants and/or clinicians would have been aware of the group allocation (<a href="./references#CD007579-bbs2-0004" title="AhnHJ , KimYA , ChoiDH . The effects of sedation using propofol TCI on the satisfaction level and side effects of parturients during regional anesthesia for a cesarean section. Korean Journal of Anesthesiology2002;43(1):66-72. ">Ahn 2002</a>; <a href="./references#CD007579-bbs2-0053" title="MokiniZ , FabbriE , Dell'AttiI , Di MartinoR , D'EttorreM , PetriniF . A randomized, controlled, double blind trial on the incidence of nausea and vomiting with prophylactic subhypnotic propofol vs metoclopramide and in combination therapy in cesarean section with subarachnoid anesthesia. European Journal of Anaesthesiology2014;31:192. NCT01781377. Prophylactic subhypnotic propofol for nausea and vomiting during for cesarean section under subarachnoid anesthesia. Https://clinicaltrials.gov/show/NCT01781377 (first received 2013 Jan 25). [CENTRAL: CN-01540221] ">Mokini 2014</a>; <a href="./references#CD007579-bbs2-0066" title="RasooliS , MoslemiF , KhakiA . Effect of sub hypnotic doses of propofol and midazolam for nausea and vomiting during spinal anesthesia for cesarean section. Anesthesiology and Pain Medicine2014;4(4):e19384. ">Rasooli 2014</a>; <a href="./references#CD007579-bbs2-0067" title="RudraA , HalderR , SenA , KunduS . Efficacy of low dose propofol for control of emetic episodes during caesarean delivery with spinal anaesthesia. Indian Journal of Anaesthesia2004;48(1):31-4. ">Rudra 2004a</a>). </p> <section id="CD007579-sec-0128"> <h5 class="title">Primary outcomes</h5> <section id="CD007579-sec-0129"> <h6 class="title">Intraoperative nausea</h6> <p>Sedatives probably reduce the number of women having intraoperative nausea (average RR 0.65, 95% CI 0.51 to 0.82, 8 studies, 593 women, random‐effects (T² = 0.00, Chi² P = 0.64, I² = 0%), <a href="./references#CD007579-fig-0059" title="">Analysis 6.1</a>). The certainty of the evidence was moderate, downgraded for serious risk of bias (<a href="./full#CD007579-tbl-0006">summary of findings Table 6</a>). </p> <p>Subgroup analysis by type of drug and dose showed no difference between the subgroups (Chi² = 5.78, df = 7 (P = 0.57), I² = 0%). </p> <p>The sensitivity analysis included one study (with 88 women) at low risk of bias of selection and attrition bias, and this showed similar findings to the main analysis although the lower CI now crosses the line of no difference (RR 0.76, 95% CI 0.53 to 1.08). </p> </section> <section id="CD007579-sec-0130"> <h6 class="title">Intraoperative vomiting</h6> <p>Sedatives probably reduce the number of women with intraoperative vomiting (average RR 0.35, 95% CI 0.24 to 0.52, 8 studies, 593 women, random‐effects (T² = 0.00, Chi² P = 0.55, I² = 0%), <a href="./references#CD007579-fig-0060" title="">Analysis 6.2</a>). The certainty of the evidence was moderate, downgraded for serious risk of bias (<a href="./full#CD007579-tbl-0006">summary of findings Table 6</a>). </p> <p>Subgroup analysis by type of drug and dose showed no difference between the subgroups (Chi² = 3.97, df = 7 (P = 0.78), I² = 0%). </p> <p>The sensitivity analysis included one (with 88 women) at low risk of bias of selection and attrition bias, and this showed similar findings to the main analysis (RR 0.43, 95% CI 0.20 to 0.95). </p> </section> <section id="CD007579-sec-0131"> <h6 class="title">Postoperative nausea</h6> <p>Sedatives may reduce the number of women with postoperative nausea but the results are very uncertain (average RR 0.25, 95% CI 0.09 to 0.71, 2 studies, 145 women, (T² = 0.47, Chi² P = 0.09, I² = 58%), <a href="./references#CD007579-fig-0061" title="">Analysis 6.3</a>) The certainty of the evidence was very low, downgraded for serious inconsistency and very serious imprecision (<a href="./full#CD007579-tbl-0006">summary of findings Table 6</a>). </p> <p>Subgroup analysis by type of drug and dose showed some difference between the groups (Chi² = 4.64, df = 2 (P = 0.10), I² = 56.9%). </p> <p>The sensitivity analysis included one study (with 88 women) at low risk of bias of selection and attrition bias, and this showed similar findings to the main analysis although the upper CI is further away from the line of no difference ( RR 0.17, 95% CI 0.09 to 0.31). </p> </section> <section id="CD007579-sec-0132"> <h6 class="title">Postoperative vomiting</h6> <p>Sedatives may reduce the number of women with postoperative vomiting (average RR 0.09, 95% CI 0.03 to 0.28, 2 studies, 145 women, (T² = 0.00, Chi² P = 0.39, I² = 0%), <a href="./references#CD007579-fig-0062" title="">Analysis 6.4</a>). The certainty of the evidence was low, downgraded for very serious imprecision (<a href="./full#CD007579-tbl-0006">summary of findings Table 6</a>). </p> <p>Subgroup analysis by type of drug and dose showed no difference between the groups (Chi² = 1.77, df = 2 (P = 0.41), I² = 0%). </p> <p>The sensitivity analysis included one study (with 88 women) at low risk of bias of selection and attrition bias, and this showed similar findings to the main analysis although the upper CI is further away from the line of no difference ( (RR 0.07, 95% CI 0.02 to 0.24). </p> </section> </section> <section id="CD007579-sec-0133"> <h5 class="title">Secondary outcomes</h5> <section id="CD007579-sec-0134"> <h6 class="title">Intraoperative 'nausea &amp; vomiting'</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD007579-sec-0135"> <h6 class="title">Postoperative 'nausea &amp; vomiting'</h6> <p>Sedatives may reduce the incidence of postoperative nausea and vomiting (average RR 0.06, 95% CI 0.02 to 0.22, 2 studies, 348 women, <a href="./references#CD007579-fig-0064" title="">Analysis 6.6</a>) . However, one study has a very extreme result (<a href="./references#CD007579-bbs2-0036" title="ISRCTN15475205. Does propofol prevent morphine-induced nausea, vomiting and itching in women who have had a Caesarean section?Http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN15475205 (first received 2019). [CENTRAL: CN-01974804] KampoS , AffulAP , MohammedS , NtimM , BuunaaimAD , AnabahTW . Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section - a randomized control trial. BMC Anesthesiology2019;19(1):177. [CENTRAL: CN-01987099] [EMBASE: 629299629] [PMID: 31521119]">Kampo 2019</a>). We have checked the paper and can find nothing to explain this result, so we also report the findings, as well excluding these data (average (RR 0.12, 95% CI 0.04 to 0.36, 1 study, 118 women). </p> </section> <section id="CD007579-sec-0136"> <h6 class="title">Adverse and side effects:</h6> <p>Although there were no estimates of a composite outcome of adverse effects, a few studies did measure a number of maternal adverse and side effects (<a href="./references#CD007579-fig-0065" title="">Analysis 6.7</a> to <a href="./references#CD007579-fig-0067" title="">Analysis 6.9</a>). </p> <p>One study of 80 women (<a href="./references#CD007579-bbs2-0056" title="NiuK , LiuH , Chen R-W, Fang Q-W, WenH , Guo S-M, et al. Use of propofol for prevention of post-delivery nausea during cesarean section: a double-blind, randomized, placebo-controlled trial. Journal of Anesthesia2018;32(5):748-55. [CENTRAL: CN-02000278] [EMBASE: 623932583] [PMID: 30209576]">Niu 2018</a>) reported no babies had Apgar scores less than seven at five minutes in either group. Also that all women in both groups initiated breastfeeding. </p> </section> </section> </section> <section id="CD007579-sec-0137"> <h4 class="title">7) Opioids antagonists versus placebo (4 studies, 380 women, Comparison 7)</h4> <p>Four studies were eligible for inclusion in this comparison (<a href="./references#CD007579-bbs2-0002" title="AbdollahpourA , AzadiR , BandariR , MirmohammadkhaniM . Effects of adding midazolam and sufentanil to intrathecal bupivacaine on analgesia quality and postoperative complications in elective cesarean section. Anesthesiology and Pain Medicine2015;5(4):e23565. ">Abdollahpour 2015</a>; <a href="./references#CD007579-bbs2-0013" title="CharuluxanananS , KyokongO , SomboonviboonW , NarasethakamolA , PromlokP . Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesthesia and Analgesia2003;96(6):1789-93. ">Charuluxananan 2003</a>; <a href="./references#CD007579-bbs2-0031" title="IbrahimAS , AlyMG , ThabetME , AbdelazizMR . Effect of adding nalbuphine to intrathecal bupivacaine with morphine on postoperative nausea and vomiting and pruritus after elective cesarean delivery: a randomized double blinded study. Minerva Anestesiologica2019;85(3):255-62. [CENTRAL: CN-01939130] [EMBASE: 2001726956] [PMID: 29856176]">Ibrahim 2019</a>; <a href="./references#CD007579-bbs2-0034" title="JangDG , ChangWY , YoonSY , KimKB . Epidural butorphanol reduces the side effects from epidural morphine after cesarean section. Korean Journal of Anesthesiology1997;33(2):297-303. ">Jang 1997</a>), but only two provided data for analysis involving 197 women (<a href="./references#CD007579-bbs2-0013" title="CharuluxanananS , KyokongO , SomboonviboonW , NarasethakamolA , PromlokP . Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesthesia and Analgesia2003;96(6):1789-93. ">Charuluxananan 2003</a>; <a href="./references#CD007579-bbs2-0031" title="IbrahimAS , AlyMG , ThabetME , AbdelazizMR . Effect of adding nalbuphine to intrathecal bupivacaine with morphine on postoperative nausea and vomiting and pruritus after elective cesarean delivery: a randomized double blinded study. Minerva Anestesiologica2019;85(3):255-62. [CENTRAL: CN-01939130] [EMBASE: 2001726956] [PMID: 29856176]">Ibrahim 2019</a>). Three studies compared opioid antagonists with placebo (<a href="./references#CD007579-bbs2-0002" title="AbdollahpourA , AzadiR , BandariR , MirmohammadkhaniM . Effects of adding midazolam and sufentanil to intrathecal bupivacaine on analgesia quality and postoperative complications in elective cesarean section. Anesthesiology and Pain Medicine2015;5(4):e23565. ">Abdollahpour 2015</a>; <a href="./references#CD007579-bbs2-0013" title="CharuluxanananS , KyokongO , SomboonviboonW , NarasethakamolA , PromlokP . Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesthesia and Analgesia2003;96(6):1789-93. ">Charuluxananan 2003</a>; <a href="./references#CD007579-bbs2-0031" title="IbrahimAS , AlyMG , ThabetME , AbdelazizMR . Effect of adding nalbuphine to intrathecal bupivacaine with morphine on postoperative nausea and vomiting and pruritus after elective cesarean delivery: a randomized double blinded study. Minerva Anestesiologica2019;85(3):255-62. [CENTRAL: CN-01939130] [EMBASE: 2001726956] [PMID: 29856176]">Ibrahim 2019</a>): two studies assessed nalbuphine, one intravenously (<a href="./references#CD007579-bbs2-0013" title="CharuluxanananS , KyokongO , SomboonviboonW , NarasethakamolA , PromlokP . Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesthesia and Analgesia2003;96(6):1789-93. ">Charuluxananan 2003</a>) and the other intrathecally (<a href="./references#CD007579-bbs2-0031" title="IbrahimAS , AlyMG , ThabetME , AbdelazizMR . Effect of adding nalbuphine to intrathecal bupivacaine with morphine on postoperative nausea and vomiting and pruritus after elective cesarean delivery: a randomized double blinded study. Minerva Anestesiologica2019;85(3):255-62. [CENTRAL: CN-01939130] [EMBASE: 2001726956] [PMID: 29856176]">Ibrahim 2019</a>); and one study assessed intrathecal sufentanil (<a href="./references#CD007579-bbs2-0002" title="AbdollahpourA , AzadiR , BandariR , MirmohammadkhaniM . Effects of adding midazolam and sufentanil to intrathecal bupivacaine on analgesia quality and postoperative complications in elective cesarean section. Anesthesiology and Pain Medicine2015;5(4):e23565. ">Abdollahpour 2015</a>). The fourth study assessed butorphanol, and although the abstract was in English, we have been unable to get the full paper translated from Korean to analyse any of the data (<a href="./references#CD007579-bbs2-0034" title="JangDG , ChangWY , YoonSY , KimKB . Epidural butorphanol reduces the side effects from epidural morphine after cesarean section. Korean Journal of Anesthesiology1997;33(2):297-303. ">Jang 1997</a>). </p> <p>The studies were undertaken in Iran, Thailand, Egypt and South Korea.</p> <p>Both studies providing data were judged to have adequate random sequence generation, although blinding was not well described and judged to be unclear in both studies. The studies were also judged to be of unclear risk for other biases. </p> <section id="CD007579-sec-0138"> <h5 class="title">Primary outcomes</h5> <section id="CD007579-sec-0139"> <h6 class="title">Intraoperative nausea</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD007579-sec-0140"> <h6 class="title">Intraoperative vomiting</h6> <p>None of the studies assessed this outcome.</p> <p><i>Postoperative nausea</i> </p> <p>It is uncertain whether opioid antagonists may reduce, increase or may make little no difference to the number of women having postoperative nausea (RR 0.75, 95% CI 0.39 to 1.45, 1 study, 120 women, <a href="./references#CD007579-fig-0072" title="">Analysis 7.3</a>). The certainty of the evidence was low, downgraded due to very serious imprecision (<a href="./full#CD007579-tbl-0007">summary of findings Table 7</a>). </p> <p>It was not possible to undertake a subgroup analysis by drug and dose because there was only one study reporting this outcome., </p> <p>It was not possible to undertake a sensitivity analysis as there was only one study assessing postoperative nausea and vomiting and this study was low risk for selection and attrition bias. </p> <p><i>Postoperative vomiting</i> </p> <p>It is uncertain whether opioid antagonists may reduce the number of women having intraoperative vomiting (RR 1.25, 95% CI 0.35 to 4.43, 1 study, 120 women, <a href="./references#CD007579-fig-0073" title="">Analysis 7.4</a>). The certainty of the evidence was low, downgraded for very serious imprecision (<a href="./full#CD007579-tbl-0007">summary of findings Table 7</a>). </p> <p>It was not possible to undertake a subgroup analysis by drug and dose because there was only one study reporting this outcome., </p> <p>It was not possible to undertake a sensitivity analysis as there was only one study assessing postoperative nausea and vomiting and this study was low risk for selection and attrition bias. </p> </section> </section> <section id="CD007579-sec-0141"> <h5 class="title">Secondary outcomes</h5> <section id="CD007579-sec-0142"> <h6 class="title">Intraoperative 'nausea &amp; vomiting'</h6> <p>No studies assessed this outcome.</p> </section> <section id="CD007579-sec-0143"> <h6 class="title">Postoperative 'nausea &amp; vomiting'</h6> <p>Nalbuphine (an opioid antagonist) may reduce postoperative nausea &amp; vomiting (RR 0.09, 95% CI 0.02 to 0.37, 1 study, 77 women, n<a href="./references#CD007579-fig-0075" title="">Analysis 7.6</a>), but the certainty of the evidence is very low and further data are needed. </p> </section> <section id="CD007579-sec-0144"> <h6 class="title">Adverse effects and side effects</h6> <p>Only two studies assessed pruritis as a side effect (<a href="./references#CD007579-fig-0076" title="">Analysis 7.7</a>) with markedly different results, so we do not have enough data on which to make a meaningful assessment. </p> </section> </section> </section> <section id="CD007579-sec-0145"> <h4 class="title">8) Acupressure/acupuncture versus placebo (14 studies, 1818 women, Comparison 8)</h4> <p>Fourteen studies compared acupressure/acupuncture with placebo, with 11 studies providing data on 1401 women (<a href="./references#CD007579-bbs2-0018" title="Direkvand-MoghadamA , KhosraviA . Effect of acupressure on post-operative nausea and vomiting in cesarean section: a randomised controlled trial. Journal of Clinical and Diagnostic Research2013;7(10):2247-9. IRCT201111146575N4. Comparing the effect of acupressure and metoclopramide on nausea and vomiting in women with spinal anesthesia for cesarean. http://en.irct.ir/trial/7020 (21 December 2011). [CENTRAL: CN-01849415] ">Direkvand‐Moghadam 2013</a>; <a href="./references#CD007579-bbs2-0019" title="DuggalKN , DouglasMJ , PeterEA , MerrickPM . Acupressure for intrathecal narcotic-induced nausea and vomiting after caesarean section. International Journal of Obstetric Anesthesia1998;7(4):231-6. ">Duggal 1998</a>; <a href="./references#CD007579-bbs2-0021" title="El-DeebAM , AhmadyMS . Effect of acupuncture on nausea and/or vomiting during and after cesarean section in comparison with ondansetron. Journal of Anesthesia2011;25(5):698-703. ">El‐Deeb 2011a</a>; <a href="./references#CD007579-bbs2-0023" title="HabibAS , Itchon-RamosN , Phillips-ButeBG , GanTJ , the Duke Women's Anesthesia (DWA) Research Group. Transcutaneous acupoint electrical stimulation with the ReliefBand for the prevention of nausea and vomiting during and after cesarean delivery under spinal anesthesia. Anesthesia and Analgesia2006;102(2):581-4. ">Habib 2006</a>; <a href="./references#CD007579-bbs2-0025" title="HarmonD , RyanM , KellyA , BowenM . Acupressure and prevention of nausea and vomiting during and after spinal anaesthesia for caesarean section. British Journal of Anaesthesia2000;84(4):463-7. HarmonD , RyanM , KellyA , BowenM . Acupressure and the prevention of nausea and vomiting during and after spinal anaesthesia for caesarean section. British Journal of Anaesthesia1999;82 Suppl:161. ">Harmon 2000</a>; <a href="./references#CD007579-bbs2-0028" title="HoCM , HseuSS , TsaiSK , LeeTY . Effect of P-6 acupressure on prevention of nausea and vomiting after epidural morphine for post-Cesarean section pain relief. Acta Anaesthesiologica Scandinavica1996;40:372-5. ">Ho 1996</a>; <a href="./references#CD007579-bbs2-0029" title="HoCM , TsaiHJ , ChanKH , TsaiSK . P6 acupressure does not prevent emesis during spinal anesthesia for cesarean delivery. Anesthesia and Analgesia2006;102(3):900-3. HoCM , TsaiSK . P-6 acupressure do not prevent emesis during cesarean section [abstract]. Canadian Journal of Anesthesia2002;49(6 Suppl):A51. ">Ho 2006</a>; <a href="./references#CD007579-bbs2-0043" title="LevinD , CohenS , MellenderS , MohiuddinA , ZhaoR , KissG , et al. Transcutaneous P6 acupoint electrical stimulation prevents both nausea and vomiting during elective cesarean section under combined spinal-epidural: a randomized control clinical trial. Anesthesia and Analgesia2018;126(4):421-2. [CENTRAL: CN-01789975] [EMBASE: 626090330]LevinD , CohenS , MellenderS , ShahU , KangP , MohiuddinA , et al. Effectiveness of p6 stimulation for reduction of nausea and vomiting during caesarean section under combined spinal-epidural anaesthesia: a randomised controlled trial. Turkish Journal of Anaesthesiology and Reanimation2019;47(2):120-7. [CENTRAL: CN-02089475] LevinD , CohenS , MohiuddinA , NaftalovichR , KangP , MellenderS , et al. How does acupressure point P6 stimulation compare to pharmacological therapy in reduction of nausea and vomiting during cesarean section with neuraxial anesthesia? Randomized control trial. Regional Anesthesia and Pain Medicine2017;42(6):no pagination. [CENTRAL: CN-01441790] [EMBASE: 619777950]">Levin 2019</a>; <a href="./references#CD007579-bbs2-0044" title="LiJZ , LiXZ , WangMS , LiJP , ShiF , YuHF . [Effects of transcutaneous electrical stimulation of auricular Shenmen point on postoperative nausea and vomiting and patient-controlled epidural analgesia in cesarean section]. [Chinese]. Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal]2012;92(27):1892-5. ">Li 2012</a>; <a href="./references#CD007579-bbs2-0057" title="NorooziniaH , MahooriA , HasaniE , Gerami-FahimM , SepehrvandN . The effect of acupressure on nausea and vomiting after cesarean section under spinal anesthesia. Acta Medica Iranica2013;51(3):163-7. ">Noroozinia 2013</a>; <a href="./references#CD007579-bbs2-0073" title="SteinDJ , BirnbachDJ , DanzerBI , KurodaMM , GrunebaumA , ThysDM . Acupressure versus intravenous metoclopramide to prevent nausea and vomiting during spinal anesthesia for cesarean section. Anesthesia and Analgesia1997;84(2):342-5. ">Stein 1997</a>). One study addressed this question but provided graphical data only (<a href="./references#CD007579-bbs2-0007" title="BirnbachDJ , SteinDJ , SaundersTA , GrunebaumA , KitainEM . Prophylactic use of acupressure for the prevention of nausea and vomiting during spinal anesthesia for cesarean section. Anesthesiology1993;79:A1020. ">Birnbach 1993</a>). Data from two studies were not included as it was unclear how many women were allocated to each group (<a href="./references#CD007579-bbs2-0045" title="LimTJ , ChiuJW , TanHM . Transcutaneous acupoint electrical stimulation for prevention of perioperative nausea and vomiting during cesarean section with spinal anesthesia [abstract]. Anesthesiology2001;95 Suppl:A1078. ">Lim 2001a</a>; <a href="./references#CD007579-bbs2-0046" title="LimTJ , LimE , ChiuJW , TanHM . Perioperative antiemetic efficacy of dexamethasone 4mg in cesarean section under spinal anaesthesia [abstract]. Anesthesiology2001;95 Suppl:A466. ">Lim 2001b</a>). All eleven studies looked at acupressure, and none studies acupuncture. </p> <p>The studies which provided data were undertaken in: USA (three studies); Iran (two studies); Canada (one study); China (two studies); Egypt (one study), Ireland (one study) and one study in the USA and Canada. </p> <p>The studies providing data were of borderline quality with only four out of 11 describing adequate blinding of all relevant parties, and a further two studies providing an incomplete description of blinding. One study was judged at high risk of bias as it seemed likely the participants and treating clinicians were not blinded to group allocation (<a href="./references#CD007579-bbs2-0018" title="Direkvand-MoghadamA , KhosraviA . Effect of acupressure on post-operative nausea and vomiting in cesarean section: a randomised controlled trial. Journal of Clinical and Diagnostic Research2013;7(10):2247-9. IRCT201111146575N4. Comparing the effect of acupressure and metoclopramide on nausea and vomiting in women with spinal anesthesia for cesarean. http://en.irct.ir/trial/7020 (21 December 2011). [CENTRAL: CN-01849415] ">Direkvand‐Moghadam 2013</a>). However, only four of the nine studies described adequate random sequence generation and only four adequate allocation concealment. We assessed the studies as low quality using GRADE criteria on the basis of inconsistency and imprecision. </p> <section id="CD007579-sec-0146"> <h5 class="title">Primary outcomes</h5> <section id="CD007579-sec-0147"> <h6 class="title">Intraoperative nausea</h6> <p>Acupressure/acupuncture may reduce the number of women having intraoperative nausea but the results are very uncertain (average RR 0.55, 95% CI 0.41 to 0.74), 9 studies, 1221 women, random‐effects (T² = 0.12, Chi² P = 0.0001, I² = 69%), <a href="./references#CD007579-fig-0077" title="">Analysis 8.1</a>). The certainty of the evidence is very low, downgraded for very serious risk of bias and serious inconsistency (<a href="./full#CD007579-tbl-0008">summary of findings Table 8</a>). </p> <p>It was not possible to undertake a subgroup analysis as all the studies used acupressure and we did not differentiate between the different types of acupressure. </p> <p>It was not possible to undertake a sensitivity analysis as none of the studies providing data were at low risk of selection and reporting bias. </p> </section> <section id="CD007579-sec-0148"> <h6 class="title">Intraoperative vomiting</h6> <p>Acupressure/acupuncture may reduce the number of women having intraoperative vomiting (average RR 0.52, 95% CI 0.33 to 0.80, 9 studies, 1221 women) (random‐effects (T² = 0.18, Chi² P = 0.05, I² = 47%), <a href="./references#CD007579-fig-0078" title="">Analysis 8.2</a>) . The certainty of the evidence is low, downgraded for very serious risk of bias (<a href="./full#CD007579-tbl-0008">summary of findings Table 8</a>). </p> <p>It was not possible to undertake a subgroup analysis as all the studies used acupressure and we did not differentiate between the different types of acupressure. </p> <p>It was not possible to undertake a sensitivity analysis as none of the studies providing data were at low risk of selection and reporting bias. </p> </section> <section id="CD007579-sec-0149"> <h6 class="title">Postoperative nausea</h6> <p>Acupressure/acupuncture may reduce the number of women having postoperative nausea but the results are very uncertain (average RR 0.46, 95% CI 0.27 to 0.75, 7 studies, 1069 women, random‐effects (T² = 0.32, Chi² P = 0.0001, I² = 81%), <a href="./references#CD007579-fig-0079" title="">Analysis 8.3</a>). The certainty of the evidence is very low downgraded for very serious risk of bias and serious inconsistency (<a href="./full#CD007579-tbl-0008">summary of findings Table 8</a>). </p> <p>It was not possible to undertake a subgroup analysis as all the studies used acupressure and we did not differentiate between the different types of acupressure. </p> <p>It was not possible to undertake a sensitivity analysis as none of the studies were low risk for selection and attrition bias. </p> </section> <section id="CD007579-sec-0150"> <h6 class="title">Postoperative vomiting</h6> <p>Acupressure/acupuncture may reduce the number of women having postoperative vomiting but the results are very uncertain (average RR 0.52, 95% CI 0.34 to 0.79, 7 studies, 1069 women, random‐effects (T² = 0.17, Chi² P = 0.01, I² = 62%), <a href="./references#CD007579-fig-0080" title="">Analysis 8.4</a>). The certainty of the evidence is very low downgraded for very serous risk of bias and serious inconsistency (<a href="./full#CD007579-tbl-0008">summary of findings Table 8</a>). </p> <p>It was not possible to undertake a subgroup analysis as all the studies used acupressure and we did not differentiate between the different types of acupressure. </p> <p>It was not possible to undertake a sensitivity analysis as none of the studies were low risk for selection and attrition bias. </p> </section> </section> <section id="CD007579-sec-0151"> <h5 class="title">Secondary outcomes</h5> <p>None of the studies reported intraoperative 'nausea + vomiting' nor postoperative 'nausea + vomiting'. </p> <section id="CD007579-sec-0152"> <h6 class="title">Adverse effects and side effects</h6> <p>It is uncertain whether acupressure/acupuncture increases side effects of anxiety, dizziness, hypotension or itching because the certainty of the evidence is very low (<a href="./references#CD007579-fig-0081" title="">Analysis 8.5</a> to <a href="./references#CD007579-fig-0084" title="">Analysis 8.8</a>). Acupressure/acupuncture may reduce the use of rescue antiemetics (average RR 0.50, 95% CI 0.36 to 0.71, 2 studies, 240 women, <a href="./references#CD007579-fig-0085" title="">Analysis 8.9</a>) but the certainty of the evidence is very low downgraded for very severs risk of bias and very severe imprecision (<a href="./full#CD007579-tbl-0008">summary of findings Table 8</a>). </p> </section> </section> </section> <section id="CD007579-sec-0153"> <h4 class="title">9) Ginger versus placebo (2 studies, 365 women, Comparison 9)</h4> <p>Two studies compared oral ginger with placebo included 365 women both provided data for the review (<a href="./references#CD007579-bbs2-0035" title="KalavaA , DarjiSJ , KalsteinA , YarmushJM , SchianodiColaJ , WeinbergJ . Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;169(2):184-8. KalavaA , WeinbergJ , JayakumarM , YarmushJM , SchianodiColaJJ . Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. In: http://www.asaabstracts.com/strands/asaabstracts/abstract.htm;jsessionid=0507CB47FEB444D841EEF290BF35A8BF?year=2011&amp;index=13&amp;absnum=4726 (accessed 1 Febraury 2012). 2011. NCT01733212. Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. Https://clinicaltrials.gov/show/NCT01733212 2012 Nov 26. [CENTRAL: CN-02041676] ">Kalava 2013</a>; <a href="./references#CD007579-bbs2-0084" title="ZeraatiH , ShahinfarJ , HesariSI , MasrorniyaM , NasimiF . The effect of ginger extract on the incidence and severity of nausea and vomiting after cesarean section under spinal anesthesia. Anesthesiology and Pain Medicine2016;6(5):e38943. [CENTRAL: CN-01760273] [EMBASE: 612722027] [PMID: 27847700]">Zeraati 2016</a>). One study described adequate random sequence generation, but both were unclear regarding allocation concealment and blinding. They were judged to be of low or unclear risk for other biases. </p> <p>One study was undertaken in USA and one in Iran.</p> <section id="CD007579-sec-0154"> <h5 class="title">Primary outcomes</h5> <section id="CD007579-sec-0155"> <h6 class="title">Intraoperative nausea</h6> <p>It is uncertain whether ginger reduces, increases or makes little to no difference in the number of women having intraoperative nausea (average RR 0.66, 95% CI 0.36 to 1.21, 2 studies, 331 women, random‐effects (T² = 0.15, Chi² P = 0.05, I² = 74%), <a href="./references#CD007579-fig-0086" title="">Analysis 9.1</a>. The certainty of the evidence is very low, downgraded for very serious risk of bias, serious inconsistency and serious imprecision (<a href="./full#CD007579-tbl-0009">summary of findings Table 9</a>). </p> <p>In a subgroup analysis by dose, there was evidence of subgroup difference ( Chi² = 3.70, df = 1 (P = 0.05), I² = 73.0%). </p> <p>The sensitivity analysis was not undertaken as neither of the studies were at low risk of bias of selection and attrition bias, </p> </section> <section id="CD007579-sec-0156"> <h6 class="title">Intraoperative vomiting</h6> <p>Ginger may reduce the number of women having intraoperative vomiting or may make little or no difference (average RR 0.62, 95% CI 0.38 to 1.00, 2 studies, 331 women, random‐effects (T² = 0.06, Chi² P = 0.16, I² = 49%), <a href="./references#CD007579-fig-0087" title="">Analysis 9.2</a>). The certainty of the evidence was very low, downgraded for very serious risk of bias, and serious imprecision (<a href="./full#CD007579-tbl-0009">summary of findings Table 9</a>). </p> <p>In a subgroup analysis by dose there was no evidence of a difference but more data are needed to be sure (Chi² = 1.97, df = 1 (P = 0.16), I² = 49.2%). </p> <p>The sensitivity analysis was not undertaken as neither of the studies were at low risk of bias of selection and attrition bias, </p> </section> <section id="CD007579-sec-0157"> <h6 class="title">Postoperative nausea</h6> <p>It is uncertain whether ginger reduces, increases or makes little to no difference to the number of women having postoperative nausea (average RR 0.63, 95% CI 0.22 to 1.77, 1 study, 92 women, <a href="./references#CD007579-fig-0088" title="">Analysis 9.3</a>). The certainty of the evidence was very low, downgraded for very serious risk of bias, and very serious imprecision (<a href="./full#CD007579-tbl-0009">summary of findings Table 9</a>). </p> <p>There is no subgroup analysis nor sensitivity analysis as there was only one study.</p> </section> <section id="CD007579-sec-0158"> <h6 class="title">Postoperative vomiting</h6> <p>It is uncertain whether ginger reduces increases, decreases or makes little to no difference to the number of women having postoperative vomiting (average RR 0.20, 95% CI 0.02 to 1.65, 1 study, 92 women, <a href="./references#CD007579-fig-0089" title="">Analysis 9.4</a>). The certainty of the evidence was very low, downgraded for very serious risk of bias and very serious imprecision (<a href="./full#CD007579-tbl-0009">summary of findings Table 9</a>). </p> <p>There is no subgroup analysis nor sensitivity analysis as there was only one study.</p> </section> </section> <section id="CD007579-sec-0159"> <h5 class="title">Secondary outcomes</h5> <p>The studies did not report any of our secondary outcomes.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007579-sec-0160" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007579-sec-0160"></div> <section id="CD007579-sec-0161"> <h3 class="title" id="CD007579-sec-0161">Summary of main results</h3> <p>We found 84 included studies involving 10,990 women with 69 studies providing useable data on 8928 women, and this covered nine comparisons. The certainty of the data was generally low and very low, mainly due to many of the studies being quite old and undertaken in times when methodological information was not required in publications, hence risk of bias is generally unclear and also many studies are small. </p> <section id="CD007579-sec-0162"> <h4 class="title">Placebo‐controlled studies</h4> <p><b>1. 5‐HT<sub>3</sub> antagonists.</b> In the 21 studies (involving 2686 women) that provided data, overall, we found that 5‐HT<sub>3</sub> antagonists (mainly ondansetron and granisetron) probably reduces postoperative nausea (moderate‐certainty evidence), may be effective in reducing intraoperative nausea and postoperative vomiting (low‐certainty evidence), but the effect on intraoperative vomiting is uncertain (very low‐certainty evidence) . There were no indications of adverse effects such as headaches, dizziness, hypotension and itchiness, although more data are needed. </p> <p><b>2. Dopamine antagonists.</b> In 20 studies (involving 1880 women) that provided data, we found that dopamine antagonists (both metoclopramide and droperidol) may be effective in reducing intraoperative vomiting and postoperative nausea (low‐certainty evidence), but it is uncertain whether they reduce intraoperative nausea and postoperative vomiting (very low‐certainty evidence). These results were broadly consistent with both metoclopramide and droperidol. However, there were insufficient data to determine if there were significant adverse effects like headaches, dizziness, hypotension and pruritus. </p> <p><b>3. Corticosteroids.</b> In 12 studies (involving 1182 women) that provided data, corticosteroids probably reduce postoperative nausea (moderate‐certainty evidence) and may reduce postoperative vomiting (low‐certainty evidence). We are uncertain whether corticosteroids reduce intraoperative nausea and vomiting (very low‐certainty evidence). There were limited data on adverse effects. </p> <p><b>4. Antihistamines.</b> In four studies (involving 514 women) that provided data, antihistamines (mainly dimenhydrinate and cyclizine) may reduce postoperative nausea (low‐certainty evidence) but may make little to no difference to intraoperative nausea, intraoperative vomiting (no events in the 149 women where this outcome was assessed) and postoperative vomiting (very low‐certainty evidence). Only one small study looked at the adverse effect of hypotension. </p> <p><b>5. Anticholenergic drugs.</b> In the six studies (involving 787 women) that provided data, we found that anticholinergic drugs (mainly glycopyrrolate and scopolamine) may be effective at reducing intraoperative nausea and postoperative vomiting (low‐certainty evidence) but may have little or no effect on intraoperative vomiting (very low‐certainty evidence). No study assessed postoperative nausea. There were few data on adverse effects. </p> <p><b>6. Sedatives.</b> In 13 studies (involving 1265 women) provided data and addressed sedatives as an intervention. Most studies included propofol, but some included midazolam and one study used ketamine. Overall, the use of sedatives probably reduces intraoperative nausea and intraoperative vomiting (moderate‐certainty evidence) and may reduce postoperative vomiting (low‐certainty evidence). It is uncertain if sedatives reduce postoperative nausea (very low‐certainty evidence). Reports generally provided insufficient data on potential adverse effects,in particular sedation. </p> <p><b>7. Opioid antagonists/partial agonists.</b> There were two studies that provided data involving 197 women assessing opioid antagonists used specifically to reduce nausea and vomiting. We found little to no difference in postoperative nausea or vomiting with these interventions (low‐certainty evidence) and there were no studies assessing intraoperative nausea and vomiting. Studies only looked at the side effect of itching and found no difference on limited data. </p> <p><b>8. Acupressure/acupuncture</b>. In the 10 studies (involving 1401 women) that provided data, we found acupressure/acupuncture may reduce the number of women having intraoperative vomiting (low‐certainty evidence) but it uncertain whether there is a reduction in intraoperative nausea, postoperative nausea and postoperative vomiting (very low‐certainty evidence). There were insufficient data on potential adverse effects. . </p> <p><b>9. Ginger.</b> In the two studies (involving 365 women) that provided data and compared ginger with placebo, it is uncertain whether ginger reduces, increases, or has no effect on intraoperative nausea and vomiting and postoperative nausea and vomiting (all very low‐certainty evidence). No side effects were assessed in either study. </p> </section> </section> <section id="CD007579-sec-0163"> <h3 class="title" id="CD007579-sec-0163">Overall completeness and applicability of evidence</h3> <p>There are good data assessing the efficacy of most standard classes of antiemetic compared with placebo in preventing nausea and vomiting during and following caesarean section under regional anaesthesia. However, most of the trials are small and the certainty of evidence is generally low. </p> <p>In this updated review we did not attempt to compare different classes of antiemetics or different combinations of therapy. </p> <p>We excluded several studies that assessed the efficacy of antiemetics given for treatment (rather than prevention) of established nausea and vomiting and these would need to be dealt with in a separate review. </p> </section> <section id="CD007579-sec-0164"> <h3 class="title" id="CD007579-sec-0164">Quality of the evidence</h3> <p>The quality of the evidence in this review varied widely. Considering just the 69 studies providing data for the review, on standard 'Risk of bias' assessment, only five studies were rated as low risk on all criteria (apart from Selective Bias). In comparison, 14 studies were rated as 'unclear' or 'high risk' on some or all criteria. Seventeen studies were rated as high risk on at least one criteria ‐ including for management of missing data (<a href="./references#CD007579-bbs2-0001" title="Abdel-AleemM , OsmanA , MorsyK . Effect of coadministration of dexamethasone with intrathecal morphine on postoperative outcomes after cesarean delivery. International Journal of Gynecology and Obstetrics2012;116(2):158-61. ">Abdel‐Aleem 2012</a>, <a href="./references#CD007579-bbs2-0006" title="BaciarelloM , CorniniA , ZasaM , PedronaP , ScrofaniG , VenutiFS , et al. Intrathecal atropine to prevent postoperative nausea and vomiting after cesarean section: a randomized, controlled trial. Minerva Anestesiologica2011;77(8):781-8. ">Baciarello 2011</a>; <a href="./references#CD007579-bbs2-0011" title="CardosoMM , LeiteAO , SantosEA , GozzaniJL , MathiasLA . Effect of dexamethasone on prevention of postoperative nausea, vomiting and pain after caesarean section: a randomised, placebo-controlled, double-blind trial. European Journal of Anaesthesiology2013;30:102-5. ">Cardoso 2013</a>; <a href="./references#CD007579-bbs2-0020" title="ApiliogullariS , GokF , CanpolatA , SoysalS , ToyH , SukanF . Comparison of prophylactic dimenhydrinate and metoclopramide for prevention of nausea-vomiting caused by intrathecal opioids in parturients undergoing caesarean delivery. Regional Anesthesia and Pain Medicine2008;33(5 Suppl 1):131. DumanA , ApiliogullariS , GokF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine in cesarean delivery. Nobel Medicus2010;6(3):13-9. DumanA , ApiliogullariS , GookF , SutcuE , SoysalS , ToyH . A randomized comparison of dimenhydrinate, metoclopramide and placebo for the prevention of nausea and vomiting following intrathecal fentanyl and morphine for cesarean delivery. Data on file. ">Duman 2010</a>) inadequate blinding (<a href="./references#CD007579-bbs2-0004" title="AhnHJ , KimYA , ChoiDH . The effects of sedation using propofol TCI on the satisfaction level and side effects of parturients during regional anesthesia for a cesarean section. Korean Journal of Anesthesiology2002;43(1):66-72. ">Ahn 2002</a>; <a href="./references#CD007579-bbs2-0018" title="Direkvand-MoghadamA , KhosraviA . Effect of acupressure on post-operative nausea and vomiting in cesarean section: a randomised controlled trial. Journal of Clinical and Diagnostic Research2013;7(10):2247-9. IRCT201111146575N4. Comparing the effect of acupressure and metoclopramide on nausea and vomiting in women with spinal anesthesia for cesarean. http://en.irct.ir/trial/7020 (21 December 2011). [CENTRAL: CN-01849415] ">Direkvand‐Moghadam 2013</a>; <a href="./references#CD007579-bbs2-0043" title="LevinD , CohenS , MellenderS , MohiuddinA , ZhaoR , KissG , et al. Transcutaneous P6 acupoint electrical stimulation prevents both nausea and vomiting during elective cesarean section under combined spinal-epidural: a randomized control clinical trial. Anesthesia and Analgesia2018;126(4):421-2. [CENTRAL: CN-01789975] [EMBASE: 626090330]LevinD , CohenS , MellenderS , ShahU , KangP , MohiuddinA , et al. Effectiveness of p6 stimulation for reduction of nausea and vomiting during caesarean section under combined spinal-epidural anaesthesia: a randomised controlled trial. Turkish Journal of Anaesthesiology and Reanimation2019;47(2):120-7. [CENTRAL: CN-02089475] LevinD , CohenS , MohiuddinA , NaftalovichR , KangP , MellenderS , et al. How does acupressure point P6 stimulation compare to pharmacological therapy in reduction of nausea and vomiting during cesarean section with neuraxial anesthesia? Randomized control trial. Regional Anesthesia and Pain Medicine2017;42(6):no pagination. [CENTRAL: CN-01441790] [EMBASE: 619777950]">Levin 2019</a>; <a href="./references#CD007579-bbs2-0053" title="MokiniZ , FabbriE , Dell'AttiI , Di MartinoR , D'EttorreM , PetriniF . A randomized, controlled, double blind trial on the incidence of nausea and vomiting with prophylactic subhypnotic propofol vs metoclopramide and in combination therapy in cesarean section with subarachnoid anesthesia. European Journal of Anaesthesiology2014;31:192. NCT01781377. Prophylactic subhypnotic propofol for nausea and vomiting during for cesarean section under subarachnoid anesthesia. Https://clinicaltrials.gov/show/NCT01781377 (first received 2013 Jan 25). [CENTRAL: CN-01540221] ">Mokini 2014</a>; <a href="./references#CD007579-bbs2-0066" title="RasooliS , MoslemiF , KhakiA . Effect of sub hypnotic doses of propofol and midazolam for nausea and vomiting during spinal anesthesia for cesarean section. Anesthesiology and Pain Medicine2014;4(4):e19384. ">Rasooli 2014</a>; <a href="./references#CD007579-bbs2-0067" title="RudraA , HalderR , SenA , KunduS . Efficacy of low dose propofol for control of emetic episodes during caesarean delivery with spinal anaesthesia. Indian Journal of Anaesthesia2004;48(1):31-4. ">Rudra 2004a</a>) or selective reporting (<a href="./references#CD007579-bbs2-0004" title="AhnHJ , KimYA , ChoiDH . The effects of sedation using propofol TCI on the satisfaction level and side effects of parturients during regional anesthesia for a cesarean section. Korean Journal of Anesthesiology2002;43(1):66-72. ">Ahn 2002</a>; <a href="./references#CD007579-bbs2-0012" title="CarvalhoJC , NairGS , DowneyK , BalkiM . Prophylactic dimenhydrinate does not reduce nausea and vomiting during cesarean section delivery under spinal anesthesia: a randomized, double-blind, placebo-controlled trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 42nd Annual Meeting; 2010 May 12-16, San Antonio, USA. 2010. NCT00791960. Prophylactic dimenhydrinate for intraoperative nausea and vomiting. Https://clinicaltrials.gov/show/NCT00791960 (first received 2008 Nov 13). [CENTRAL: CN-01485523] ">Carvalho 2010</a>; <a href="./references#CD007579-bbs2-0031" title="IbrahimAS , AlyMG , ThabetME , AbdelazizMR . Effect of adding nalbuphine to intrathecal bupivacaine with morphine on postoperative nausea and vomiting and pruritus after elective cesarean delivery: a randomized double blinded study. Minerva Anestesiologica2019;85(3):255-62. [CENTRAL: CN-01939130] [EMBASE: 2001726956] [PMID: 29856176]">Ibrahim 2019</a>; <a href="./references#CD007579-bbs2-0034" title="JangDG , ChangWY , YoonSY , KimKB . Epidural butorphanol reduces the side effects from epidural morphine after cesarean section. Korean Journal of Anesthesiology1997;33(2):297-303. ">Jang 1997</a>; <a href="./references#CD007579-bbs2-0070" title="KjaerK . Dexamethasone for the prevention of post-operative nausea and vomiting in patients undergoing cesarean sections. https://clinicaltrials.gov/ct2/show/results/NCT01734161 (27 November 2012). [CENTRAL: CN-01538899] SelzerA , PryorKO , TangelV , O'ConnellK , KjaerK . The effect of intravenous dexamethasone on postoperative nausea and vomiting after Cesarean delivery with intrathecal morphine: a randomized-controlled trial [Effet de la dexamethasone intraveineuse sur les nausees et vomissements postoperatoires apres un accouchement par cesarienne avec morphine intrathecale: un essai randomise controle]. Canadian Journal of Anesthesia2020;67:817-26. [CENTRAL: CN-02072818] [EMBASE: 2004140352] [PMID: 31989472]SelzerAR , PickJ , AbramovitzS , GadallaF , DarwichA , KjaerK . The effect of a single dose of intravenous dexamethasone on nausea and vomiting when administered prior to intrathecal morphine for cesarean section: a randomized, placebo-controlled, double-blinded trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 47th Annual Meeting; 2015 May 13-17; Colorado, USA. 2015:T-03. ">Selzer 2020</a>; <a href="./references#CD007579-bbs2-0075" title="TkachenkoR , PyasetskaN . The efficiency of intrathecal dexamethasone for spinal anaesthesia in elective caesarean section. Regional Anesthesia and Pain Medicine2019;44(10):A192. [CENTRAL: CN-01999210] [EMBASE: 629475510]">Tkachenko 2019</a>; <a href="./references#CD007579-bbs2-0079" title="VoigtM , FrohlichCW , HuttelC , KrankeP , MennenJ , BoessneckO , et al. Prophylaxis of intra- and postoperative nausea and vomiting in patients during cesarean section in spinal anesthesia. Medical Science Monitor2013;19:993-1000. ">Voigt 2013</a>). One study was rated as high risk for other bias due to a poorly controlled study protocol (<a href="./references#CD007579-bbs2-0024" title="HabibAS , GeorgeRB , McKeenDM , WhiteWD , ItukUS , MegallaSA , et al. Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. Obstetrics and Gynecology2013;121(3):615-23. NCT01216410. Prevention of intraoperative nausea and vomiting during cesarean section. Https://clinicaltrials.gov/show/NCT01216410 (first received 2010 Oct 6). [CENTRAL: CN-02025773] ">Habib 2013</a>). </p> <p>Of the 84 studies providing data, 37 described adequate random sequence generation, however only 18 described adequate allocation concealment. </p> <p>Using GRADE criteria for assessing the certainty of the evidence, we found the following.</p> <p>Comparison 1: 5HT<sub>3</sub> antagonists: moderate‐certainty evidence for postoperative nausea (downgraded for serious risk of bias); low‐certainty evidence for intraoperative nausea (downgraded for serious risk of bias and serious inconsistency) and postoperative vomiting (downgraded for serious risk of bias and possible publication bias); very low‐certainty evidence for intraoperative vomiting (downgraded for serious risk of bias, serious inconsistency and possible publication bias). (<a href="./full#CD007579-tbl-0001">summary of findings Table 1</a>). </p> <p>Comparison 2: dopamine antagonists: low‐certainty evidence for intraoperative vomiting and postoperative nausea and very low‐certainty evidence for intraoperative nausea and postoperative vomiting. Intraoperative nausea (downgraded for serious risk of bias and serious inconsistency; intraoperative vomiting (downgraded for serious risk of bias); postoperative nausea (downgraded for serious risk of bias) and postoperative vomiting (downgraded for serious risk of bias and possible publication bias) (<a href="./full#CD007579-tbl-0002">summary of findings Table 2</a>). </p> <p>Comparison 3: corticosteroids: moderate‐certainty evidence for postoperative nausea (downgraded for serious risk of bias); low‐certainty evidence for postoperative vomiting (downgraded for serious risk of bias and serious inconsistency); very low‐certainty for intraoperative nausea (downgraded for very serious risk of bias and serious inconsistency) and intraoperative vomiting (downgraded for very serious risk of bias and serious imprecision) (<a href="./full#CD007579-tbl-0003">summary of findings Table 3</a>). </p> <p>Comparison 4: antihistamines: very low‐certainty evidence for intraoperative nausea, intraoperative vomiting and postoperative vomiting (all downgraded for very serious risk of bias and very serious imprecision); and low‐certainty evidence for postoperative nausea (downgraded for very serious risk of bias) (<a href="./full#CD007579-tbl-0004">summary of findings Table 4</a>). </p> <p>Comparison 5: anticholinergics: low‐certainty evidence for intraoperative nausea (downgraded for very serious risk of bias) and postoperative vomiting (downgraded for serious risk of bias and serious imprecision); very low‐certainty evidence for intraoperative vomiting (downgraded for very serious risk of bias, serious inconsistency and serious imprecision) (<a href="./full#CD007579-tbl-0005">summary of findings Table 5</a>). </p> <p>Comparison 6: sedatives: moderate‐certainty evidence for intraoperative nausea (downgraded for serious risk of bias) and intraoperative vomiting (downgraded for serious risk of bias); low‐certainty evidence for postoperative vomiting (downgraded for very serious imprecision); very low‐certainty evidence for postoperative nausea (downgraded for serious inconsistence and very serious imprecision) (<a href="./full#CD007579-tbl-0006">summary of findings Table 6</a>). </p> <p>Comparson 7: opioid antagonists: low‐certainty evidence for postoperative nausea (downgraded for very serious imprecision) and postoperative vomiting (downgraded for very serious imprecision) (<a href="./full#CD007579-tbl-0007">summary of findings Table 7</a>). </p> <p>Comaprison 8: acupressure/acupuncture: low‐certainty evidence for intraoperative vomiting (downgraded for very serious risk of bias); very low‐certainty evidence for intraoperative nausea (downgraded for very serious risk of bias and serious inconsistency), postoperative nausea (downgraded for very serious risk of bias and serious inconsistency and postoperative vomiting (downgraded for very serious risk of bias and serious inconsistency) (<a href="./full#CD007579-tbl-0008">summary of findings Table 8</a>). </p> <p>Comparison 9: ginger: very low‐certainty evidence for: intraoperative nausea (downgraded for risk of bias, serious inconsistency and serious imprecision), intraoperative vomiting (downgraded for risk of bias and serious imprecision); postoperative nausea (downgraded for serious risk of bias and very serious imprecision and postoperative vomiting (downgraded for serious risk of bias and very serious imprecision) (<a href="./full#CD007579-tbl-0009">summary of findings Table 9</a>). </p> </section> <section id="CD007579-sec-0165"> <h3 class="title" id="CD007579-sec-0165">Potential biases in the review process</h3> <p>The possibility of introducing bias was present at every stage of the review process. We attempted to minimise bias in a number of ways; two review authors assessed eligibility for inclusion, carried out data extraction and assessed risk of bias. Each worked independently. Nevertheless, the process of assessing risk of bias, for example, is not an exact science and includes many personal judgements. </p> </section> <section id="CD007579-sec-0166"> <h3 class="title" id="CD007579-sec-0166">Agreements and disagreements with other studies or reviews</h3> <p>The findings of this study are broadly consistent with previously published reviews of nausea and vomiting at caesarean section (<a href="./references#CD007579-bbs2-0359" title="BalkiM , CarvalhoJC . Intraoperative nausea and vomiting during cesarean section under regional anesthesia. International Journal of Obstetric Anesthesia2005;14:230-41.">Balki 2005</a>). Systematic reviews assessing specific medications such as ondansetron (<a href="./references#CD007579-bbs2-0370" title="RonaldGB , AllenTK , HabibAS . Serotonin receptor antagonists for the prevention and treatment of pruritus, nausea, and vomiting in women undergoing cesarean delivery with intrathecal morphine: a systematic review and meta-analysis. Anesthesia &amp; Analgesia2009;109(1):174-82.">George 2009</a>; <a href="./references#CD007579-bbs2-0380" title="ZhouC , ZhuY , BaoZ , WangX , Liu Q. Efficacy of ondansetron for spinal anesthesia during cesarean section: a meta-analysis of randomized trials. Journal of International Medical Research2018;46(2):654-62.">Zhou 2018</a>) and metoclopramide (<a href="./references#CD007579-bbs2-0375" title="MishrikyBM , HabibAS . Metoclopramide for nausea and vomiting prophylaxis during and after Caesarean delivery: a systematic review and meta-analysis. British Journal of Anaesthesia2012;108(3):374-83.">Mishriky 2012</a>) have demonstrated efficacy, however a meta‐analysis of acupressure did not show a positive effect (<a href="./references#CD007579-bbs2-0358" title="AllenTK , HabibAS . P6 stimulation for the prevention of nausea and vomiting associated with cesarean delivery under neuraxial anesthesia: a systematic review of randomized controlled trials. Anesthesia &amp; Analgesia2008;107(4):1308-12.">Allen 2008</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007579-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD007579-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD007579-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-FIG-03" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007579-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 1: Nausea ‐ intraoperative" data-id="CD007579-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 1: Nausea ‐ intraoperative </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 2: Vomiting ‐ intraoperative" data-id="CD007579-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 2: Vomiting ‐ intraoperative </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 3: Nausea ‐ postoperative" data-id="CD007579-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 3: Nausea ‐ postoperative </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 4: Vomiting ‐ postoperative" data-id="CD007579-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 4: Vomiting ‐ postoperative </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 5: 'Nausea + Vomiting' ‐ intraoperative (not pre‐specified)" data-id="CD007579-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 5: 'Nausea + Vomiting' ‐ intraoperative (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 6: 'Nausea + Vomiting' ‐ postoperative ‐ (not pre‐specified)" data-id="CD007579-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 6: 'Nausea + Vomiting' ‐ postoperative ‐ (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 7: Maternal satisfaction" data-id="CD007579-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 7: Maternal satisfaction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 8: Maternal adverse outcomes" data-id="CD007579-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 8: Maternal adverse outcomes </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 9: Headache/dizziness/vertigo" data-id="CD007579-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 9: Headache/dizziness/vertigo </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 10: Hypotension" data-id="CD007579-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 10: Hypotension </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 11: Pruritus/itching" data-id="CD007579-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 11: Pruritus/itching </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 12: Dry mouth" data-id="CD007579-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 12: Dry mouth </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 13: Drowsiness/sedation" data-id="CD007579-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 13: Drowsiness/sedation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 5‐HT3 antagonists vs placebo, Outcome 14: Rescue antiemetic (not pre‐specified)" data-id="CD007579-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: 5‐HT<sub>3</sub> antagonists vs placebo, Outcome 14: Rescue antiemetic (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dopamine antagonists vs placebo, Outcome 1: Nausea ‐ intraoperative" data-id="CD007579-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Dopamine antagonists vs placebo, Outcome 1: Nausea ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dopamine antagonists vs placebo, Outcome 2: Vomiting ‐ intraoperative" data-id="CD007579-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Dopamine antagonists vs placebo, Outcome 2: Vomiting ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dopamine antagonists vs placebo, Outcome 3: Nausea ‐ postoperative" data-id="CD007579-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Dopamine antagonists vs placebo, Outcome 3: Nausea ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dopamine antagonists vs placebo, Outcome 4: Vomiting ‐ postoperative" data-id="CD007579-fig-0021" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Dopamine antagonists vs placebo, Outcome 4: Vomiting ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dopamine antagonists vs placebo, Outcome 5: 'Nausea + vomiting' ‐ intraoperative (not pre‐specfied)" data-id="CD007579-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Dopamine antagonists vs placebo, Outcome 5: 'Nausea + vomiting' ‐ intraoperative (not pre‐specfied) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dopamine antagonists vs placebo, Outcome 6: 'Nausea + vomiting' ‐ postoperative (not pre‐specified)" data-id="CD007579-fig-0023" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Dopamine antagonists vs placebo, Outcome 6: 'Nausea + vomiting' ‐ postoperative (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dopamine antagonists vs placebo, Outcome 7: Maternal satisfaction" data-id="CD007579-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Dopamine antagonists vs placebo, Outcome 7: Maternal satisfaction</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dopamine antagonists vs placebo, Outcome 8: Anxiety" data-id="CD007579-fig-0025" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: Dopamine antagonists vs placebo, Outcome 8: Anxiety</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dopamine antagonists vs placebo, Outcome 9: Headache/dizziness" data-id="CD007579-fig-0026" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: Dopamine antagonists vs placebo, Outcome 9: Headache/dizziness</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-002.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dopamine antagonists vs placebo, Outcome 10: Hypotension" data-id="CD007579-fig-0027" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-002.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: Dopamine antagonists vs placebo, Outcome 10: Hypotension</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-002.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dopamine antagonists vs placebo, Outcome 11: Rescue antiemetics (not pre‐specified)" data-id="CD007579-fig-0028" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-002.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2: Dopamine antagonists vs placebo, Outcome 11: Rescue antiemetics (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-002.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dopamine antagonists vs placebo, Outcome 12: Sedation" data-id="CD007579-fig-0029" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-002.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2: Dopamine antagonists vs placebo, Outcome 12: Sedation</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-002.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Dopamine antagonists vs placebo, Outcome 13: Pruritus/itching" data-id="CD007579-fig-0030" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-002.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2: Dopamine antagonists vs placebo, Outcome 13: Pruritus/itching</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-002.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Corticosteroids vs placebo, Outcome 1: Nausea ‐ intraoperative" data-id="CD007579-fig-0031" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Corticosteroids vs placebo, Outcome 1: Nausea ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Corticosteroids vs placebo, Outcome 2: Vomiting ‐ intraoperative" data-id="CD007579-fig-0032" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Corticosteroids vs placebo, Outcome 2: Vomiting ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Corticosteroids vs placebo, Outcome 3: Nausea ‐ postoperative" data-id="CD007579-fig-0033" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Corticosteroids vs placebo, Outcome 3: Nausea ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Corticosteroids vs placebo, Outcome 4: Vomiting ‐ postoperative" data-id="CD007579-fig-0034" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Corticosteroids vs placebo, Outcome 4: Vomiting ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Corticosteroids vs placebo, Outcome 5: 'Nausea + Vomiting' ‐ intraoperative (not pre‐specified)" data-id="CD007579-fig-0035" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Corticosteroids vs placebo, Outcome 5: 'Nausea + Vomiting' ‐ intraoperative (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Corticosteroids vs placebo, Outcome 6: 'Nausea + Vomiting' ‐ postoperative ‐ (not pre‐specified)" data-id="CD007579-fig-0036" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Corticosteroids vs placebo, Outcome 6: 'Nausea + Vomiting' ‐ postoperative ‐ (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Corticosteroids vs placebo, Outcome 7: Hypotension" data-id="CD007579-fig-0037" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: Corticosteroids vs placebo, Outcome 7: Hypotension</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-003.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Corticosteroids vs placebo, Outcome 8: Bradycardia" data-id="CD007579-fig-0038" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-003.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3: Corticosteroids vs placebo, Outcome 8: Bradycardia</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-003.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Corticosteroids vs placebo, Outcome 9: Shivering" data-id="CD007579-fig-0039" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-003.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3: Corticosteroids vs placebo, Outcome 9: Shivering</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-003.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Corticosteroids vs placebo, Outcome 10: Rescue antiemetics (not pre‐specified)" data-id="CD007579-fig-0040" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-003.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3: Corticosteroids vs placebo, Outcome 10: Rescue antiemetics (not pre‐specified)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-003.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Antihistamines vs placebo, Outcome 1: Nausea ‐ intraoperative" data-id="CD007579-fig-0041" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Antihistamines vs placebo, Outcome 1: Nausea ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Antihistamines vs placebo, Outcome 2: Vomiting ‐ intraoperative" data-id="CD007579-fig-0042" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Antihistamines vs placebo, Outcome 2: Vomiting ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Antihistamines vs placebo, Outcome 3: Nausea ‐ postoperative" data-id="CD007579-fig-0043" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Antihistamines vs placebo, Outcome 3: Nausea ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Antihistamines vs placebo, Outcome 4: Vomiting ‐ postoperative" data-id="CD007579-fig-0044" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Antihistamines vs placebo, Outcome 4: Vomiting ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Antihistamines vs placebo, Outcome 5: Hypotension" data-id="CD007579-fig-0045" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: Antihistamines vs placebo, Outcome 5: Hypotension</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Anticholinergics vs placebo, Outcome 1: Nausea ‐ intraoperative" data-id="CD007579-fig-0046" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Anticholinergics vs placebo, Outcome 1: Nausea ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Anticholinergics vs placebo, Outcome 2: Vomiting ‐ intraoperative" data-id="CD007579-fig-0047" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Anticholinergics vs placebo, Outcome 2: Vomiting ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Anticholinergics vs placebo, Outcome 3: Nausea ‐ postoperative" data-id="CD007579-fig-0048" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Anticholinergics vs placebo, Outcome 3: Nausea ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Anticholinergics vs placebo, Outcome 4: Vomiting ‐ postoperative" data-id="CD007579-fig-0049" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Anticholinergics vs placebo, Outcome 4: Vomiting ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-005.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Anticholinergics vs placebo, Outcome 5: 'Nausea + Vomiting' ‐ intraoperative (not pre‐specified)" data-id="CD007579-fig-0050" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-005.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5: Anticholinergics vs placebo, Outcome 5: 'Nausea + Vomiting' ‐ intraoperative (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-005.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Anticholinergics vs placebo, Outcome 6: 'Nausea + vomiting' ‐ postoperative (not pre‐specified)" data-id="CD007579-fig-0051" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-005.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5: Anticholinergics vs placebo, Outcome 6: 'Nausea + vomiting' ‐ postoperative (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-005.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Anticholinergics vs placebo, Outcome 7: Blurred vision" data-id="CD007579-fig-0052" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-005.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5: Anticholinergics vs placebo, Outcome 7: Blurred vision</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-005.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Anticholinergics vs placebo, Outcome 8: Anxiety/Disorientation" data-id="CD007579-fig-0053" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-005.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5: Anticholinergics vs placebo, Outcome 8: Anxiety/Disorientation</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-005.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Anticholinergics vs placebo, Outcome 9: Dizziness" data-id="CD007579-fig-0054" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-005.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5: Anticholinergics vs placebo, Outcome 9: Dizziness</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-005.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Anticholinergics vs placebo, Outcome 10: Hypotension" data-id="CD007579-fig-0055" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-005.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5: Anticholinergics vs placebo, Outcome 10: Hypotension</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-005.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Anticholinergics vs placebo, Outcome 11: Pruritus/itching" data-id="CD007579-fig-0056" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-005.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5: Anticholinergics vs placebo, Outcome 11: Pruritus/itching</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-005.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Anticholinergics vs placebo, Outcome 12: Xerostomia/dry mouth" data-id="CD007579-fig-0057" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-005.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5: Anticholinergics vs placebo, Outcome 12: Xerostomia/dry mouth</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-005.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Anticholinergics vs placebo, Outcome 13: Drowsiness" data-id="CD007579-fig-0058" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-005.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.13</div> <div class="figure-caption"> <p>Comparison 5: Anticholinergics vs placebo, Outcome 13: Drowsiness</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-005.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sedatives vs placebo, Outcome 1: Nausea ‐ intraoperative" data-id="CD007579-fig-0059" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Sedatives vs placebo, Outcome 1: Nausea ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sedatives vs placebo, Outcome 2: Vomiting ‐ intraoperative" data-id="CD007579-fig-0060" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Sedatives vs placebo, Outcome 2: Vomiting ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sedatives vs placebo, Outcome 3: Nausea ‐ postoperative" data-id="CD007579-fig-0061" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: Sedatives vs placebo, Outcome 3: Nausea ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sedatives vs placebo, Outcome 4: Vomiting ‐ postoperative" data-id="CD007579-fig-0062" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: Sedatives vs placebo, Outcome 4: Vomiting ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-006.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sedatives vs placebo, Outcome 5: 'Nausea + vomiting' ‐ intraoperative (not pre‐specified)" data-id="CD007579-fig-0063" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-006.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6: Sedatives vs placebo, Outcome 5: 'Nausea + vomiting' ‐ intraoperative (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-006.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sedatives vs placebo, Outcome 6: 'Nausea + vomiting' ‐ postoperative (not pre‐specified)" data-id="CD007579-fig-0064" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-006.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6: Sedatives vs placebo, Outcome 6: 'Nausea + vomiting' ‐ postoperative (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-006.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sedatives vs placebo, Outcome 7: Pruritis/itching" data-id="CD007579-fig-0065" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-006.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6: Sedatives vs placebo, Outcome 7: Pruritis/itching</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-006.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sedatives vs placebo, Outcome 8: Hypotension" data-id="CD007579-fig-0066" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-006.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6: Sedatives vs placebo, Outcome 8: Hypotension</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-006.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sedatives vs placebo, Outcome 9: Shivering" data-id="CD007579-fig-0067" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-006.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6: Sedatives vs placebo, Outcome 9: Shivering</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-006.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sedatives vs placebo, Outcome 10: Apgar score &lt; 7 at 5 mins" data-id="CD007579-fig-0068" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-006.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6: Sedatives vs placebo, Outcome 10: Apgar score &lt; 7 at 5 mins</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-006.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Sedatives vs placebo, Outcome 11: Initiation of breastfeeding" data-id="CD007579-fig-0069" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-006.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.11</div> <div class="figure-caption"> <p>Comparison 6: Sedatives vs placebo, Outcome 11: Initiation of breastfeeding</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-006.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 1: Nausea ‐ intraoperative" data-id="CD007579-fig-0070" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 1: Nausea ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 2: Vomiting ‐ intraoperative" data-id="CD007579-fig-0071" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 2: Vomiting ‐ intraoperative </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-007.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 3: Nausea ‐ postoperative" data-id="CD007579-fig-0072" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-007.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 3: Nausea ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-007.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 4: Vomiting ‐ postoperative" data-id="CD007579-fig-0073" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-007.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 4: Vomiting ‐ postoperative </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-007.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 5: 'Nausea + vomiting' ‐ intraoperative (not pre‐specified)" data-id="CD007579-fig-0074" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-007.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 5: 'Nausea + vomiting' ‐ intraoperative (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-007.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 6: 'Nausea + vomiting' ‐ postoperative (not pre‐specified)" data-id="CD007579-fig-0075" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-007.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 6: 'Nausea + vomiting' ‐ postoperative (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-007.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 7: Pruritus/itching" data-id="CD007579-fig-0076" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-007.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7: Opioid antagonist/partial agonist vs placebo, Outcome 7: Pruritus/itching</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-007.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Acupressure/acupuncture vs placebo, Outcome 1: Nausea ‐ intraoperative" data-id="CD007579-fig-0077" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Acupressure/acupuncture vs placebo, Outcome 1: Nausea ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Acupressure/acupuncture vs placebo, Outcome 2: Vomiting ‐ intraoperative" data-id="CD007579-fig-0078" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: Acupressure/acupuncture vs placebo, Outcome 2: Vomiting ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-008.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Acupressure/acupuncture vs placebo, Outcome 3: Nausea ‐ postoperative" data-id="CD007579-fig-0079" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-008.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8: Acupressure/acupuncture vs placebo, Outcome 3: Nausea ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-008.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Acupressure/acupuncture vs placebo, Outcome 4: Vomiting ‐ postoperative" data-id="CD007579-fig-0080" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-008.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8: Acupressure/acupuncture vs placebo, Outcome 4: Vomiting ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-008.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Acupressure/acupuncture vs placebo, Outcome 5: Anxiety" data-id="CD007579-fig-0081" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-008.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8: Acupressure/acupuncture vs placebo, Outcome 5: Anxiety</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-008.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Acupressure/acupuncture vs placebo, Outcome 6: Dizziness" data-id="CD007579-fig-0082" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-008.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8: Acupressure/acupuncture vs placebo, Outcome 6: Dizziness</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-008.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Acupressure/acupuncture vs placebo, Outcome 7: Hypotension" data-id="CD007579-fig-0083" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-008.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.7</div> <div class="figure-caption"> <p>Comparison 8: Acupressure/acupuncture vs placebo, Outcome 7: Hypotension</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-008.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Acupressure/acupuncture vs placebo, Outcome 8: Pruritus/itching" data-id="CD007579-fig-0084" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-008.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.8</div> <div class="figure-caption"> <p>Comparison 8: Acupressure/acupuncture vs placebo, Outcome 8: Pruritus/itching</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-008.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Acupressure/acupuncture vs placebo, Outcome 9: Rescue antiemetic (not pre‐specified)" data-id="CD007579-fig-0085" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-008.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.9</div> <div class="figure-caption"> <p>Comparison 8: Acupressure/acupuncture vs placebo, Outcome 9: Rescue antiemetic (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-008.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Ginger vs placebo, Outcome 1: Nausea ‐ intraoperative" data-id="CD007579-fig-0086" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Ginger vs placebo, Outcome 1: Nausea ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Ginger vs placebo, Outcome 2: Vomiting ‐ intraoperative" data-id="CD007579-fig-0087" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: Ginger vs placebo, Outcome 2: Vomiting ‐ intraoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-009.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Ginger vs placebo, Outcome 3: Nausea ‐ postoperative" data-id="CD007579-fig-0088" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-009.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-009.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9: Ginger vs placebo, Outcome 3: Nausea ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-009.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007579-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/urn:x-wiley:14651858:media:CD007579:CD007579-CMP-009.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Ginger vs placebo, Outcome 4: Vomiting ‐ postoperative" data-id="CD007579-fig-0089" src="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-009.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_t/tCD007579-CMP-009.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9: Ginger vs placebo, Outcome 4: Vomiting ‐ postoperative</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/media/CDSR/CD007579/image_n/nCD007579-CMP-009.04.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007579-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">5‐HT3 antagonists compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>5‐HT3 antagonists compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing regional anaesthesia for caesarean section<br/><b>Setting:</b> hospitals across low‐, middle‐ and high‐income countries<br/><b>Intervention:</b> 5‐HT3 antagonists<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with 5‐HT3 antagonists</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.55<br/>(0.42 to 0.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1419<br/>(12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>479 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>263 per 1000<br/>(201 to 340) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.46<br/>(0.29 to 0.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1414<br/>(11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>3 4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>241 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>111 per 1000<br/>(70 to 176) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.40<br/>(0.30 to 0.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1340<br/>(10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>338 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>135 per 1000<br/>(101 to 183) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.47<br/>(0.31 to 0.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1450<br/>(10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>5 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>228 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>107 per 1000<br/>(71 to 157) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 1 for risk of bias: &gt; 90% of data comes from studies with unclear selection bias </p> <p><sup>2</sup> Downgrade 1 for inconsistency: there may be substantial heterogeneity I<sup>2</sup> = 65%, Chi<sup>2</sup> P = 0.0009. </p> <p>3 Downgrade 1 for risk of bias: &gt; 80% of data comes from studies with unclear selection bias </p> <p>4 Downgrade 1 for inconsistency: there may be substantial heterogeneity I<sup>2</sup> = 58%, Chi<sup>2</sup> P = 0.008. </p> <p>5 Downgrade 1 for publication bias: there is some evidence of possible publication bias in the funnel plot. </p> <p>6 Downgrade 1 for risk of bias: &gt; 65% of data comes from studies with unclear selection bias </p> <p>7 Downgrade 1 for risk of bias: &gt; 70% of data comes from studies with unclear selection bias </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">5‐HT3 antagonists compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007579-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Dopamine antagonists compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dopamine antagonists compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing regional anaesthesia for caesarean section<br/><b>Setting:</b> hospitals across low‐, middle‐ and high‐income countries<br/><b>Intervention:</b> dopamine antagonists<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with dopamine antagonists (B)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.38<br/>(0.27 to 0.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1180<br/>(15 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>444 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>169 per 1000<br/>(120 to 231) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.41<br/>(0.28 to 0.60) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>942<br/>(12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>211 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000<br/>(59 to 127) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.61<br/>(0.48 to 0.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>601<br/>(7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>393 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>240 per 1000<br/>(189 to 311) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.63<br/>(0.44 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>860<br/>(9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>264 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>167 per 1000<br/>(116 to 243) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for risk of bias: all the data come from studies with unclear risk of selection bias. </p> <p><sup>2</sup> Downgrade 1 for inconsistency. Moderate to substantial heterogeneity, I<sup>2</sup> = 54%, Chi<sup>2</sup> P = 0.005 </p> <p><sup>3</sup> Downgrade 1 for publication bias: evidence of some publication bias in the funnel plot </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Dopamine antagonists compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007579-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Corticosteroids compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Corticosteroids compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing regional anaesthesia for caesarean section<br/><b>Setting:</b> hospitals across low‐, middle‐ and high‐income countries<br/><b>Intervention:</b> corticosteroids<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with corticosteroids (C)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.56<br/>(0.37 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>609<br/>(6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>403 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>226 per 1000<br/>(149 to 334) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.52<br/>(0.31 to 0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>609<br/>(6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>141 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73 per 1000<br/>(44 to 123) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.59<br/>(0.49 to 0.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>733<br/>(6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>491 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>290 per 1000<br/>(240 to 358) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.68<br/>(0.49 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>793<br/>(7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>355 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>241 per 1000<br/>(174 to 337) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for risk of bias: all the data comes from studies with unclear risk of selection bias </p> <p><sup>2</sup> Downgrade 1 for inconsistency: there is moderate heterogeneity I<sup>2</sup> = 50% and Chi<sup>2</sup> P = 0.06. </p> <p><sup>3</sup> Downgrade 1 for imprecision: Wide CI close to line of no difference. Only 61 events out of 609 women. </p> <p><sup>4</sup> Downgrade 1 for risk of bias: 69% of data comes from studies with unclear risk of selection bias. </p> <p><sup>5</sup> Downgrade 1 for risk of bias: 83%% of data comes from studies with unclear risk of selection bias. </p> <p><sup>6</sup> Downgrade 1 for inconsistency: may show moderate heterogeneity. I<sup>2</sup> = 52%. Chi<sup>2</sup> P = 0.03. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Corticosteroids compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007579-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Antihistamines compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Antihistamines compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> preventing nausea and vomiting<br/><b>Setting:</b> in women undergoing regional anaesthesia for caesarean section<br/><b>Intervention:</b> antihistamines<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with antihistamines</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/>(0.47 to 2.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>149<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>155 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>153 per 1000<br/>(73 to 327) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>149<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only one RCT with no intraoperative vomiting events</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.44<br/>(0.30 to 0.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>514<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>309 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>136 per 1000<br/>(93 to 198) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.48<br/>(0.29 to 0.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>333<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>91 per 1000<br/>(55 to 153) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for risk of bias; only one study with unclear risk of bias across 6 domains and high risk for one domain </p> <p><sup>2</sup> Downgrade 2 for imprecision: wide CI, only 23 events out of 149 women in a single study. </p> <p><sup>3</sup> Downgrade 2 for imprecision: there are no events. </p> <p><sup>4</sup> Downgrade 2 for risk of bias: all data from studies with unclear risk of selection bias </p> <p><sup>5</sup> Downgrade 1 for imprecision: only 45 events out of 333 women. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Antihistamines compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007579-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Anticholinergics compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Anticholinergics compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing regional anaesthesia for caesarean section<br/><b>Setting:</b> hospitals across low‐, middle‐ and high‐income countries<br/><b>Intervention:</b> anticholinergics<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with anticholinergics</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67<br/>(0.51 to 0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>453<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>665 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>446 per 1000<br/>(339 to 579) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.79<br/>(0.40 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>453<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>304 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>240 per 1000<br/>(122 to 468) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.55<br/>(0.41 to 0.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>161<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>728 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>401 per 1000<br/>(299 to 539) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for risk of bias: all the data from studies with unclear selection bias. </p> <p><sup>2</sup> Downgrade 1 for inconsistency: there may be moderate heterogeneity I<sup>2</sup> = 52% Chi<sup>2</sup> P = 0.10. </p> <p><sup>3</sup> Downgrade 1 for imprecision: wide CI, crossing the line of no difference. 120 events out of 453 women participants. </p> <p><sup>4</sup> Downgrade 1 for risk of bias: only one study with unclear allocation concealment but adequate sequence generation </p> <p><sup>5</sup> Downgrade 1 for imprecision: a single study shows a wide confidence interval away from the line of no difference but with 91 events out of 161 women participants. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Anticholinergics compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007579-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Sedatives compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Sedatives compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing regional anaesthesia for caesarean section<br/><b>Setting:</b> hospitals across low‐, middle‐ and high‐income countries<br/><b>Intervention:</b> sedatives<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with sedatives (F)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.65<br/>(0.51 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>593<br/>(8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>375 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>244 per 1000<br/>(191 to 308) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.35<br/>(0.24 to 0.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>593<br/>(8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>294 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1000<br/>(71 to 153) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.25<br/>(0.09 to 0.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>145<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>441 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>110 per 1000<br/>(40 to 313) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.09<br/>(0.03 to 0.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>145<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>356 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000<br/>(11 to 100) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 1 for risk of bias: 56% of data from studies with low risk of selection bias. </p> <p>2 Downgrade 1 for risk of bias: 75% of data were from studies with unclear selection bias. </p> <p><sup>3</sup> Downgrade 1 for inconsistency: moderate heterogeneity. I<sup>2</sup> = 58%. Chi<sup>2</sup> P = 0.09. </p> <p><sup>4</sup> Downgrade 2 for imprecision: low number of events ‐ 37 and low number of participants 145. Wide CI though a reasonable distance from line of no difference. </p> <p><sup>5</sup> Downgrade 2 for imprecision: low number of events ‐ 23 and low number of participants 145. Wide CI but a good distance from the line of no difference although the data of high effectiveness comes from just one study of 44 women. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Sedatives compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007579-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Opioid antagonists compared to placebo for preventing nausea and vomiting</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Opioid antagonists compared to placebo for preventing nausea and vomiting</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> preventing nausea and vomiting<br/><b>Setting:</b> in women undergoing regional anaesthesia for caesarean section<br/><b>Intervention:</b> opioid antagonists<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with opioid antagonists</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(0 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.75<br/>(0.39 to 1.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>120<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>267 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1000<br/>(104 to 387) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.25<br/>(0.35 to 4.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>120<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000<br/>(23 to 295) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for imprecision. Only 28 events out of 120 women in one study. Wide CI crossing line of no difference. </p> <p><sup>2</sup> Downgrade 2 for imprecision. Only 9 events out of 120 women in one study. Wide CI crossing line of no difference. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Opioid antagonists compared to placebo for preventing nausea and vomiting</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007579-tbl-0008"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Acupressure/acupuncture compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Acupressure/acupuncture compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing regional anaesthesia for caesarean section<br/><b>Setting:</b> hospitals across low‐, middle‐ and high‐income countries<br/><b>Intervention:</b> acupressure/acupuncture<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with acupressure/acupuncture (K)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.55<br/>(0.41 to 0.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1221<br/>(9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>466 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>256 per 1000<br/>(191 to 345) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.52<br/>(0.33 to 0.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1221<br/>(9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>236 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>123 per 1000<br/>(78 to 189) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.46<br/>(0.27 to 0.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1069<br/>(7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>411 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1000<br/>(111 to 308) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.52<br/>(0.34 to 0.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1069<br/>(7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>302 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>157 per 1000<br/>(103 to 239) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for risk of bias: all the data comes from studies which are unclear risk of selection bias. </p> <p><sup>2</sup> Downgrade 1 for inconsistency: substantial heterogeneity I<sup>2</sup> = 69% Chi<sup>2</sup> P = 0.0010. </p> <p><sup>3</sup> Downgrade 1 for inconsistency: substantial heterogeneity. I<sup>2</sup> = 81% and Chi<sup>2</sup> P = &lt; 0.0001. Could be downgrade by 2, borderline decision </p> <p><sup>4</sup> Downgrade 1 for inconsistency: moderate heterogeneity. I<sup>2</sup> = 62% and Chi<sup>2</sup> P = 0.01. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Acupressure/acupuncture compared to placebo for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007579-tbl-0009"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Ginger compared to placebo for preventing nausea and vomiting</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Ginger compared to placebo for preventing nausea and vomiting</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> preventing nausea and vomiting<br/><b>Setting:</b> in women undergoing regional anaesthesia for caesarean section?<br/><b>Intervention:</b> ginger<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with ginger</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.66<br/>(0.36 to 1.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>331<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>586 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>387 per 1000<br/>(211 to 709) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ intraoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.62<br/>(0.38 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>331<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>408 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>253 per 1000<br/>(155 to 408) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.63<br/>(0.22 to 1.77) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>92<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>174 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>110 per 1000<br/>(38 to 308) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vomiting ‐ postoperative</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.20<br/>(0.02 to 1.65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>92<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>5 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>109 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/>(2 to 179) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade 2 for risk of bias: Only 2 studies both with unclear risk of selection bias </p> <p><sup>2</sup> Downgrade 1 for inconsistency. Substantial heterogeneity. I<sup>2</sup> = 74%, Chi<sup>2</sup> P = 0.05 </p> <p><sup>3</sup> Downgrade 1 for imprecision. Very wide CI crossing the line of no difference. 170 events and 331 women participants </p> <p><sup>4</sup> Downgrade 1 for imprecision: Wide CI. meeting the line of no difference. 112 events and 331 women participating </p> <p><sup>5</sup> Downgrade 2 for risk of bias: Only 1 study with unclear risk of selection bias </p> <p><sup>6</sup> Downgrade 2 for imprecision: Wide CI. Only 6 events out of 92 women </p> <p><sup>7</sup> Downgrade 2 for imprecision: Wide CI crosses line of no difference. 5 events only and just 92 women included </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Ginger compared to placebo for preventing nausea and vomiting</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/full#CD007579-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007579-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">5‐HT3 antagonists vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Nausea ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1419</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.42, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Ondansetron ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.41, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Ondansetron ‐ 8 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.20, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 Granisetron ‐ 1 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.59, 2.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.4 Granisetron 3 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.18, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Vomiting ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1414</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.29, 0.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Ondansetron ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1059</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.31, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Ondansetron ‐ 8 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.02, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 Granisetron ‐ 1 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.19, 2.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.4 Tropisotron 2 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Nausea ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.30, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Ondansetron ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1023</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.26, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Ondansetron ‐ 8 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.18, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.3 Granisetron ‐ 40 mcg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.14, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.4 Tropisotron ‐ 2 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.12, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Vomiting ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.31, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Ondansetron ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.27, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Ondansetron ‐ 8 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.19, 5.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.3 Granisetron ‐ 40 mcg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.12, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.4 Tropisotron ‐ 2 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.01, 4.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 'Nausea + Vomiting' ‐ intraoperative (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.53, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Tropisotron ‐ 2 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.53, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 'Nausea + Vomiting' ‐ postoperative ‐ (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.41, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Ondansetron ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.40, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Ondansetron ‐ 8 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.19, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.3 Tropisotron ‐ 2 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.12, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.4 Granisetron ‐ 0.1 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.22, 2.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Maternal satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Ondansetron ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Ondansetron ‐ 8 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.3 Granisetron ‐ 1 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.4 Granisetron ‐ 3 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Maternal adverse outcomes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Ondansetron ‐ 8 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Headache/dizziness/vertigo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>433</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.60, 1.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 Ondansetron ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>433</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.60, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.72, 2.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 Ondansetron ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.48, 4.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 Granisetron ‐ 1 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.12, 72.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Pruritus/itching <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>488</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.69, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.1 Ondansetron ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>298</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.36, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.2 Ondansetron ‐ 8 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.84, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Dry mouth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.17, 3.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 Ondansetron ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.17, 3.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Drowsiness/sedation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.94 [0.45, 34.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.1 Ondansetron ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.94 [0.45, 34.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Rescue antiemetic (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.11, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">5‐HT3 antagonists vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007579-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Dopamine antagonists vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Nausea ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.27, 0.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Metoclopramide ‐ 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>748</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.24, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Metoclopramide ‐ 20 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.10, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.3 Metoclopramide ‐ 0.15 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.12, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.4 Droperidol ‐ 0.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.17, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.5 Droperidol ‐ 0.625 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.15, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.6 Droperidol ‐ 1.25 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.17, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.7 Droperidol ‐ 5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.09, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Vomiting ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>942</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.28, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Metoclopramide ‐ 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>610</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.27, 0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Metoclopramide ‐ 0.15 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.3 Droperidol ‐ 0.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.09, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.4 Droperidol ‐ 0.625 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.07, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.5 Droperidol ‐ 1.25 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.10, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.6 Droperidol ‐ 5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.02, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Nausea ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>601</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.48, 0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Metoclopramide ‐ 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>454</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.49, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Metoclopramide ‐ 0.15 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.16, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.3 Droperidol ‐ 1.25 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.43, 6.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Vomiting ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>860</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.44, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Metoclopramide ‐ 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>653</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.44, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Metoclopramide ‐ 0.15 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.12, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.3 Droperidol ‐ 1.25 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.32, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 'Nausea + vomiting' ‐ intraoperative (not pre‐specfied) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.02, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Metoclopramide ‐ 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.02, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 'Nausea + vomiting' ‐ postoperative (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.05, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Metoclopramide ‐ 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.02, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.2 Droperidol ‐ 0.625 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.12, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Maternal satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.91, 2.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 Metoclopramide ‐ 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.91, 2.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Anxiety <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.00 [0.48, 33.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.1 Metoclopramide ‐ 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.00 [0.48, 33.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 Headache/dizziness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.1 Metoclopramide ‐ 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>563</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.90, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.1 Metoclopramide ‐ 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.77, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.2 Metoclopramide ‐ 0.15 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [0.66, 3.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.3 Droperidol ‐ 0.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.80, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.4 Droperidol ‐ 0.625 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.69, 2.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.11 Rescue antiemetics (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.03, 2.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.12 Sedation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.54 [2.78, 11.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.1 Metoclopramide ‐ 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.24 [1.73, 10.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.2 Droperidol ‐ 0.625 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.17 [2.77, 24.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.13 Pruritus/itching <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>504</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.93, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.1 Metoclopramide ‐ 10 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>429</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.93, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.2 Droperidol ‐ 1.25 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.55, 1.53]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Dopamine antagonists vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007579-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Corticosteroids vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Nausea ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>609</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.37, 0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Dexamethasone ‐ 4 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.68, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 Dexamethasone ‐ 4 mg IT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.15, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.3 Dexamethasone ‐ 8 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>347</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.37, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Vomiting ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>609</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.31, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Dexamethasone ‐ 4 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.33, 2.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 Dexamethasone ‐ 4 mg IT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.02, 2.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.3 Dexamethasone ‐ 8 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>347</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.23, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Nausea ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>733</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.49, 0.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 Dexamethasone ‐ 2.5 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.19, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.2 Dexamethasone ‐ 4 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.30, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.3 Dexamethasone ‐ 5 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.13, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.4 Dexamethasone ‐ 8 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.60, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.5 Dexamethasone ‐ 8 mg IT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.39, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.6 Dexamethasone ‐ 10 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.26, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Vomiting ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>793</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.49, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 Dexamethasone ‐ 2.5 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.22, 2.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 Dexamethasone ‐ 4 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.3 Dexamethasone ‐ 5 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.08, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.4 Dexamethasone ‐ 8 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.79, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.5 Dexamethasone ‐ 8 mg IT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.31, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.6 Dexamethasone ‐ 10 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.27, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 'Nausea + Vomiting' ‐ intraoperative (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [0.96, 2.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 Dexamethasone ‐ 8 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [0.96, 2.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 'Nausea + Vomiting' ‐ postoperative ‐ (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.79, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.1 Dexamethasone ‐ 8 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.79, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.34, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.1 Dexamethasone ‐ 4 mg IT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.25, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.2 Dexamethasone ‐ 8 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.53, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.8 Bradycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.30, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8.1 Dexamethasone ‐ 4 mg IT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.14, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8.2 Dexamethasone ‐ 8 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.32, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.9 Shivering <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.41, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.9.1 Dexamethasone ‐ 4 mg IT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.26, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.9.2 Dexamethasone ‐ 8 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.42, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.10 Rescue antiemetics (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.53, 1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.10.1 Dexamethasone 8 mg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.53, 1.57]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Corticosteroids vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007579-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Antihistamines vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Nausea ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.47, 2.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 Dimenhydrinate ‐ 25 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.47, 2.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Vomiting ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 Dimenhydrinate ‐ 25 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Nausea ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.30, 0.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 Dimenhydrinate ‐ 25 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.31, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.2 Dimenhydrate ‐ 50 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>215</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.21, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.3 Dimenhydrate ‐ 100 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.05, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.4 Cyclizine ‐ 50 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.28, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Vomiting ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.29, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.1 Dimenhydrinate ‐ 25 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.01, 2.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.2 Dimenhydrate ‐ 50 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.19, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.3 Cyclizine ‐ 50 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.27, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.90, 2.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5.1 Dimenhydrinate ‐ 25 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.90, 2.40]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Antihistamines vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007579-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Anticholinergics vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Nausea ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.51, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 Glycopyrrolate ‐ 0.2 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.22, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.2 Scopolamine patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.51, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Vomiting ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.40, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 Glycopyrrolate ‐ 0.2 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.12, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.2 Scopolamine patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.36, 2.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Nausea ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Vomiting ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.41, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.1 Scopolamine patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.41, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.5 'Nausea + Vomiting' ‐ intraoperative (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.6 'Nausea + vomiting' ‐ postoperative (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>334</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.25, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6.1 Atropine ‐ 100 mcg IT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.14, 0.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6.2 Atropine ‐ 100 mcg IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.45, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6.3 Scopolamine 0.3 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.22, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.7 Blurred vision <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>407</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.21, 3.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7.1 Scopolamine patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.98 [0.37, 10.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7.2 Atropine ‐ 100 mcg intrathecal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.18, 4.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7.3 Atropine ‐ 100 mcg intravenous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.00, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.8 Anxiety/Disorientation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>407</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.35, 2.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8.1 Scopolamine patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.97 [0.12, 72.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8.2 Atropine ‐ 100 mcg intrathecal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.19, 3.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8.3 Atropine ‐ 100 mcg intravenous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.18, 4.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.9 Dizziness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.37, 2.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9.1 Scopolamine patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.39, 2.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9.2 Scopolamine 0.3 mg/5 mL IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.10 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>293</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.58, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.10.1 Glycopyrrolate ‐ 0.2 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.50, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.10.2 Atropine ‐ 100 mcg intrathecal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.07, 3.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.10.3 Atropine ‐ 100 mcg intravenous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.09, 10.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.11 Pruritus/itching <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>407</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.65, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.11.1 Scopolamine patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.66, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.11.2 Atropine ‐ 100 mcg intrathecal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.19, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.11.3 Atropine ‐ 100 mcg intravenous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.36, 2.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.12 Xerostomia/dry mouth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>334</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.53, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.12.1 Atropine ‐ 100 mcg intrathecal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.12.2 Atropine ‐ 100 mcg intravenous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.36, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.12.3 Scopolamine 0.3 mg/5 mL IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.35, 4.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.13 Drowsiness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.12, 72.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.13.1 Scopolamine 0.3 mg/5 mL IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.12, 72.31]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Anticholinergics vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007579-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Sedatives vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Nausea ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>593</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.51, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.1 Propofol ‐ 0.5 mg/kg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.19, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.2 Propofol ‐ 1.0 mg/kg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.26, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.3 Propofol ‐ 1.5 mg/kg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.09, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.4 Propofol ‐ 10 mg IV ‐ single dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.39, 3.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.5 Propofol ‐ 20 mg + 1.0 mg/kg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.47, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.6 Propofol TCI target 1 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.23, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.7 Midazolam ‐ 1.0 mg + 1.0 mg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.48, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.8 Ketamine 0.4.mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.19, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.9 Intrathecal midazolam 2 mg vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Vomiting ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>593</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.24, 0.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.1 Propofol ‐ 0.5 mg/kg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.24, 3.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.2 Propofol ‐ 1.0 mg/kg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.15, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.3 Propofol ‐ 1.5 mg/kg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.05, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.4 Propofol ‐ 10 mg IV ‐ single dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.06, 6.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.5 Propofol ‐ 20 mg + 1.0 mg/kg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.05, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.6 Propofol TCI target 1 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.10, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.7 Midazolam ‐ 1.0 mg + 1.0 mg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.01, 3.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.8 Ketamine 0.4 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.15, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.9 Intrathecal midazolam 2 mg vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Nausea ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.09, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.1 Propofol ‐ 10 mg IV ‐ single dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.38 [0.23, 24.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.2 Propofol ‐ 20 mg + 1.0 mg/kg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.06, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.3 Midazolam ‐ 1.0 mg + 1.0 mg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.08, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 Vomiting ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.03, 0.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.1 Propofol ‐ 10 mg IV ‐ single dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.02, 9.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.2 Propofol ‐ 20 mg + 1.0 mg/kg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [0.00, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.3 Midazolam ‐ 1.0 mg + 1.0 mg/hr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.02, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.5 'Nausea + vomiting' ‐ intraoperative (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.6 'Nausea + vomiting' ‐ postoperative (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.02, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.1 Propofol ‐ 0.5 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [0.01, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.2 Propofol TCI target 1 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.3 Propofol TCI target 1.5 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.04, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.4 Propofol TCI target 2 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.01, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.7 Pruritis/itching <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.02, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.1 Propofol ‐ 0.5 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.01, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.2 Propofol TCI target 1 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.01, 2.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.3 Propofol TCI target 1.5 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.01, 2.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.4 Propofol TCI target 2 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.01, 2.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.8 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.86, 1.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.8.1 Propofol TCI target 1 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.83, 2.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.8.2 Propofol TCI target 1.5 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.20, 3.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.8.3 Propofol TCI target 2 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.44, 6.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.9 Shivering <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.08, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.9.1 Propofol TCI target 1 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.06, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.9.2 Propofol TCI target 1.5 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.02, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.9.3 Propofol TCI target 2 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.04, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.10 Apgar score &lt; 7 at 5 mins <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.10.1 Propofol TCI target 1 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.11 Initiation of breastfeeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.95, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.11.1 Propofol TCI target 1 ug/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.95, 1.05]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Sedatives vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007579-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Opioid antagonist/partial agonist vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Nausea ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Vomiting ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.3 Nausea ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.39, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3.1 Nalbuphine ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.39, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.4 Vomiting ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.35, 4.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4.1 Nalbuphine ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.35, 4.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.5 'Nausea + vomiting' ‐ intraoperative (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.6 'Nausea + vomiting' ‐ postoperative (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.02, 0.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.6.1 Nalbuphine ‐ 0.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.02, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.7 Pruritus/itching <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.02, 5.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.7.1 Nalbuphine ‐ 0.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.04, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.7.2 Nalbuphine ‐ 4 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.74, 0.99]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Opioid antagonist/partial agonist vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007579-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Acupressure/acupuncture vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Nausea ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.41, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.1 Acupressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.41, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 Vomiting ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.33, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.1 Acupressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.33, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.3 Nausea ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1069</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.27, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3.1 Acupressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1069</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.27, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.4 Vomiting ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1069</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.34, 0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4.1 Acupressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1069</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.34, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.5 Anxiety <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.07, 15.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5.1 Acupressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.07, 15.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.6 Dizziness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.07, 15.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.6.1 Acupressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.07, 15.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.7 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.54, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.7.1 Acupressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.54, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.8 Pruritus/itching <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.85, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.8.1 Acupressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>395</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.85, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.9 Rescue antiemetic (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.36, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Acupressure/acupuncture vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007579-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Ginger vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Nausea ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.36, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.1 Ginger ‐ 1 g oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.68, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.2 Ginger ‐ 25 drops oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.26, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 Vomiting ‐ intraoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.38, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.1 Ginger 1 g oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.52, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.2 Ginger ‐ 25 drops oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.26, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.3 Nausea ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.22, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3.1 Ginger ‐ 25 drops oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.22, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.4 Vomiting ‐ postoperative <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.02, 1.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4.1 Ginger ‐ 25 drops oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.02, 1.65]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Ginger vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007579.pub3/references#CD007579-tbl-0018">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007579.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD007579-note-0015">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD007579-note-0024">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007579-note-0022">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007579-note-0023">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD007579-note-0021">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD007579-note-0019">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD007579-note-0020">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD007579-note-0017">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD007579-note-0018">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007579-note-0014">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD007579-note-0016">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007579\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007579\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007579\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007579\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007579\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=l7AWCCEw&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007579.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007579.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007579.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007579.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007579.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726192311"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007579.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726192314"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007579.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e8da15dd7f431',t:'MTc0MDcyNjE5Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 